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ABSTRACT
INFLUENCES OF MATERNAL OBESITY ON INDUCTION OF LABOR
REQUIRING CERVICAL RIPENING
by
JESSICA ANN ELLIS
Statement of the Problem
Although obese women are less likely to initiate spontaneous labor than normal
weight women, have longer labors, and higher rates of cesarean birth, evidence suggests
little is known about the most effective methods for labor induction requiring cervical
ripening in women with obesity. Using a population-based sample we evaluated the
relationships between maternal obesity and methods for induction of labor requiring
cervical ripening.
Methods
This retrospective cohort study used data from 41,359 women in the nationally
representative Consortium of Safe Labor (CSL) dataset, collected from 2006 to 2012.
Women with a low risk pregnancy (cephalic, singleton, and term gestation), undergoing
induction of labor were included. The primary outcome of this study was cesarean birth
after the use of cervical ripening methods. The secondary outcome was the time to birth
with the use of cervical ripening methods. Binomial regression models and a survival
analysis were adjusted for age, parity, race, insurance, and hospital type.
Results
Of the 41,359 cases included in the study, 6,035 women received one or more
cervical ripening methods for induction of labor. The odds for cesarean birth in the

v

highest obesity category (obese cat 3) were lower after using misoprostol [aOR 3.44; CI
1.95-6.07] than using other prostaglandins [aOR 7.03; CI 3.98-12.43], and lower using
mechanical means [aOR 3.69; CI 2.04-6.68} then using either prostaglandin [aOR 3.94;
CI 2.67-2.54] compared to normal weight women. The time to birth in the highest obesity
category (Obese Cat 3) had higher hazard after using other prostaglandins [aHR 1.62; CI
1.20-2.11] and lower hazard after using mechanical means [aHR .91; CI .65-1.28] when
compared to the use of misoprostol.
Conclusions
These data suggest women with obesity have more cesarean births with the use of
other prostaglandins for cervical ripening than with the use of mechanical means when
misoprostol is the comparison group. Women with obesity also require a longer time to
birth after using other prostaglandins and a shorter time to birth after using mechanical
means when compared to using misoprostol. Clinicians can better support women with
obesity requiring cervical ripening for induction of labor with careful consideration of
cervical ripening method choice and effective counseling on length of labor induction,
and risk for cesarean birth.
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CHAPTER I
INTRODUCTION
In the past three decades, the incidence of obesity in the United States (U.S.) has
tripled (Flegal, Kruszon-Moran, Carroll, Fryar, & Ogden, 2016). Current birth certificate
data in the U.S. indicates over 50% of women who gave birth had a body mass index
(BMI) that is either overweight (25.6%) or obese (24.8%) (Branum, Kirmeyer, &
Gregory, 2016). Prevalence of maternal obesity is even higher across racial and ethnic
minority groups, with nearly half of Hispanic women (45.75%) and over half of nonHispanic Black women (56.9%) being obese during childbearing years (Hales, Carroll,
Fryar, & Ogden, 2017). Intrapartum complications associated with maternal obesity
include increased rates of post-partum hemorrhage, sepsis, a prolonged hospital
admission, increased fetal birth weight, and increased risk of fetal distress (Mission,
Marshall, & Caughey, 2013).
Use of labor induction for all women in the United States has increased
significantly, rising from 9.9% in 1990 to 23.1% in 2008, and remains at this level today
(Martin et al., 2007; Osterman & Martin, 2014) Among women with obesity, use of labor
induction is much more common with rates over 30% (Wolfe et al., 2011). Not only are
women with obesity more likely to undergo induction of labor, often the induction
process is unsuccessful leading to an increased rates of cesarean births (Kabiru & Denise
Raynor, 2004).
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Among all types of labor onset (spontaneous and induced) an increased rate of
cesarean births are seen with each stepwise increase in BMI category (Berendzen &
Howard, 2013). A similar relationship between BMI and cesarean birth has been
observed among women with induced labors (Zhao, Zhang, & Zhou, 2017). Slow labor
progression, known as labor dystocia, can lead to the use of cesarean birth among women
with obesity (Neal, Lowe, et al., 2015; Neal, Ryan, et al., 2015; Wu, Chen, & Chien,
2013). In addition, women with obesity are less likely to initiate spontaneous labor than
normal weight women (Bogaerts, Witters, Van den Bergh, Jans, & Devlieger, 2013;
Stirrat et al., 2014). Some postulate that these obesity-associated changes in labor onset
and progression are caused by hormone signaling that is altered in women with a high
BMI (Bogaerts et al., 2013; Carlson, Hernandez, & Hurt, 2015). With increased obesity
rates among women it is important for researchers and clinicians to understand the best
method for induction of labor to optimize maternal and fetal processes and outcomes in
this population.
To explore this problem, we plan to examine outcomes associated with different
labor induction methods among women stratified by their BMI category. To ensure
sufficient sample size in each BMI category, we will conduct this analysis using a large,
multi-site, dataset. Specifically, we plan to compare outcomes in women undergoing
induction of labor using prostaglandins vs. mechanical devices. Our proposed model is
supported by early evidence that mechanical devices work better in women with obesity
than prostaglandins for induction of labor (Suidan, Rondon, Apuzzio, & Williams, 2015).
Our improved understanding of the process and outcomes of induction methods will
allow for better care of childbearing women, with a goal of reducing primary cesarean
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sections due to a failed induction of labor.
Body Mass Index
Body mass index (BMI) is a value derived from the mass and height of an
individual (Institute of Medicine, 2009; World Health Organization, n.d.). This score is
an attempt to quantify the amount of tissue mass, fat and bone density of an individual.
BMI is calculated by dividing a person’s weight in kilograms by the square of the height
in meters. BMI is commonly interpreted in categories from underweight to obese (See
Figure 1). This study will use the following standard weight status categories (Institute of
Medicine, 2009).
Categories

BMI (kg/m2)

Underweight

 18.5

Normal Weight

18.5 - 24.9

Overweight

25 - 29.9

Obesity (Class 1) 30 - 34.9
Obesity (Class 2) 35 - 39.9
Obesity (Class 3)  40
Figure 1. Body Mass Index Categories
Labor Induction
Induction of labor has been defined by World Health Organization (WHO) as “the
process of artificially stimulating the uterus to start labor” (WHO, 2011, p. 6). The goal
of labor induction is to stimulate uterine contractions that will eventually result in a
vaginal birth (ACOG, 2009). The following section explores the interplay of cervical
readiness and parity, the number of times a woman has given birth, on induction of labor.

4
Both cervical readiness and parity impact induction of labor (Melamed, Ben-Haroush,
Kremer, Hod, & Yogev, 2010). Additionally, the indications, contraindications, risks and
benefits of induction of labor are outlined.
Cervical Assessment
Cervical readiness is an important component in labor induction. To prepare for
birth the cervix, which is the lower segment of the uterus that sits at the top of the vagina,
begins to soften (ripen), thin out (efface), and open (dilate). The cervical remodeling
process begins weeks before labor starts (ACOG, 2009). When a woman’s cervix is ready
for induction it is said to be ripe. Cervical ripening as defined by the American Congress
of Obstetricians and Gynecologists (ACOG) as the process where the cervix softens and
thins out in preparation for labor; medications or devices maybe used to help facilitate
this process (ACOG, 2009). A recent randomized trial of nulliparous women, compared
women being induced to women with expectant management, finding 63.5% of the
women randomized to the induction of labor group required cervical ripening (W.
Grobman, 2018).
Bishop score. Developed in 1964, the Bishop score is a cervical scoring system
which is commonly used for assessing cervical readiness for labor (Bishop, 1964;
Penfield & Wing, 2017). This score accounts for the position, consistency, effacement,
and dilation of the cervix, as well as the fetal station (location) of the presenting fetal part
relative to the ischial spines (see Figure 2). A modified Bishop score has been developed
which replaces effacement with cervical length. Scoring for these systems includes
assigning a numeric score of 0-3 to each category, which is summed for a possible
maximum score of 13. A modified Bishop score of less than 6 generally means the cervix
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would benefit from cervical ripening (Penfield & Wing, 2017). In other research a Bishop
score of less than 5 was used as a cut off point for cervical ripening (W. Grobman, 2018;
Lassiter et al., 2016) and a Bishop score 5 or greater in nulliparous women was found to
be predictive of successful induction of labor at term (Zelig, Nichols, Dolinsky, Hecht, &
Napolitano, 2013).
Factor

0

Dilation
(cm)
closed

Effacement
(%)
0-30

1

1-2

2
3

Score

-3

Cervical
consistency
Firm

Position of
the cervix
Posterior

40-50

-2

Medium

Central

3-4

60-70

-1, 0

Soft

Anterior

5-6

80

+ 1, +2

-

-

Station *

Figure 2. Modified Bishop Scoring System *Station reflects a -3 to +3 scale. Modified
from Bishop, 1964
Assessing the Influence of Parity
Parity is the number of times a woman has given birth (Medical Dictionary Farlex
and Partners, 2009). A nulliparous woman has never given birth, whereas a multiparous
woman has given birth more than one time to a fetus over 20 weeks’ gestation (Levine,
Hirshberg, & Srinivas, 2014). Understanding the influences of parity on the likelihood of
cesarean birth is important when inducing an individual. In a woman who is nulliparous,
it is unknown if the pelvis can adequately accommodate the passage of the fetus or if the
uterus will contract with sufficient strength to achieve vaginal birth. In a recent study on
term labor induction and risk of cesarean (n = 863) researchers found that of women
requiring induction of labor, nulliparous women were more likely to have a cesarean birth
than multiparous women (27% vs 13%) (Levine et al., 2014).
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Indications and Contraindications
Labor induction among all women most commonly occurs for indicated or
medical reasons. Women with obesity have higher rates of medical complications in
pregnancy making them more likely to require induction of labor than normal weight
women. A medical induction is indicated when the health of the mother or the fetus is at
risk. Reasons for medical induction include maternal medical conditions (e.g,. gestational
diabetes, renal disease, chronic pulmonary disease) gestational or chronic hypertension,
preeclampsia, eclampsia, pre-labor rupture of membranes, chorio-amnionitis, a post term
pregnancy, fetal demise, fetal compromise (i.e. severe fetal growth restriction, isoimmunization, oligohydramnios) and fetal macrosomia (ACOG, 2009; WHO, 2011).
Elective inductions occur in special situations when a person is induced for non-medical
reasons such as living far from the hospital. According to professional guidelines
published by ACOG, elective inductions are not to be performed prior to 39 weeks of
pregnancy (ACOG, 2009).
Contraindications to labor induction include all contraindications to a vaginal
birth (ACOG, 2009). Some contraindications are absolute such as transverse fetal lie or a
severe degree of placenta previa, where the placenta is completely covering the cervix
(ACOG, 2009). Other contraindications are relative, including active genital herpes
(HSV) infection, untreated human immunodeficiency virus (HIV) infection, a high
floating fetal head, or a previous myomectomy entering the uterine cavity (ACOG, 2009).
Benefits and Risks
When the benefits of expeditious delivery outweigh the risks of remaining
pregnant, inducing labor can be justified as a therapeutic intervention. When used
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appropriately, induction of labor can improve health of mothers and babies. Risks
associated with induction of labor have been reported as uterine hyperstimulation and
uterine rupture, increased risk of cesarean birth, fetal distress, fetal death, and increased
risk of infection for the mother and fetus (ACOG, 2009). Uterine hyper-stimulation, also
known as uterine tachysytole, can cause changes in the fetal heart rate, including variable
decelerations. The following definition for uterine tachysytole is given by the Association
of Women’s Health, Obstetric and Neonatal Nurses (AWOHNN) (Kunz, Loftus, &
Nichols, 2013):
1. “More than five contractions in 10 minutes averaged over a 30-minute window;
2. A series of single contractions lasting 2 minutes or more;
3. Contractions of normal duration occurring within one minute of each other”
(ACOG, 2003, p. 1446; Simpson & Creehan, 2008, p. 397).
4. “Insufficient return of uterine resting tone between contractions via palpation or
intra-amniotic pressure above 25 mm Hg between contractions via intrauterine
pressure catheter [IUPC]” (Simpson & Creehan, 2008, p. 397).
Expectant Management
Currently research regarding induction of labor compares women undergoing
induction of labor to similar women with expectant management. Expectant management
is a medical management strategy where a person’s condition is closely monitored, but
treatment is not given unless the condition changes or symptoms appear (Medical
Dictionary, 2009 Farlex and Partners). For example, a woman either receives an
induction of labor or a woman is closely monitored for changing health conditions and/or
early labor symptoms before receiving any medical interventions. This is a newer way of
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thinking about induction of labor, as much of the previous research was based on
induction of labor outcomes being compared to spontaneous labor outcomes. We must
now compare the risks of inducing labor to the risks of remaining pregnant.
Labor Induction Methods
This section will outline and define different methods of labor induction (ACOG,
2009; Mozurkewich et al., 2011; WHO, 2011). Prostaglandins and mechanical devices
are used for induction of labor when women need cervical ripening. Oxytocin Other
methods used for labor induction of labor fall into two broad categories: those used in the
hospital for a medical induction of labor (oxytocin and AROM) and methods that are
often used informally to induce labor outside of the hospital setting, (stripping
membranes, nipple stimulation, sexual intercourse, castor oil, and acupuncture), these
methods will be referred to as non-medical methods for inducing labor.
Prostaglandins
Endogenous prostaglandins are chemicals that are made by the body that have
many effects, including causing the cervix to ripen and the uterine muscles to contract.
Synthetic prostaglandins are drugs that are given to ripen the cervix and induce labor.
Synthetic prostaglandins mimic compounds found naturally in the body. Prostaglandins
can be administered by many routes including buccal, oral, vaginal or rectal routes
(ACOG, 2009). When compared to placebo, prostaglandins increase the likelihood the
birth will occur within 24 hours, but also increase the risk of uterine tachysystole.
There are two main types of prostaglandins used for induction of labor
misoprostol and dinoprostone. Misoprostol is a synthetic prostaglandin analogue E1
(PGE1) that can be used for both cervical ripening and induction of labor. The
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medication was originally approved by the Food and Drug Administration (FDA) for the
treatment of peptic ulcers. In 2002, the FDA added a labeled use for labor induction and
cervical ripening, but misoprostol is not FDA approved for labor induction (U.S. Food
and Drug Administration- Misoprostol, n.d.). Common PGE1 dosing for induction of
labor is 25-50 micrograms (mcg) administered either vaginally or sublingually.
Dinoprostone, a prostaglandin analogue E2 (PGE2) is also commonly used for induction
of labor. Currently, there are two PGE2 preparations that are commercially available for
use in the United States (ACOG, 2009). One is a vaginal gel and the other is a vaginal
insert. Both are used for cervical ripening in women who are at or near-term gestation.
Mechanical Devices
Mechanical devices for cervical ripening exert a local pressure that stimulates the
release of prostaglandins (Tenore, 2003). Mechanical methods include the use of Foley
catheters, double balloon devices, extra amniotic saline infusion, and occasionally
hydroscopic dilators, laminaria or dilapan (Mozurkewich et al., 2011). Mechanical
devices are most commonly used in inpatient settings but are being investigated for use in
outpatient settings, outside of the hospital (Policiano, Pimenta, Martins, & Clode, 2017).
Mechanical devices mechanically dilate the cervix. A transcervical catheter has a small
tube with a balloon at the end, the tube is inserted in the opening of the cervix and the
balloon places mechanical pressure directly on the cervix as the balloon is inflated with
saline (ACOG, 2009; Tenore, 2003). Several types of transcervial catheters are used
including single balloon catheters such as the Foley Bulb catheter and double balloon
catheters such as the Cook’s Catheter (Mozurkewich et al., 2011). Often the Foley is
tethered or taped to the leg, creating additional pressure (Tenore, 2003). Hydroscopic
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dilators are placed in the cervical opening, then absorb both endocervical and local tissue
fluids causing expansion, providing a controlled mechanical pressure on the cervix
(Tenore, 2003). Side effects are bleeding, membrane rupture, and placental disruption. A
recent retrospective study of nulliparous women using hydroscopic dilators verses
balloon catheters found the vaginal birth rate with hydroscopic dilators was equivalent to
using a balloon catheter and safe when comparing maternal and fetal outcomes (Ryosuke
Shindo, 2017).
Oxytocin and Amniotomy
Oxytocin, a hormone that causes contractions of the uterus, was first isolated in
1948 for synthetic production (ACOG, 2009). Synthetic oxytocin is commonly used to
both initiate (induce) or augment (speed up) labor, and is used postpartum to prevent
hemorrhage (den Hertog, de Groot, & van Dongen, 2001). Today, oxytocin is one of the
most widely used drugs in the United States, approximately 50% of women reported
oxytocin use during their labor (Declercq, Sakala, Corry, Applebaum, & Herrlich, 2014).
Amniotomy, also known as artificial rupture of membranes (AROM), is a procedure
where the amniotic sac is deliberately ruptured to induce or accelerate labor (Busowski &
Parsons, 1995). The procedure has been used for the past two centuries with varying
popularity. If used alone for labor induction, AROM may result in unpredictable intervals
to the onset of labor (Bricker & Luckas, 2000). AROM is most effective for labor
induction when used in combination with oxytocin once the cervix is favorable (Penfield
& Wing, 2017).
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Other Common Methods
There are many other methods recognized for their ability to induce labor in
women who require cervical ripening. Five additional methods are detailed here
including stripping membranes, breast or nipple stimulation, sexual intercourse, castor oil
and acupuncture.
Stripping or sweeping membranes to induce labor is a practice that dates back to
antiquity (Heilman & Sushereba, 2015). In modern times, membrane sweeping is
accomplished with sweeps, from a gloved hand, over the membranes that connect the
amniotic sac to the wall of the uterus. This action causes the body to release
prostaglandins which soften and ripen the cervix. Membrane sweeping is commonly used
to avoid a formal induction of labor (WHO and HRP, 2015).
Breast or nipple stimulation has been used as a natural and inexpensive means of
labor induction. Nipple stimulation releases endogenous oxytocin. Nipple stimulation is
achieved by either manual stimulation of the nipple or use of a breast pump.
Sexual intercourse is also thought to stimulate labor through three different
mechanisms 1) physical stimulation of the lower uterine segment 2) endogenous release
of oxytocin from orgasm or 3) direct action of prostaglandins found in semen
(Kavanagh, Kelly, & Thomas, 2001).
Castor oil (Ricinus communis) is classified by the FDA as a laxative, it also
seems effective at labor induction. Researchers are finding that castor oil increases
cervical ripening and enhanced uterine contractions (Knoche, Selzer, & Smolley, 2008).
The mechanism of action seems to be the activation of a metabolite, ricinoleic acid,
which acts on prostaglandin EP3 receptors in the smooth muscles of the uterus and
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intestines (DeMaria et al., 2017; Tunaru, Althoff, Nusing, Diener, & Offermanns, 2012).
Acupuncture is a form of Chinese medicine where thin needles are inserted into
the body. Overall acupuncture showed some benefit in improving cervical status for
induction of labor, but no clear benefit on reduction of cesarean birth (Smith, Armour, &
Dahlen, 2017). However, more research is needed on the use of acupuncture for labor
induction, including well designed trials.
While there are many different methods available for inducing labor that also
requires cervical ripening. The reminder of the dissertation will focus on prostaglandins
(misoprostol and dinoprostone), mechanical methods. These methods are used for
cervical ripening and are present in contemporary medical records. Oxytocin and
amiotomy will as be explored as they are also commonly used methods for medical
induction of labor. Clinicians should consider each method, weighing availability and
feasibility for use. Each induction should start with a thorough patient assessment, prior
to choosing the appropriate agent to induce labor as the outcome of induction of labor
may be affected by method choice. Clinicians must make informed decisions when
choosing the best method for induction of labor, as there are many factors affecting labor
induction that must be considered.
Outcomes of Induction of Labor
This section focuses on outcomes of induction labor, namely unsuccessful
induction, also known as a failed induction and cesarean birth. An induction of labor may
be declared a failed induction once set time parameters have been exceeded. Other
outcomes include the success or failure of cervical ripening and the time to birth, which is
often defined as the time from hospital admission to the time of birth.
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Failed Induction
Sometimes labor induction does not work and the induction is declared a ‘failed’
induction of labor. While the definition for failed labor induction of labor continues to
evolve, current thoughts are that a failed induction occurs when a woman remains in the
latent phase of labor for an extended period of time, such as 12 hours or more after being
induced (Spong, Berghella, Wenstrom, Mercer, & Saade, 2012). The definition of a failed
induction should also account for cervical dilation with the timeframe starting at the
initiation of oxytocin and AROM. For example, if cervical dilation of 4 cm and 90%
effacement, or 5 cm of dilation regardless of effacement is not achieved within 12 hours
of time and the woman is still in the latent phase of labor after induction, a failed
induction of labor is diagnosed (Rouse, Owen, & Hauth, 2000). Recently, the timeframe
for latent phase during induction was suggested to be increased to 15 hours based on
findings that a longer duration did not cause additional maternal or fetal distress (W. A.
Grobman et al., 2018). The decision to continue labor beyond this should be
individualized. A failed induction can lead to use of a different method or to cesarean
birth.
Cesarean Birth
Cesarean birth is the delivery of the infant through incisions in the abdominal wall
and uterus (ACOG - Cesarean birth, 2015). The international healthcare community
estimates that an ideal cesarean section rate is 10-15% (Betran et al., 2015; WHO and
HRP, 2015). This rate is suggested as optimal for achieving the best health outcomes for
mothers and neonates, accounting for medically necessary cesarean births. The U.S.
cesarean birth rate is 30%-32% (Martin, Hamilton, & Osterman, 2016) which is double
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the suggested medically necessary rate (WHO, 2015). While cesarean births are
becoming increasingly common in developed and developing countries, the overall health
of women and infants does not seem to increase with a cesarean birth rate greater than
15% (Betran et al., 2015). Cesarean births are associated with short and long-term risks
that may extend many years beyond the surgery and pose risks to the mother, her children
and to future pregnancies (Catalano & Shankar, 2017; Keag, Norman, & Stock, 2018).
Women with obesity have a higher risk for poor maternal and neonatal outcomes
following cesarean birth than women at normal weight (Mission et al., 2013).
Purpose of Study
The purpose of the proposed study is to examine the choice, and effectiveness of
methods used for induction of labor in women with obesity. With several recent metaanalyses and clinical trials reporting decreased risk of cesarean birth among induced
women compared to those managed expectantly, rates of labor induction are likely to rise
in the future due to changes in clinical practice (Gibbs Pickens et al., 2018; Gibson,
Waters, & Bailit, 2016; Lee et al., 2016). However, the labor induction methods that are
most effective and safe for obese women are not currently known (Carlson et al., 2015).
Until clinicians have better information on how to optimally implement labor induction in
women with obesity, this vulnerable population could see continued increases in the rate
of cesarean birth due to failed labor induction.
Significance of the Study for Nursing
This study is significant to nursing in several ways. The study focuses on
precision healthcare for a select group of individuals. The results of the study will add to
the existing body of knowledge regarding individualized care for women with obesity. In
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addition, this study will hopefully create new knowledge that can help nurses and other
healthcare providers understand the use and limitations of induction methods/medications
for optimal health outcomes.
This study also is significant to the field of advanced-practice nursing, as
Certified Nurse Midwives manage the labors and inductions of many women with
obesity. Increased understanding of induction of the labor is needed to guide their
practice, including normal variations in the induction processes, the actions of cervical
ripening and how each of these things differs among women with obesity.
This study has the potential to influence the practice of hospital nurses, hospital
staffing, and allocation of health care resources. By increasing the knowledge base
regarding effectiveness of labor induction interventions, this study could potentially assist
hospital nurses to decrease length of hospital stay for women with obesity who are
induced. This change would impact staffing of nurses on Labor and Delivery units across
the United States (CMQCC, 2018).
Research Aims
Aim 1. Interventions: Compare the effectiveness of labor induction methods (PGE1,
PGE2, and Mechanical methods) in women undergoing labor induction requiring cervical
ripening by BMI category.


Hypothesis 1: the odds of requiring intervention to initiate labor will be higher in
obese women by BMI category when compared with normal weight women.

Aim 2. Time to birth: Compare the effectiveness of labor induction methods
(misoprostol, dinoprostone and mechanical methods) by the time to birth with results
stratified by BMI category.
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Hypothesis 1: Women induced using misoprostol for cervical ripening will have a
shorter time to birth as compared to women induced using dinoprostone, and this
time differential will be more pronounced with each successive BMI category.



Hypothesis 2: The time to birth will be shorter with mechanical methods than the
use of either prostaglandin (PGE1 or PGE2).

Aim 3: Cesarean birth: Examine the risk of cesarean birth after labor induction among
women by BMI category.


Hypothesis 1: Compared to women with normal range body mass index, the odds
of cesarean birth following labor induction will be higher with each increase in
body mass index category.



Hypothesis 2: The odds of cesarean birth in women induced with misoprostol will
be lower compared to the odds in similar women induced using dinoprostone.



Hypothesis 3: Women with obesity (in any obesity category) who are induced
using mechanical means will have lower odds of cesarean birth than women with
obesity (in any obesity category) induced with prostaglandins (misoprostol or
dinoprostone).
Assumptions



The data in the electronic record are accurately recorded



A rate of 10%-15% adequately represents medically necessary cesarean deliveries
in the U.S. population
Conceptual Framework
The Quality Health Outcomes Model (QHOM) will guide the selection and analysis

of the variables for the proposed study (Mitchell, Ferketich, & Jennings, 1998; Mitchell
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& Lang, 2004). The QHOM has been used to guide the development of outcomes-based
databases, interventions, and research (Mitchell et al., 1998). Two functions of the model
are to (1) identify variables in clinical research, and (2) provide a framework for
outcomes research and management that compares treatment options as well as
organizational or systems-level interventions. The QHOM has been used to measure
outcomes in a variety of patient settings including skilled nursing facilities, ambulatory
care settings, surgical units, and for inpatient hospitalization (Altares Sarik & KutneyLee, 2016; Cohen, Dick, & Stone, 2016; Gerolamo, 2004, 2006).
In previous obstetrics research the QHOM was used to examine the relationships
between labor induction and cesarean birth (Mayberry & Gennaro, 2001; Wilson, Effken,
& Butler, 2010). In a secondary analysis (n = 62,816) the model was used to determine
what variation in cesarean birth rates was due to differences in hospitals, providers, and
patients (Wilson et al., 2010). Wilson et al. (2010) found the occurrence of cesarean birth
in nulliparous women was related to maternal age, race, education level, the number of
prenatal visits, and place of childbirth. Cesarean birth and epidural analgesia, were
associated with significant differences in quality health outcomes for women (Mayberry
& Gennaro, 2001). Thus, the QHOM is appropriate as a framework to examine the
clinical interventions of labor induction processes and outcomes in search of better
clinical outcomes for women undergoing induction of labor.
Concepts in the Quality Health Outcomes Model
The QHOM illustrates integration and interaction of four concepts; system
characteristics, individual characteristics, interventions, and outcomes (Mitchell et al.,
1998). The relationships in the model are circular in nature. With both system
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characteristics and individual characteristics acting on the interventions and outcomes in
the model. The original model has equal input from both system and individual
characteristics as demonstrated with a bidirectional arrow between the two influences, as
well as curved arrows towards the interventions and outcomes.
In the proposed study, the adapted QHOM provides guidance in the selection of
variables that may influence the type of birth. The systems characteristics, (hospital size,
location and type and provider type), individual characteristics (BMI, age, parity, and
cervical status), interventions (the method used for cervical ripening or labor induction)
and the outcomes (type of birth) and secondary outcomes (success or failure of the
cervical ripening method and the time to birth) as well as maternal and neonatal adverse
events (See Figure 2).
System characteristics. The system characteristics as defined by the original
theorists are traditional structure and process elements (Mitchell et al., 1998). System
characteristics are the characteristics of a structured system, such as a hospital system, or
provider network. The hospital size, location, ownership, individual demographics,
provider training and skill mix, and technology are among many of the structural
elements included in the system characteristics. The system characteristics included in
the adapted model for this study are the hospital type, and size.
Individual characteristics. Outcomes in the model may be affected by the
characteristics of the individuals who are receiving the interventions (Mitchell et al.,
1998). Outcomes research has raised awareness on the important need to adjust
interventions based on individual characteristics, such as general health, demographics,
and disease risk factors.
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In the proposed study, individual characteristics will be conceptualized as
maternal characteristics before cervical ripening. Maternal characteristics of interest
include body mass index (BMI), age, parity, and cervical status on admission. The
proposed study will examine women undergoing induction of labor who have carried the
pregnancy to term (gestational age greater than 37 weeks), have a cephalic presentation
(head first presentation), and a singleton pregnancy (one fetus).
Interventions. Clinical interventions are the actions that are altered with the
intent of changing other constructs in the model (Mitchell et al., 1998). Interventions are
directly or indirectly influenced by system and individual characteristics. The
intervention of interest is induction of labor using either prostaglandins, or mechanical
means for cervical ripening.
Outcomes. Outcomes of treatment interventions from general research have been
widely based on the Five D’s: death, disability, dissatisfaction, disease, and discomfort
before use of this model (Mitchell et al., 1998). The QHOM allows for measurement and
analysis of outcomes related to increased health status, increased functionality, and an
increase in the quality of life. The primary outcomes of interest are the success or failure
of labor induction, which will be measured by the time to birth and type of birth.
Secondary outcomes in the model are the maternal and neonatal adverse events as
complications associated with maternal obesity included post-partum hemorrhage, sepsis,
prolonged hospital admission, increased fetal birth weight and fetal distress (Mission et
al., 2013).
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Figure 3. Quality Health Outcomes Model

CHAPTER II
LITERATURE REVIEW
This chapter provides an overview of the current literature on induction of labor
in women with obesity. The chapter will first describe current thoughts, theories and
evidence of the physiology of cervical ripening and labor initiation, and the differences in
cervical ripening and labor initiation for women with obesity. Then, the remainder of the
chapter is guided by the QHOM, the conceptual framework of this dissertation. Literature
will be reviewed related to each of the four concepts in the model; system characteristics,
individual characteristics, interventions and outcomes.
Brief Review of the Physiology of Labor Initiation
This section describes current theories on normal physiology of cervical ripening
and labor initiation in women with a normal weight, as well as proposed theories
regarding the pathophysiology of cervical ripening and labor initiation in women with
obesity. Some current literature is included to support biological based theories on the
physiology and pathophysiology of cervical ripening and labor initiation. This section
adds insight on the reasons labor is induced more frequently in women with obesity.
Physiology of Cervical Remodeling
Towards the end of pregnancy, the cervix begins to soften in preparation for birth.
This softening is due to cervical remodeling at the cellular level. According to Yellon
(2017), cervical remodeling occurs in three phases (Yellon, 2017). Phase 1- softening of
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the cervix, due to the breakdown of collagen and extracellular remodeling. Phase 2cervical ripening, there is a continued breakdown of the collagen structure resulting in
further ripening. Structures that were previously present such glands and smooth muscle
tissue are broken down during this period of tissue remodeling. Phase 3- cervical dilation,
when the cervix effaces into the uterus allowing labor to result in birth.
Biochemical changes occur during the process of cervical remodeling. In general,
the cervical remodeling process is much like the inflammatory process (Yellon, 2017).
There is an increased presence of immune cells and macrophages in the lower uterine
segment. During the transition from Phase 1 to Phase 2 going from a soft to a ripe cervix,
there is a noted increase in vascular permeability and elevated concentrations of proinflammatory mediators. Also, there is significant degradation of extracellular linked
collagen. Additionally, increased numbers of macrophages are noted. Therefore,
macrophages may play a significant role in cervical remodeling. The presence of
macrophages in other tissues has been known to restructure the extracellular matrix
(Yellon, 2017).
Physiologic Differences in Women with Obesity
Women with obesity have difficulty initiating labor at term when compared to
normal weight women (Harper et al., 2012; Hermesch, Allshouse, & Heyborne, 2016;
Stirrat et al., 2014). These changes in labor initiation are thought to be caused by
endocrine and inflammatory alterations present in women with obesity (Carlson,
Hernandez, & Hurt, 2015). The following pathophysiologic conditions are associated
with obesity; increased blood cholesterol levels, increased leptin levels, which seem to
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disrupt normal labor progression (Bogaerts, Witters, Van den Bergh, Jans, & Devlieger,
2013; Hajagos-Tóth, 2017; Wendremaire et al., 2013).
First, increased blood cholesterol levels lead to changes in cell membrane
permeability ultimately decreasing myometrial (uterine) activity (Hajagos-Tóth, 2017).
Cellular level changes associated with obesity seem to promote cervical collagen
synthesis in late gestation delaying the onset of labor. Increased leptin levels are noted,
which appear to increase placental PGE2 release leading to inflammation (Wendremaire
et al., 2013). Additionally, maternal obesity is associated with increased circulating leptin
levels, which may affect the cellular remodeling of the myometrial extracellular matrix
that occurs before the onset of labor (Wendremaire et al., 2013). The changes noted in the
remodeling of the cervical collagen matrix may play a role in the increased need for
cervical ripening in women with obesity (Wendremaire et al., 2013).
The Quality Health Outcomes Model
The Quality Health Outcomes Model as the conceptual framework for the study
will now be discussed. The model is made up of four components 1) system
characteristics, 2) individual characteristics, 3) interventions and 4) outcomes. The
system characteristics and the individual characteristics collectively influence the
intervention and the outcomes within the model. The literature review will present
relevant studies to support the chosen variables that make up the individual
characteristics (age, parity, cervical status and BMI) and the system characteristics
(hospital size, type, and location). Literature will also be presented related to induction of
labor in women with obesity, interventions or methods such as prostaglandins,
mechanical devices, and other methods. The outcomes are time to birth and cesarean
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birth. All literature has been retrieved by online proxy using either the Georgia State
University or the Emory University online library.
System Characteristics
System characteristics are the influences that system-level factors have on
interventions and outcomes. Current literature suggests that hospital type, size, and
geographic location influence the labor induction methods, time to birth, and cesarean
birth rates among all women.
Hospital Type, Size, and Geographic Location
The location and type of hospital are system variables that may affect both the
intervention and the outcomes within the health quality outcomes model. Literature
related to system characteristics and the methods for induction, and time to birth is
lacking so cesarean birth rates will be explored in this section.
Location of a hospital in a rural or urban setting has been shown to impact
cesarean birth rates among all women. Smaller community hospitals in rural locations
tend to have a higher variation in the cesarean birth rate than larger hospitals
(Kozhimannil, Law, & Virnig, 2013). Rural and urban differences in care may be
explained by the demographics of the populations, health disparities, and access to care
(ACOG, 2014; Kent, McClure, Zaitchik, & Gohlke, 2013; Kozhimannil, Casey, Hung,
Prasad, & Moscovice, 2016). Rural minority populations are also more likely to be obese
and less likely to have access to high-level care. Additionally, teaching hospitals show
less variability in cesarean birth rates than other types of a hospital such as community
hospitals (Kozhimannil et al., 2013)
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The type and location of the hospital have been shown to affect labor induction
for all women by way of the relationship between induction and cesarean birth rates
(Kozhimannil et al., 2013; Wilson, Effken, & Butler, 2010). Hospital cesarean birth rates
have been shown to vary widely in nationwide data from 593 U.S. hospitals
(Kozhimannil et al., 2013). The cesarean birth rates reportedly varied ten-fold across
hospitals, ranging from 7.1 percent to 69.9 percent. The cesarean birth rates for low-risk
women varied fifteen-fold between hospitals, ranging from 2.4 percent to 36.5 percent
(Kozhimannil et al., 2013). By including only low-risk women and effectively controlling
for high-risk complications, one would expect to see less variation in the cesarean birth
rate among low-risk women. However, this was not the case, which indicates other
factors also affect cesarean birth rates. For example, hospitals may have varied practice
patterns among providers.
Primary cesarean births are a contributing factor to the increase in the overall
cesarean birth rate seen over the past two decades (Caughey, 2015). Primary cesarean
birth is defined as a cesarean birth that is performed when a woman, who has not
previously had a vaginal birth, has a cesarean section with a singleton fetus, a cephalic
presentation, and term gestation. Primary cesareans rates have been shown to vary threefold across hospitals in the U.S. and cannot always be attributed to patient mix or patient
caseload (Sebastiao et al., 2016). In a retrospective cohort study (n= 412,192), Sebastiao
(2016) examined individual and hospital level factors that contributed to the primary
cesarean rate in Florida (Sebastiao et al., 2016). The overall primary cesarean rate among
nulliparous, low-risk women in this sample was 23 percent, with hospital-specific
estimates that ranged from 12.8 percent to 47.3 percent depending on hospital location.
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Hospital geographic location was found to contribute to hospital variation in the primary
cesarean birth rate among low-risk women in Florida (Sebastiao et al., 2016).
Literature describing the influences of system characteristics for women with
obesity being induced was non-existent related to the methods of inducing labor, and the
time to birth. System characteristics have been shown to influence the primary outcome
of cesarean birth, which varied widely in both national data and statewide data from
Florida. Cesarean birth among all women was influenced by system level characteristics.
While the system level factors influencing maternal obesity among women undergoing
induction of labor seem to affect the outcomes, other factors such as individual factors
also play a role.
Individual Characteristics
Individual characteristics of women have been shown to affect labor induction
methods and outcomes. A woman’s age, parity, cervical status, and BMI will be explored
in this section. These characteristics have been shown to be independent factors affecting
the success of labor induction with cervical ripening among women (Frederiks, 2012).
Maternal Age
Maternal age is an individual characteristic that is associated with higher rates of
birth complications and a higher rate of cesarean birth. A nationally representative cohort
(n = 4,109,297) was examined for associations between maternal age and labor and birth
complications (Cavazos-Rehg et al., 2015). The study found higher odds of having
complications with childbearing at the extremes of the childbearing age range. Maternal
age was found to be an independent risk factor for having a failed induction of labor
among nulliparous women (Frederiks, 2012). A study (n = 537), examining the
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influences of maternal age compared elderly nulliparous women, over the age of 35 to
non-elderly nulliparous women (Hadar et al., 2017) found that elderly nulliparous women
had a higher rate of cesarean birth (36.2% versus 21.4%, p = 0.009). This difference was
not significant after adjustment for maternal BMI, indication for birth, birth weight and
gestational age at birth (Hadar et al., 2017).
Parity
A woman’s parity or the number of previous births over 20 weeks' gestation plays
a significant role in both cervical ripening success, and the need for emergent cesarean
birth after induction of labor (Gauthier et al., 2012; Isono et al., 2011). Gauthier 2012
(n = 285), found that lower parity was significantly and independently associated with
prostaglandin ripening failure [parity < 2 births (OR, 2.50; CI, 1.20–5.26], meaning
higher parity is associated with cervical ripening success. In a different study, the need
for emergent cesarean birth after induction of labor (n = 1,029) found multiparous
women had a significantly lower cesarean birth rate as compared to nulliparous women
(2% vs. 17.6%) (Isono et al., 2011). Additionally, there is evidence that regardless of a
woman's parity, the rate for primary cesarean has been shown to increase with increasing
BMI (Kunzier, Park, Cioffi, Calixte, & Vintzileos, 2016; Vahratian, Siega-Riz, Savitz, &
Zhang, 2005).
Cervical Status
A woman’s cervical status measured by Bishop score or cervical dilation before
induction of labor impacts both the choice of cervical ripening method and the associated
outcomes (Gauthier et al., 2012). Gauthier (2012) reported that a lower Bishop score was
significantly and independently associated with prostaglandin ripening failure (Bishop
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score less than 3 (OR, 2.62; CI, 1.45 – 4.72) compared to Bishop score greater than 3).
Additionally, the absence of cervical dilation was found to be an independent risk factor
for failed induction of labor among nulliparous women (Frederiks, 2012).
Body Mass Index
BMI is an important predictor of the need for induction of labor as well as
induction of labor success. This section will focus inconsistencies in the classification of
body mass index used in different studies. The BMI categories differed between studies,
and the timing of BMI collection occurs at different intervals.
Body Mass Index Classification. This section will discuss how BMI has been
categorized. Most commonly, studies used the World Health Organizations (WHO) BMI
classification categories, which consist of the categories of underweight (BMI < 18.5
kg/m2), normal weight (BMI 18.5 - 24.99 kg/m2), overweight (BMI 25 - 29.99 kg/m2),
and obese (BMI > 30 kg/m2) (World Health Organization, n.d.). Within the obese
category, there are three BMI categories, Obese Class I (BMI 30 - 34.99 kg/m2), Obese
Class II (BMI 35 - 39.99 kg/m2), and Obese Class III (BMI > 40 kg/m2) (World Health
Organization, n.d.).
BMI categories are not always used consistently. Most commonly, women with a
BMI over 30 kg/m2 were considered obese. One study used a BMI over 29 kg/m2 as the
cut off for women with obesity (Vahratian, Zhang, Troendle, Savitz, & Siega-Riz, 2004);
whereas in another study, women with a BMI of less than 28 kg/m2 were considered lean
(Hill, Reed, & Cohen, 2015). Often times, studies lacked the sample size needed for
analysis, so the BMI categories were collapsed into fewer categories for analysis, most
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commonly lean and obese (Anabusi, Mei-Dan, Hallak, & Walfisch, 2016; Lassiter et al.,
2016; Melamed, Ben-Haroush, Kremer, Hod, & Yogev, 2010).
The timing of measurement for the collection of the maternal BMI measurement
in relation to pregnancy varies (Table 1). A pre-pregnancy BMI was recorded at either
the first prenatal visit or by self-report of the last known weight before pregnancy
(Gauthier et al., 2012; Melamed et al., 2010; O'Dwyer et al., 2013). A study reported
using a self-reported pre-pregnancy BMI but collected the information up to 25 weeks of
pregnancy, which is well beyond the first trimester (Vinturache, Moledina, McDonald,
Slater, & Tough, 2014). The hospital admission BMI was another timing for BMI
collection (Anabusi et al., 2016; Lassiter et al., 2016; Pevzner, Powers, Rayburn,
Rumney, & Wing, 2009; Roloff, Peng, Sanchez-Ramos, & Valenzuela, 2015; Suidan,
Rondon, Apuzzio, & Williams, 2015). Finally, a study collected, reported, and stratified
study outcomes using both the pre-pregnancy BMI and the hospital admission BMI
(Beckwith, Magner, Kritzer, & Warshak, 2016). Thus, BMI at time of hospital admission
is the most common timing for collection of BMI in women undergoing induction of
labor.
Body mass index and labor induction.
Women with obesity are more likely than women of normal weight to undergo
labor induction due in large part to their higher risks for antepartum complications and
post-term pregnancy (Caughey, Snegovskikh, & Norwitz, 2008; Ruhstaller, 2015). Once
they are induced, women with obesity are more likely to have a failed labor induction as
compared to normal weight women (Wolfe, Rossi, & Warshak, 2011). Higher maternal
BMI has been associated with higher failed induction of labor. In a cohort study (n = 279,
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521) the rate of failed induction increased with an increase in maternal BMI categories
(Wolfe et al., 2011).
Interventions
Compared to expectant management, induction of labor has been shown to result
in better outcomes with fewer cesarean births and better neonatal outcomes. In a large
study (n = 362,154) women undergoing induction of labor had decreased odds of
cesarean birth at 37 weeks’ gestation (OR, 0.44; CI, 0.34 - 0.57), 38 weeks’ gestation
(OR, 0.43; CI, 0.38 - 0.50), 39 weeks’ gestation (OR, 0.46; CI, 0.41 - 0.52), and 40
weeks’ gestation (OR, 0.57; CI, 0.50 - 0.65) (Darney et al., 2013). Another study
(n = 74,725) examining perinatal outcomes of women with obesity found the odds of
cesarean birth were lower for both nulliparous and multiparous women with term elective
induction as compared with expectant management (Lee et al., 2016). The odds of
cesarean birth were lower among nulliparous women with elective induction of labor
compared to expectant management at 37 weeks (OR, 0.55; CI, 0.34 - 0.90) and 39
weeks’ gestation (OR, 0.77; CI 0.63 - 0.95) compared to expectant management. Among
multiparous women with a prior vaginal birth, elective induction was associated with
lower odds of cesarean at 37 weeks’ gestation (OR, 0.39; CI, 0.24 - 0.64), 38 weeks’
gestation (OR, 0.65; CI, 0.51 - 0.82), and 39 weeks’ gestation (OR, 0.67; CI, 0.56 - 0.81).
Additionally, elective induction at 38 weeks’ gestation, 39 weeks’ gestation, and 40
weeks’ gestation was associated with lower odds of macrosomia (Lee et al., 2016). There
was no difference noted in other perinatal outcomes for induction compared to expectant
management.
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Induction of labor requiring cervical ripening for women with obesity tends to
take longer, require higher doses of cervical ripening methods, may have higher failure
rates, and may lead to a higher rate of cesarean births (Lassiter et al., 2016). This section
will examine studies where prostaglandins and mechanical methods have been used for
induction of labor with cervical ripening among women with obesity. There will also be a
brief review of other induction of labor methods and the influences of maternal obesity
on the use of oxytocin and amniotomy.
Induction of Labor Requiring Cervical Ripening
While labor can be induced by many methods, the main focus of this study will be
the induction of labor requiring cervical ripening stratified by BMI categories (see Table
1). The main methods for cervical ripening are the two prostaglandins misoprostol and
dinoprostone and mechanical methods mainly transcervical catheters.
Prostaglandins for Induction of Labor.
Using prostaglandins as a method for induction of labor usually suggests the
women have an unfavorable cervix needing cervical ripening. Prostaglandin cervical
ripening methods commonly include the use of misoprostol (PGE1) or dinoprostone
(PGE2) (see Table 1).
Misoprostol (PGE1). A study (n = 329) using misoprostol alone for cervical
ripening with outcomes stratified by BMI categories found a significant increase in the
time to birth with increasing BMI (Lassiter et al., 2016). Women with a high BMI
required more doses of misoprostol and had a higher rate of cesarean birth as compared
to normal weight women. The Lassiter study also reported among women with obesity,
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higher doses of cervical ripening methods were needed to achieve successful cervical
ripening.
Dinoprostone (PGE2). A study (n = 488) using dinoprostone for cervical
ripening reports findings of significantly higher cervical ripening failure rates in women
with each increase in BMI category (Melamed et al., 2010). Overweight women with a
BMI of 26 - 30 kg/m2 were 5.75 times more likely to experience cervical ripening failure
and women with a BMI > 30 kg/m2 were 6.22 times more likely to experience cervical
ripening failure as compared with normal weight women (Melamed et al., 2010). In a
different study, cervical ripening failure after using dinoprostone (n = 285) was 53.7% for
women with obesity (BMI < 30 kg/m2) as compared to 34.2% for normal weight women
(Gauthier et al., 2012). Additionally, the odds of having a first ripening attempt failure
were significantly increased 2.22 times in women with obesity as compared to normal
weight women. These two small studies with similar research designs suggest
dinoprostone has higher cervical ripening failure rates among women with obesity as
compared with normal weight women.
A study (n = 1, 927) using dinoprostone alone or with the use of oxytocin
(O'Dwyer et al., 2013) reports an emergency cesarean birth rate of (19.5 %) among
normal weight nulliparous women; (27.4%) among overweight nulliparous women and
(34.6%) among nulliparous women with obesity. For multiparous women, the cesarean
birth rates were (2.2%) for normal weight women, (0.6%) for overweight women, and
(3.4%) for women with obesity. Nulliparous women with obesity were found to have the
highest cesarean birth rates among this sample (O'Dwyer et al., 2013).
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Comparisons of differing types of prostaglandins. Eleven studies compared the
use of the types of prostaglandins (see Table 1). A study compared prostaglandin use for
induction of labor (n = 564) among a sample of women with obesity misoprostol
(52.7%), and dinoprostone (47.3%) (Suidan et al., 2015). Finding the misoprostol group
had a higher successful cervical ripening rate (78.1% vs. 66.7%) (OR, 1.79; CI, 1.23 –
2.60) and a lower cesarean birth rate (39.1% vs. 51.3%) (OR, 0.61; CI, 0.44 – 0.85] when
compared to the dinoprostone group (Suidan et al., 2015). In a study comparing
prostaglandin dosing and type (misoprostol vs. dinoprostone) (n = 331), the misoprostol
group had a significantly shorter time to active labor (median 8 hours versus 12 hours), a
decreased overall time to birth [median; 11 hours versus 17 hours] and a decreased stay
on the labor and delivery unit [median; 16 hours versus 24 hours] (Kunzier et al., 2016).
The results of the Kunzier study remained significant after being adjusted for BMI. These
results indicate that dinoprostone may not be as effective as misoprostol for cervical
ripening in women with obesity.
In a secondary analysis of data from a randomized controlled trial (n = 1,273) the
dosing and safety of three prostaglandin vaginal inserts were compared; dinoprostone 10
milligrams (mg), misoprostol 50 micrograms (mcg) and misoprostol 100 micrograms
(mcg) (Pevzner et al., 2009). The researchers found that cesarean birth occurred in 21.3%
of lean women (BMI less than 30 kg/m2), 29.8% of women with obesity (BMI 30 -39
kg/m2), and 36.5% of women with a BMI of 40 kg/m2 or higher. Data from the secondary
analysis were used rather than the original study as the outcomes had been stratified by
BMI category. Data from the original study were not stratified by BMI category and
showed similar cesarean birth rates for all three prostaglandin vaginal insert preparations;
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dinoprostone 10 mg (72.9%), misoprostol 50 mcg (71.1%), and misoprostol 100 mcg
(71.7%) (Wing, 2008).
Mechanical methods for induction of labor.
Mechanical methods include the use of transcervical catheters. A look at a
Cochrane review (2012) on the use of mechanical methods for induction of labor at term
which included 71 trials (n = 9,722) (Jozwiak et al., 2012) giving insight to the efficacy
of the use of mechanical method for labor induction among all women. The results
indicate mechanical methods had similar cesarean birth rates to women using vaginal
PGE2 (eight studies; 1,203 women; RR, 0.16; CI 0.06 - 0.39) and misoprostol (3% versus
9%) (nine studies; n = 1,615; RR, 0.37; CI 0.25 - 0.54) (Jozwiak et al., 2012). When
compared to oxytocin, mechanical methods were shown to reduce the risk of cesarean
birth (five studies; n = 398; RR 0.62; CI 0.42 - 0.90) (Jozwiak et al., 2012). The
following section reports the use mechanical methods for induction of labor among
women with obesity.
Transcervical catheters. Transcervical catheters are commonly used for induction
of labor. There are different types of catheters such as single balloon catheters, for
example, a Foley balloon catheter, or double balloon catheters like the Cook’s catheter.
These transcervical catheters are used to dilate the cervix in preparation for labor (See
Table 1).
The Anabusi study (n = 181) compared outcomes between two types of
mechanical devices, the Foley catheter, and the Cooks catheter. The results of this study
found no statistically significant differences in outcome based on catheter type and
maternal BMI category (Anabusi et al., 2016). The Beckwith study (n = 709), compared
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cervical ripening with a Foley bulb and the use of misoprostol. Women with obesity had
a higher cesarean birth rate than non-obese women with the use of misoprostol (35%
versus 26% respectively) but not with mechanical ripening (31% versus 29%
respectively, p = .69). The results of the limited data in this study suggest that mechanical
methods are not affected by BMI (Beckwith et al., 2016).
Other mechanical methods. Hydroscopic dilators, either synthetic like Dilapan or
laminaria can be used for mechanical dilation of the cervix at term, but these other
methods seemed to be used in different ways than transcervical catheters for mechanical
cervical ripening. Commonly, hydroscopic dilators were used for mechanical cervical
dilation in cases of missed abortion early pregnancy (Khooshideh, Yarmohammadi,
Shahriari, & Sheikh, 2017), as part of cervical management for surgical abortion
(Firouzabadi, Sekhavat, Tabatabaii, & Hamadani, 2012; Kapp, Lohr, Ngo, & Hayes,
2010), or with induction of labor for second-trimester fetal demise (Drey et al., 2014). A
study used laminaria was for term induction (n = 782) after premature rupture of
membranes (PROM) (Kurasawa et al., 2014). The researchers reported the Bishop score
increased from 2.5 cm to 6.1 cm with laminaria use. Because the results of this study
were not stratified by BMI category, it is unknown if women with obesity would respond
the same as the normal weight women. No literature was located where laminaria or other
any other mechanical methods were used in term pregnancy induction of labor requiring
cervical ripening with outcomes stratified by BMI category.
Other Methods for Induction of Labor
Oxytocin and amniotomy will be reviewed in this section as other methods for
induction of labor. While the use of the prostaglandins and mechanical means for cervical
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ripening are the main focus for this study, the use of oxytocin and amniotomy for
induction of labor should not be overlooked. Oxytocin may be used alone for induction of
labor but is often used in conjunction with other methods.
Oxytocin.
Oxytocin use for labor induction is well studied among all women and is growing
in use for women with a higher BMI. Oxytocin can be used in conjunction with other
methods for induction of labor. A study previously reviewed for the use of
prostaglandins also reported the findings from oxytocin use by BMI category as the time
oxytocin was used in hours [BMI < 30 kg/m2, 7.17 hours; BMI 30 - 40 kg/m2; 8.54 hours;
BMI > 40 kg/m2: 10.39 hours] (Lassiter et al., 2016). In a separate study where
prostaglandins were used for cervical ripening, reported outcomes of oxytocin use and
duration of use (n = 1,273) found increasing use of oxytocin with each increase in BMI
category. The reported dose and duration was as follows: a) the lean group (2.6 units and
6.5 hours); b) the obese group (3.5 units and 7.7 hours) and c) the extremely obese group
(5.0 units and 8.5 hours) (Pevzner et al., 2009). Many studies indicate that women with
obesity undergoing labor induction with oxytocin required a longer time in labor, and
higher doses of oxytocin (Hill et al., 2015; Maeder et al., 2017; O'Dwyer et al., 2013;
Pevzner et al., 2009; Roloff et al., 2015; Vinturache et al., 2014).
Amniotomy.
Amniotomy, the artificial rupture of the amniotic membranes (AROM), can be
used to induce labor for women with a term gestation and a favorable cervix (Bishop
score of > 7) ("ACOG Practice Bulletin No. 107: Induction of labor," 2009). Amniotomy
is often paired with the use of oxytocin, as there is evidence that the use of amniotomy
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with low dose oxytocin had a faster induction to birth time when compared to amniotomy
alone (Bricker & Luckas, 2000). The use of amniotomy among women with obesity did
not show an increase in uterine activation following amniotomy, while for women with
normal weight did (Hiersch et al., 2015). Amniotomy alone may not induce labor in
women with obesity.
Outcomes
The outcomes are the product of the intervention and are affected by the system
and individual characteristics. Common outcomes reported after induction of labor
among women with obesity are the success or failure of cervical ripening, time to birth,
and type of birth. These outcomes will be explored in this section.
Time to Birth
The time to birth is a commonly reported labor outcome among women
undergoing induction of labor. Time to birth was found to be either a primary or
secondary outcome in several studies regarding induction of labor with cervical ripening
stratified by BMI category (Anabusi et al., 2016; Hill et al., 2015; Lassiter et al., 2016;
Pevzner et al., 2009). The Anabusi study (n = 181) defined the time to birth as the time
from device insertion for mechanical ripening to birth. The median time to birth (in hours
and minutes) was 16 hours for normal weight women and 16 hours and 57 minutes for
women with obesity (Anabusi et al., 2016). Lassiter (2016) used the time to birth as the
primary outcome, defining the time to birth as the time from the start of labor induction
to birth (Lassiter et al., 2016). The Lassiter study found women with a higher BMI had a
significantly longer time to birth than normal weight women. The Pevzner study
(n = 1,273), reported the time to birth in hours, as the time from insertion of the induction
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method to the time of birth. A statistically significant relationship (p < .001) was reported
between a prolonged duration of labor and higher BMI categories (Pevzner et al., 2009).
Prolonged time to birth was seen with increasing BMI category (Anabusi et al., 2016;
Lassiter et al., 2016; Pevzner et al., 2009). The time to birth has been reported in both
hours and minutes and is calculated as the time from the start of an induction method to
birth.
Type of Birth
The type of birth is a commonly reported labor outcome among women undergoing
induction of labor. Types of birth include vaginal birth, assisted vaginal birth or operative
vaginal birth, and cesarean birth. Cesarean birth is the primary outcome of this study.
Vaginal birth. Vaginal birth is the birth of a neonate through the vagina and is
regarded as the preferred method of birth, if possible. A vaginal birth may be either
spontaneous or induced. After induction of labor requiring cervical ripening, the rate of
spontaneous vaginal births decreases as BMI increases (Callaway, Prins, Chang, &
McIntyre, 2006; Smith, Shah, Pell, Crossley, & Dobbie, 2007).
Assisted vaginal birth. Assisted vaginal birth is a vaginal birth where forceps or
vacuum assistance is needed to assist in the birth of the neonate. Assisted vaginal birth is
sometimes called operative birth. The use of assisted vaginal birth is declining, with
reported use down from 9.01% in 1990 to 3.21% in 2014 among all women in the United
States (Hamilton, Martin, & Osterman, 2015). The use of assisted vaginal birth among
women with obesity is unclear due to the low incidence of the intervention (Carlson
et al., 2015).
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Cesarean birth. Cesarean birth is the primary outcome of the proposed study. The use
of cesarean birth after induction of labor has been linked to failed induction of labor.
Common indications for cesarean birth after induction of labor among women with a
high BMI were the failure of labor progression (failure to progress), cephalopelvic
disproportion (CPD), or non-reassuring fetal heart rate (Kawakita et al., 2016). The
cesarean birth rate was also found to be higher by BMI category after induction of labor
(n =329) [BMI < 30 kg/m2, 17.48%; BMI 30- 40 kg/m2, 37.09%; BMI > 40 kg/m2, 40%]
(Lassiter et al., 2016).
Maternal and Fetal Adverse Outcomes
Maternal adverse outcomes. Maternal adverse outcomes are a way of measuring the
effects of an intervention such as induction of labor. Having a higher BMI places a
woman at a higher risk for adverse outcomes including postpartum hemorrhage, sepsis,
prolonged hospital stay, and other complications (P. Agrawal, 2015; Mission, Marshall,
& Caughey, 2013). Postpartum hemorrhage has been defined clinically as an estimated
blood loss of 500 milliliters (ml) or more for a vaginal birth and 1,000 ml or more for
cesarean birth (Grobman, 2012; Sentilhes et al., 2016). Maternal sepsis is a maternal
infection which is measured by a fever of 101 degrees Fahrenheit or higher or the use of
antibiotics in the postpartum period (Le Gouez, Benachi, & Mercier, 2016). The average
hospital stay is one to two nights for a vaginal birth and three to four nights after having a
cesarean birth. Therefore, a prolonged hospital stay after birth can be a signal that
maternal complications are present (Glantz, 2005; Grobman, 2012). Assessing adverse
maternal outcomes is an important part of ensuring induction of labor methods are both
safe and effective.
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Fetal adverse outcomes. The incidence of adverse fetal outcomes is also
increased among women with obesity (S. Agrawal & Singh, 2016; Mission et al., 2013;
O'Reilly & Reynolds, 2013). Common fetal adverse outcomes among women with
obesity are congenital anomalies, intrauterine fetal demise (IUFD), fetal macrosomia, and
fetal distress in labor (S. Agrawal & Singh, 2016; Mission et al., 2013; O'Reilly &
Reynolds, 2013). There is a two-fold increase in the incidence of IUFD in women with
obesity (Mission et al., 2013). Additionally, babies born to women with obesity tend to
have fetal macrosomia, defined as a fetal weight over 4,000 grams (gm) (Mission et al.,
2013). Fetal macrosomia places an infant at an increased lifetime risk for diabetes, heart
disease, and obesity (Agrawal & Singh, 2016; O'Reilly & Reynolds, 2013). Assessing
adverse fetal outcome for labor induction methods is as important as assessing adverse
maternal outcomes for ensuring safe and effective methods for labor induction.
Gaps in the Literature
The use of cervical ripening with induction of labor for women with a high BMI
has not been studied extensively. Previous studies of labor induction indicate there is a
complex process affected by population health, hospital type and location, provider
difference or training, and the regional availability of health care. By gaining a wellinformed understanding of the phenomena of successful cervical ripening, providers will
be better prepared to make clinical decisions. Women will have the benefit of better
physiologic preparation for labor induction and have a better chance at achieving vaginal
birth. Understanding outcomes based on BMI stratification could reduce the risk of
medical intervention and reduce the overall cost of care.
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Initial evidence indicates that misoprostol may be a better choice for
prostaglandin cervical ripening than dinoprostone in women with a high BMI and that
mechanical cervical ripening may work better than pharmacological cervical ripening.
The time to birth was longer for women who were induced and women who had a higher
BMI, but there is little literature regarding the time to birth in women with a high BMI.
What is known about labor induction with cervical ripening among women with a high
BMI has been largely based on the retrospective analysis of cohort studies. While there
are a few studies with large sample sizes, these existing studies do not appropriately
control for parity, which plays a significant role in labor induction outcomes regardless of
obesity category. A multiparous woman with a previous vaginal birth has a higher chance
at a subsequent vaginal birth than a nulliparous woman who has not yet had a vaginal
birth. Little is known regarding whether a woman’s BMI affects labor induction
outcomes based on the type of cervical ripening method used for induction of labor. It is
unknown if either pharmacological or mechanical means of cervical ripening will result
in a different cesarean birth rate among nulliparous women with a high BMI. Finally, the
best practices of inducing women with a high BMI in a manner that achieves optimal
outcomes are yet to be defined. The proposed study will be a beginning step to examine
whether different cervical ripening methods result in different outcomes for women who
are overweight and women with obesity as compared to normal weight women
undergoing induction of labor.
In summary, there is a need for the proposed study, as it will add to the growing
body of knowledge about women who are overweight and obese and labor induction
outcomes. The large sample size of the proposed study will address the limitation of
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small sample sizes previously reported in the literature. Understanding the optimal
timing, and dosing of labor induction methods in women who are overweight and women
with obesity can guide practice by influencing clinical decisions, clinical guidelines, and
future policy regarding induction of labor.
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Table 1
Study Characteristics- Prostaglandin and Mechanical Methods for Labor Induction
Study, Country,
Years of
Included Births
Anabusi, 2016
Israel, 20072011

Beckwith, 2016
USA 2008-2011

Sample

Methodology

181

Cohort study

709

Retrospective
cohort

Inclusion
Criteria

Primary
and
Secondary
Aims

Singleton
pregnancy,
cephalic
presentation,
intact
membranes at
term, planning
induction, and
unfavorable
cervix
 Mixed parity

Primary
Time to
birth
Successful
ripening
Cesarean
birth rates
Maternal
and
neonatal
adverse
events

Singleton, live
born, nonanomalous infant
Induced labor

Primary
Failure to
achieve
active labor
Secondary
Cesarean
birth rate
Doses of
misoprostol
use
Need for
protocol
deviation



Mixed parity

Timing of
BMI
collection and
BMI
categories
used (kg/m2)
Hospital
admission

Induction Method Used
and Dosing Schedule



Non-obese <
30
Obese > 30

Pre-pregnancy
and hospital
admission
Non-obese <
30
Obese > 30



Outcomes

Cook or Foley catheter
Prostaglandins PV (In
cases of first attempt
failure)

Cesarean birth
rate was 17.6%
vs. 25.3% for
normal weight
and women with
obesity,
respectively

Misoprostol 25 mcg PV
Foley bulb inflated to 30
ml and tethered;
accompanied by
Oxytocin a

Women with
obesity had a
higher cesarean
birth rate with
misoprostol
(35% versus
26%,
p.0.03) but not
with mechanical
ripening (31%
versus 29%,
p.0.69)

(Table 1 Continues)
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(Table 1 Continued)
Study, Country,
Years of
Included Births
Gauthier, 2012
France, 20082009

Sample

Methodology

285

Retrospective
cohort with
case
matching

Inclusion
Criteria
BMI between
20- 25 kg/m2
and > 30
kg/m2,
singleton, live
birth, term
gestation, one
previous
cesarean,
cephalic, no
contraindications
to vaginal birth,
Bishop score <
6, and over 18
years of age


Kunzier, 2016
USA
2012-2014

331

Retrospective
cohort

Primary
and
Secondary
Aims
Primary
First
cervical
ripening
attempt
failure

Timing of
BMI
collection and
BMI
categories
used (kg/m2)
First prenatal
visit

Induction Method Used
and Dosing Schedule

Outcomes



Dinoprostone 10 mg for
12 hours if Bishop score
< 3, or 1 mg if Bishop
score 4-6

Cervical
ripening failure
was higher
among women
with obesity
(53.7%) as
compared to
women with a
normal weight
(34.2%).



Misoprostol 50 mcg PV
Dinoprostone 10 mg PV

Misoprostol had
a shorter length
of labor reduced
cost without
increase adverse
fetal effects

Normal 20-25
Obesity
Moderate 3035
Severe 35-40
Morbid > 40

Mixed parity

Term IOL
Bishop score < 4

Primary
Length of
hospital stay
Cost
comparisons

Results
adjusted for
BMI

(Table 1 Continues)
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(Table 1 Continued)
Study, Country,
Years of
Included Births
Lassiter, 2016
USA, 2012-2013

Sample

Methodology

329

Retrospective
cohort

Inclusion
Criteria
All women
undergoing
induction at the
research site,
gestational age
37 weeks, and
Bishop score < 5
Mixed parity

Melamed, 2010
Israel, 20002007

488

Retrospective
cohort
Case
comparison
3:1 ratio

All women
admitted who
failed to respond
to PGE2 cervical
ripening
compared to
women with
successful
cervical
ripening.
Singleton,
cephalic, one
previous
cesarean, and no
contraindication
for vaginal birth


Primary
and
Secondary
Aims
Primary
Time to
birth
Secondary
Number of
doses of
misoprostol
Duration of
oxytocin
Cesarean
birth
Primary
Failure of
cervical
ripening
with PGE2

Timing of
BMI
collection and
BMI
categories
used (kg/m2)
Hospital
admission

Induction Method Used
and Dosing Schedule

 Misoprostol 25 mcg PV
 Oxytocin 1 mU/min
increased 1-2 mU every
30 min

Group 1 < 30
Group 2 30-40
Group 3 > 40

First prenatal
visit
Normal 21-25
Overweight
26-30
Obese > 30

Outcomes



Dinoprostone 3 mg PV

 Oxytocin 2.5 mU/min,

increased by 2.5 mU/min
every 20 min

Time to birth
was increased
with BMI
Increased risk of
cesarean birth

Predictors of
cervical ripening
failure are
maternal age
above 30 years,
pre-pregnancy
BMI above 25
kg/m2, cervical
dilation, cervical
effacement and
gestational age
less than 37
weeks

Mixed parity

(Table 1 Continues)
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(Table 1 Continued)
Study, Country,
Years of
Included Births
O’Dwyer, 2013
Ireland 20082010

Sample

1,927

Inclusion
Criteria

Methodology

Prospective
cohort

Singleton in the
first trimester,
Northern
European race,
older than 18
years, able to
give consent and
no gestational
diabetes mellitus


Pevzner, 2009
USA, 2006-2007

1,273

Cohort study

Primary
and
Secondary
Aims
Primary
Mode of
birth
Obstetric
outcomes

Timing of
BMI
collection and
BMI
categories
used (kg/m2)
On enrollment
(in the first
trimester)

Induction Method Used
and Dosing Schedule

Outcomes




Prostaglandin PVc
Oxytocin





Misoprostol 100 mcg PV
Misoprostol 50 mcg PV
Dinoprostone 10 mg PV

Underweight
< 18
Normal 20 -29
Obese > 30

Mixed parity

18 years or
older, low parity
(3 or less
previous births),
singleton, and 
36 weeks’
gestation
Mixed parity

Primary
Reached
active labor
Secondary
Total
oxytocin
for
induction
Less than
24 hours to
birth
Type of
birth

Hospital
admission
Lean < 30
Obese 30-39
Extremely
obese > 40

Labor induction
on nulliparous
women is
associated with
increased rates
of emergency
cesarean birth
and increased
use of
interventions
such as epidural
and fetal blood
sampling
Increased
incidence of
cesarean birth
with increasing
BMI, higher
doses of
oxytocin use and
a longer time to
birth

(Table 1 Continues)
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(Table 1 Continued)
Study, Country,
Years of
Included Births
Roloff,
2014(Roloff et
al., 2015)
USA 2012

Sudain, 2015
USA
2008-2013

Sample

Methodology

413

Retrospective
cohort

564

Retrospective
cohort

Inclusion
Criteria
Viable singleton
pregnancies at
term (37-42
weeks’
gestation), and
cephalic
presentation

Primary
Cumulative
oxytocin
needed for
vaginal
birth

Cephalic,
singleton
gestational age
>24 weeks,
Bishop score <
6, BMI > 30

Primary
Successful
cervical
ripening
Cesarean
birth rates

kg/m2

Vinturache
2014(Vinturache
et al., 2014)
Canada, 20082010

1996

Retrospective
cohort

Primary
and
Secondary
Aims

Timing of
BMI
collection and
BMI
categories
used (kg/m2)
Hospital
admission
Non-obese
< 30
Obese >30
Hospital
admission
> 30

Induction Method Used
and Dosing Schedule


Misoprostol 25-50 mcg
PO or PV
 Foley Bulb ripening [n =
2]
 Oxytocin at 1-2 mU per
min and increased by 1-2
mU every 20-30 min
 Misoprostol 50 mcg PV
 Misoprostol 25 mcg PO
Dinoprostone 10 mg PV

Mixed parity

Term singleton
pregnancies,
participation in
All Our Babies
cohort study

Primary
Type of
birth
Secondary
Obstetric
outcomes

On enrollment
(before 25
weeks’
gestation)

 Oxytocin c
Prostaglandins c

Outcomes

All women were
induced.
More oxytocin
Similar labor
length for obese
and normal
weight women.
Use of
misoprostol
leads to lower
cesarean birth
rate as
compared with
dinoprostone
Similar rates of
maternal and
fetal
complications
Obese women
were more
likely to be
induced and
have cesarean
birth compared
to normal
weight women

Normal 18.524.9
Overweight
25-29.9
Obese >30
Table Notes. BMI, Body mass index; kg, kilogram; m2 meter; PO, by mouth; PV, per vagina; IOL, Induction of Labor; min, minute; max, maximum;
cm, centimeters; ml milliliters; mu; mcg.

CHAPTER III
METHODS
This chapter describes the methods for the proposed study including the research
design, the sampling design, and the plan for analysis. A retrospective cohort study
design will be used to perform a secondary analysis of the Consortium of Safe Labor
(CSL) database. The CSL database is a large nationally representative database
containing over 228,000 labor and delivery records that are electronically linked with
neonatal outcomes (Zhang et al., 2010).
Proposed Research Study Design
This proposed study will use a retrospective cohort study design. In a cohort
study, an investigator selects a group of exposed and non-exposed individuals and makes
comparisons in the incidence of disease (Gordis, 2014). According to Gordis, there are
two important reasons for conducting cohort studies. First, cohort studies allow
researchers to determine whether there is an association between a characteristic and the
development of a disease, by studying the characteristics of individuals and/or groups.
Second, it is possible to derive inferences regarding possible causal relationships that
have been found.
The retrospective cohort design uses the same design as the cohort study
described above; it uses data that is already obtained to help shorten the timeframe
needed to complete the research (Gordis, 2014). There are certain biases to be aware of
when designing and conducting a retrospective cohort study. The two main biases
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associated with cohort studies are selection bias and information bias (Gordis, 2014).
Selection bias addresses individuals who are lost to follow-up (Gordis, 2014), this type of
bias is minimized in the proposed study as the data were collected at a single point in
time. There is a chance for selection bias by individuals who began care at a CSL site but
changed sites prior to delivery, there is nothing in particular that can be done to reduce
this potential bias except for being aware that the bias may exist. Information bias is the
bias that arises from measurement or reporting error. The proposed study may be prone to
information bias from using secondary analysis for existing data. Having different data
quality for the exposed and non-exposed groups will be minimized as the whole sample is
taken from one dataset. Information bias may exist form differences in reporting between
the sites. For example, some centers did a better job of collecting data on women with
normal weight, while other centers did a better job of collecting data on women who were
obese. The investigator or others may also unintentionally introduce information bias
during the analysis of the data and the interpretation of the findings.
Sampling Design
The proposed study is a secondary analysis of data from the Consortium on Safe
Labor (CSL) database. This database is an existing National Institutes of Health (NIH)
database which is publicly available for use with permission (National Institute of Health,
n.d.). Permission for data use has been obtained by the researcher and Georgia State
University. The sample will include women who are present in CSL database, underwent
an induction of labor, who had with a singleton fetus with cephalic presentation, a term
gestation  37 weeks, and a plan for a vaginal delivery. Exclusion criteria are women
with documented placenta previa, placenta accrete, active herpes or untreated HIV,
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antepartum stillbirth, eclampsia, prior uterine scar, or congenital/chromosomal anomalies
of the neonate. These factors were excluded because all are either contraindications for
vaginal birth, or conditions that would be expected to significantly alter the labor course,
thus confounding our analysis of BMI influences on labor induction processes/outcomes.
Additional exclusions are missing data in CSL to calculate BMI (height and weight at
labor admission), missing data in CSL on inclusion or exclusion criteria, and missing data
in CSL on important demographic variables (race/ethnicity, maternal age). Table 2
presents an example of variables that can be used for sample selection within the CSL
database.
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Table 2
Example of Variable to use for Sample Selection within the CSL Database
Variable

Variable name in
CSL dataset

CSL
Number

Variable label in
CSL dataset

Inclusion
Singleton fetus

Cephalic
presentation

Term  37
weeks
Induction of
labor

Numfetus
CS-mult
TTTwin

29

Number of Fetuses

69

Admpresent
CSbreech
PesentDel
Delfetalpos
Breech9
BESTGA

79
106

Induction

126

Twin to twin
transfusion
Presentation
CSbreech
PesentDel
Delfetalpos
Breech9
Best estimate GA
(week)
Labor induction

Induction_new

585

Anteprevia

55

Placenta previa

Activeherpes
HIV
CS_HIV
CS_Fetanom
Ind_anomaly
Conanomaly9_1

42
27
116
114
129

Active genital herpes
HIV

nanomalies9_new3

661

75

Exclusion
Complete
placenta Previa
Active herpes
HIV infection
Congenital
anomaly in
fetus
Chromosomal
anomaly in
fetus

NEW neonatal ICD9 collection:
chromosomal
anomaly (ICD-9
code 758)
Eclampsia
Eclampsia
49
Prenatal history:
eclampsia
Prior uterine
uscar
581
Derived variable:
scar
previous uterine scar
Antepartum
Outcome1
516
Newborn
stillbirth
Information: Birth
outcome
Notes. CSL, consortium of safe labor. HIV, Human immunodeficiency virus. ICD,
international classification of diseases
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Consortium of Safe Labor Dataset Description
The Consortium on Safe Labor (CSL) database was a prospectively collected
cohort study of all the women delivering at 23 weeks’ gestation or greater between 2002
and 2008 in 12 clinical centers with 19 hospitals across nine American College of
Obstetricians and Gynecologists (ACOG) districts (Zhang et al., 2010). The CSL includes
a total of 228,668 deliveries with linked data for 233,844 newborns. Many women had
more than one child during the data collection period so the data from the first birth from
each subject in the study will be selected to avoid intra-person correlation, leaving
206,969 births for analysis (Zhang et al., 2010).
The CSL database contains detailed information from the electronic medical
records on maternal demographic characteristics, medical history, reproductive and
prenatal history, labor and delivery, as well as postpartum and newborn information.
Information from the neonatal intensive care unit (NICU) is linked to the newborn
records. Information on hospital type is also included in the database (Zhang et al., 2010).
Data are included from eight university-affiliated teaching hospitals, nine teaching
community hospitals, and two non-teaching community hospitals. These hospitals were
chosen because of the availability of the electronic medical records at each institution and
their geographic distribution.
Projected Sample Size
A power analysis (a priori) was performed to determine the sample size needed to
ensure statistical significance (Polit, 2010). For multinomial logistic regression the power
level was set at 0.8. The alpha level is 0.05. The data are assumed to have two tails, a
normal distribution, and an odds ratio of 1.5. The power analysis was performed using G
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Power 3.1 ("G Power," 2017). The output from the analysis shows a critical z value of
1.95. The estimate of the required sample size is 503 participants. The sample size should
result in sufficient power to detect a moderate effect size (Faul, 2009).
A power analysis for a linear regression with three predictor variables was also
conducted. The power level was set at 0.8. The alpha level is 0.05. The data are assumed
to have two tails, a normal distribution The power analysis was performed using G Power
3.1 ("G Power," 2017). The output from the analysis shows a lower critical r2 of .004 and
an upper critical r2 of 0.16. The estimate of the required sample size is 58 participants.
The sample size should result in sufficient power to detect a moderate effect size. The
actual power is estimated at .95 (Faul, 2009).
Data Collection and Instruments
Retrospective cohort studies commonly collect data for comparison between two
groups, exposed and non-exposed (Gordis, 2014). The groups to be compared will be
based on the type of labor induction method (prostaglandins, or mechanical) in women
undergoing induction of labor. The groups will be stratified by BMI category. Primary
comparisons will be made on the type of birth. Secondary outcomes will be other labor
outcomes (time to birth, and maternal and fetal adverse outcomes). The hospital type may
influence induction of labor outcomes in women with obesity. The influences of
individual and system characteristics will be summarized using multivariate statistics.
Selected adverse maternal and fetal outcomes will be analyzed and reported. Table 3 is an
overview of the study variables with examples of operational definitions from the CSL
database.
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Table 3
Overview of Study Variables
Framework
concept
Individual
characteristics

Conceptual
variable

Operational
definition

CSL
number

Maternal age

Age, in years, of
the mother at
hospital admission

6

Maternal race

Race or ethnicity

Parity

Number of times a
woman has given
birth over 20
weeks gestational
age

BMI

Variable name
in CSL dataset

Variable label in CSL
dataset

momage

Maternal age

Momrace new

Maternal race

7

Parity

Reproductive history: parity

Pre-pregnancy
BMI

16

PrBMI

BMI (mg/kg2)

Maternal height

542

Height_new

Height (m), some missing data
replaced with data from repeat
pregnancies

Delivery
admission weight

71

Admweight

Admission to L&D: weight in
gm

541

(Table 3 Continues)
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(Table 3 Continued)
Framework
concept

Conceptual
variable
Cervical status

Operational
definition
Bishop score at
admission

CSL
Variable name
number in CSL dataset
83
AdmBishop

Variable label in CSL
dataset
Labor and delivery: admission
bishop score

Cervical dilation

89

Dilat_1st

Repeated measures: dilation
at 1st exam

Hospital Type

Academic or
community

216

Hostype

Type of hospital

Hospital Level

Obstetric care
level

217

HosLevel

Hospital level for obstetric
care

NICU level

226

HosNICUlevel

Highest level of neonatal care

Induction of labor

Induction of labor

126

Induction

Labor and delivery summary:
labor induction

misoprostol

Misoprostol

143

MthInd_miso

Method of Induction:
Cytotec/misoprostol/PGE1

dinoprostone

Dinoprostone

145

MthInd_PGE2

Method of Induction: Other
prostaglandins

System
characteristics

Intervention

(Table 3 Continues)
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(Table 3 Continues)
Framework
concept

Conceptual
variable
Transcervical
catheter

Operational
definition
Transcervical
catheter

CSL
Variable name
number in CSL dataset
144
MthInd_Mec

Variable label in CSL
dataset
Method of Induction:
Mechanical

Oxytocin

Oxytocin

146

MthInd_Oxy

Method of induction:
Oxytocin/ Pitocin

AROM

AROM

142

MthInd_AROM

Method of Induction: AROM

Type of birth

Cesarean Birth

252

Delmode_B1

Labor and delivery summary:
Mode of delivery

256

Operative_B1

Labor and delivery summary:
Mode of delivery

Time to birth

772

Inducttime

Derived: Minutes from
Induction to delivery

Cervical ripening
time

773

Ripentime

Derived: Minutes from
cervical ripening to delivery

Outcomes

Time to birth

Maternal adverse
outcomes

(Table 3 Continues)

57
(Table 3 Continued)
Framework
concept

Conceptual
variable

Operational
definition
3rd and 4th-degree
perineal laceration

CSL
number
201

Variable name
in CSL dataset
Lac_majperi

Variable label in CSL
dataset
Lacerations major Perineal (3rd
and 4th degree)

Postpartum
hemorrhage

190

Postbleed

Maternal Postpartum:
Hemorrhage

Maternal fever

192

Postfever

Maternal Postpartum: Fever

Transfer to ICU
during
hospitalization
Blood transfusion

199

MomICU

Maternal Postpartum: ICU
admission

153

Bloodproduct

Labor and Delivery summary:
Blood products

Shoulder dystocia

175

Shoulder

Labor and Delivery summary:
Shoulder dystocia

Maternal death

200

Momdeath

Maternal Postpartum: Maternal
death

APGAR <7 at 5
min

296

APGAR5_1

Newborn Information: 5 min
Apgar

Neonatal adverse
outcomes

(Table 3 Continues)
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(Table 3 Continued)
Framework
concept

Conceptual
variable

Operational
definition
NICU admission

CSL
number
280

Variable name
in CSL dataset
NICUadmit1

Variable label in CSL
dataset
Newborn Information: NICU
admission

Neonatal sepsis

344

Nsepsis1

NICU Outcomes: Sepsis

Birth-related
injury

288

Bthinjury9_1

Newborn information: Birth
injury (ICD-9codes: 767)

Neonatal death

432

Ndeath1

NICU Outcomes: Death

Outcome 1
Notes. Consortium of safe labor (CSL). Body mass index (BMI). Neonatal intensive care unit, (NICU). Intensive care unit,
(ICU). Minutes (min) International classification of diseases (ICD). Artificial Rupture of Membranes (AROM).
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Operational Definitions of Variables
Exposure variable definitions.
Labor induction. The variable for labor induction is labeled as induction and
described as induction of labor. Labor induction is recorded as No/yes/unknown in the
dataset. Mechanical means. The dataset contains a variable named MthInd_Mec, which is
described as Method of Induction: mechanical. Recorded as no/yes/missing. The predefined category was mechanical method, which likely was mainly transcervical
catheters, but other mechanical methods may be included in this category (personal email
with Katherine Laughon Grantz, PI CSL). Previous publications from the CSL database
on induction of labor used method categories defined by the variables in the CSL
database (Laughon et al., 2012). Misoprostol. The dataset contains a variable labeled
MthInd_miso, which is described as Method of induction cyotec/misoprostol/PGE1.
Prostaglandin E2. The dataset contains a variable for Prostaglandin E2 labeled
MthInd_PGE2, which is described as other prostaglandins. The variable is recorded as
no/yes/missing. Oxytocin. The variable for Oxytocin is MthInd_Oxy, which is described
as Method of induction: Oxytocin/Pitocin. The variable for PGE2 is also recorded as
no/yes/missing. Amniotomy. The variable for Amniotomy is MthInd: AROM, which is
described as method of induction: Amniotomy/AROM. The variable is also recorded as
no/yes/missing. Body mass index. The proposed study will use the BMI at the time of
hospital admission created from the maternal height and admission weight gain recorded
in the data set. The proposed study will use BMI as categorical variable, using the WHO
BMI categories previously described as cut-off points.
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Outcome variable definitions.
Time to birth. The time to birth is recorded as a continuous variable in minutes.
The variable label is Inducttime, which is described as a Derived variable representing
Minutes from Induction to delivery. The variable is recorded as a continuous variable in
minutes. Cesarean birth. The outcome of cesarean birth will be used after induction of
labor and a trial of labor. By using induction of labor and a trail of labor cases are
selected were vaginal birth was the original plan. This outcome does not include planned
or pre-labor cesarean births. There are several variables to be assessed for this outcome of
cesarean birth. A variable in the dataset that represents cesarean birth Delmode_B1, is
described as information from the labor and delivery summary, as mode of delivery. A
second variable labeled Operative B_1, described as originating from the labor and
delivery summary as mode of birth will also be used to check for additional cesarean
births. The types of births for these variables are recorded as vaginal, vaginal assisted,
VBAC, cesarean, cesarean repeat.
Maternal and fetal adverse outcome variables.
Maternal outcomes. 3rd and 4th degree perineal lacerations, postpartum
hemorrhage (≥ 500 ml estimated blood loss for a vaginal birth or ≥ 1000 ml following a
cesarean birth), maternal fever > 100.1° F, transfer to ICU during hospitalization, need
for dilatation and cartage (D & C) in first 24 hours postpartum, unplanned return to
surgery, need for transfusion of blood or blood products, shoulder dystocia, and maternal
death. Neonatal outcomes. APGAR score < 7 at 5 minutes, NICU admissions, neonatal
sepsis diagnosis, birth-related injury diagnosis and neonatal death
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Plan for Analysis
The data will be analyzed using IBM SPSS Statistics (Version 25). Initially, the
data will be assessed for errors, missing data, and normality (Pallant, 2016). Errors or
values that fall out of range will be assessed using frequencies, minimum, and maximum
values. Missing data will be assessed by checking the number of valid and missing cases.
Missing data will be dealt with by either deletion or imputation. Normality will be
checked by using descriptive statistics then assessing for kurtosis or skewness.
Sample Characteristics
The sample characteristic data will include demographic data and other data to
describe the sample. The following variables will be reported: Maternal age, race, marital
status, education level, insurance type, parity, admission Bishop score (cervical dilationif Bishop score not present), and delivery BMI category.
Planned Analysis of Aims
With statistical support from Research Assistant Professor of epidemiology and
biostatistics, Brian Barger, PhD, Director of the center for leadership at the Georgia State
University school of Public Health, the following data analysis plan was created. Each
Aim contains the associated hypotheses and the plan for analysis.
Aim 1
Aim 1 states “Interventions: Compare the effectiveness of labor induction methods
(PGE1, PGE2, and mechanical methods) in women undergoing labor induction requiring
cervical ripening by BMI category”. Aim 1 Hypothesis 1: the odds of requiring
intervention to initiate labor will be higher by each BMI category compared with normal
weight women.
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Planned analysis. Multinomial logistic regression with an alpha level of 0.05 will be
used to determine the risk of cervical ripening with each increase in body mass index
category. Logistic regression is “a multivariate statistical technique used for predicting a
categorical dependent variable” p. 330 (Polit, 2010). This statistical test is used to analyze
the relationship between multiple independent variables and a single dependent variable.
Since logistic regression is based on estimation, the assumptions are less restrictive than a
linear model. Multinomial logistic regression is used when there are multiple categories
in the dependent variable (Polit, 2010).
Aim 2
Aim 2 states “Time to birth: Compare the effectiveness of labor induction
methods (misoprostol, dinoprostone and mechanical methods) by the time to birth with
results stratified by BMI category.”
Hypotheses-Aim 2. A2H1: Women induced using misoprostol for cervical
ripening will have a shorter time to birth as compared to women induced using
dinoprostone, and this time differential will be more pronounced with each successive
BMI category. A2H2: The time to birth will be shorter with mechanical methods than the
use of either prostaglandin (PGE1 or PGE2).
Planned analysis. Survival Analysis. A cox proportional hazard regression with
an alpha level of 0.05 will be used to determine differences in cervical ripening methods
and the time to birth (Meyers, Gamst, & Guarino, 2017).
Aim 3
Aim 3 states “Cesarean birth: Examine the risk of cesarean birth after labor
induction among women by BMI category.”
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Hypotheses-Aim 3. A3H1: Compared to women with normal range BMI, the odds of
cesarean birth following labor induction will be higher with each increase in body mass
index category. A3H2: The odds of cesarean birth in women induced with misoprostol
will be lower compared to the odds in similar women induced using dinoprostone. A3H3:
Women with obesity (in any obesity category) who are induced using mechanical means
will have lower odds of cesarean birth than women with obesity (in any obesity category)
induced with prostaglandins (misoprostol or dinoprostone).
Planned analysis. The plan for analysis is a multinomial logistic regression.
Multinomial logistic regression with an alpha level of 0.05 will be used to determine the
risk of cesarean birth with each increase in body mass index category.
Potential confounding variables.
Maternal height: maternal height as documented in the CSL database
(Kominiarek et al., 2010), Maternal educational level, Maternal race: as documented in
the CSL database (white, Black, American Indian Asian Native Hawaiian, other),
Maternal age: Age, in years, of the mother at hospital admission as documented in the
CSL database, Birthweight: weight of the neonate in kilograms, as documented on the
first full assessment after birth in the CSL database. Socioeconomic status (SES) by
insurance type reported in the CSL dataset.
Human Subject Consideration
The application will be submitted to the Georgia State University Institutional
Review Board (IRB) for non-human subject research. IRB approval may not be necessary
to conduct the study since these data have been de-identified. The category for the
proposed research study will be non-human subject research.
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Confidentiality. Confidentiality will be maintained while accessing and storing
the de-identified data. The de-identified data will be accessed by users after completion
of a data use agreement. Only those involved in the analysis will have access to the data.
The data will be downloaded from the NIH website and stored in a secure online storage
system, which is a password protected.
Inclusion of women, minorities, and children. Women, minorities, and children
will be included in the proposed research. Since the focus of this study is labor induction
with different types of cervical ripening methods, all participants will be women. All
minorities that meet inclusion criteria will be included. Because the database is a
national database and has a large sample size of over 228,000, we expect an adequate
representation of minorities. All children from the database meeting inclusion criteria will
be included. The number of children included in the sample may be small but should
reflect current trends in teen birth in the U.S.
Summary
Research on the outcomes of induction of labor requiring cervical ripening among
women with obesity is limited. The existing studies had small sample sizes, some
inconsistencies in BMI category and noted differences in labor induction protocols. The
research design supports hypothesis formation and testing. Bivariate and multivariate
statistics will be used for analysis. Strengths of the proposed the research design supports
inferences regarding a possible causal relationship from the patterns of association. A
weakness of the retrospective cohort study design includes the potential for information
bias due to the use of existing data that was collected for a different purpose.

CHAPTER IV
RESULTS
This chapter presents the results of this retrospective cohort study to determine the
relationships among maternal BMI and the use of cervical ripening methods for inducing
labor. Descriptive statistics are presented for both individual and system sample
characteristics and for major study variables included in the interventions and outcomes.
This study explored three aims. Aim 1 explored the use and effectiveness of induction
methods used for cervical ripening by BMI category. Aim 2 explored the time from
hospital admission to birth by the induction method used with results stratified by BMI
category. Aim 3 explored the type of birth by induction method used with results
stratified by BMI category. The results of hypotheses testing are reported within each
aim.
Sample Selection
A sample of women with a healthy, low risk pregnancy at term gestation was
selected. This sample was selected from the Consortium of Safe Labor database, the
inclusion and exclusion criteria details follow.
Women with a singleton fetus, cephalic presentation, undergoing induction of
labor were included in the sample. This cohort of women with healthy low risk
pregnancies was chosen as the study to ensure study outcomes were comparable to other
published literature using healthy low risk pregnancies.
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The database was cleaned using two sets of exclusion criteria. The initial
exclusions included women with a preterm gestational age of less than 37 weeks or a post
term gestational age that was greater than or equal to 42 weeks. Women were excluded
who had multiple gestations. Women with a non -cephalic presentation were excluded by
excluding fetal presentations that were coded as non- cephalic, vertex, or head down.
Women with spontaneous labor were also excluded, by excluding women who had an
admission cervical exam that was greater than or equal to 6 cm on admission. The other
exclusions included placenta previa or accrete, having a prior uterine scar, HIV, HSV,
eclampsia, or fetal chromosomal anomaly. Women with antepartum stillbirth were
excluded as the induction process is often clinically different for these women. Women
who didn’t undergo a trial of labor, as evidenced by cases were only one vaginal exam
was charted in the database, were excluded. Cases with missing data used to calculate
BMI at time of hospital admission (height and weight at hospital admission) were
excluded. The dataset was collected over several years so those who had a subsequent
pregnancy within the dataset were excluded due to the need for independent observation.
Figure 1 provides details about the sample selection.
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Figure 4. Sample Selection Flowsheet. Notes. BMI, body mass index. HIV, human
immunodeficiency virus. HSV, Herpes Simplex virus.
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Sample Characteristics
The sample characteristics for this study includes both individual characteristics
and systems characteristics. Descriptive statistics were calculated including median, and
interquartile range. Values are reported as number and percent (n (%)) for categorical
variables, and median, interquartile range (IQR) for continuous variables, due to the
distribution of the data. Data were analyzed using the Statistical Package for the Social
Sciences (SPSS) version 25.0.
Model predictors for individual characteristics were maternal age, BMI at time of
hospital admission, parity and cervical status. Known theoretical predictors from the
literature include maternal height, maternal race, maternal insurance status, gestational
age and birth weight. These known predictors were included with the sample
characteristics and as covariates for analysis. The model predictors for system
characteristics were the hospital type, the level of obstetric care and the NICU level.
Individual Characteristics
The individual characteristics of maternal age, height, parity, race/ethnicity, BMI
at time of admission, cervical dilation at time of admission, gestational age, and birth
weight in grams, were included in the sample individual characteristics for this study.
The maternal age and maternal height were reported as continuous variables in the
dataset. Both were found to be non-normally distributed using statistics for skewness and
kurtosis. The median maternal age was 27 years at time of hospital admission. The
median maternal height was 1.63 meters, which equal 5 feet 4 inches.
The sample was almost evenly divided between nulliparous (49.8%), and
multiparous (50.2%) women. For maternal race, the majority of the women in the sample
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were non-Hispanic White (53.3%), with non-Hispanic Black (19.3%) and Hispanic
(18.4%) being the second and third largest groups, respectively. The remaining
racial/ethnicity categories were Asian/pacific islander (n = 1,523; 3.7%), multiracial (n =
27; 0.1%), other (n = 972; 2.4%), and unknown (n = 1,163; 2.8%). The insurance type
for the majority of the women in the sample was private insurance (52.5%). The next
largest group was public insurance (27.2%). Other insurance types within the sample
were self-pay (n = 444; 0.1%) and other (n = 89; 0.2%), and unknown (n = 7,883;
19.1%).
The median maternal BMI on admission was 29.9 kg/m2. When the sample was
stratified by BMI categories, the underweight women (n = 23; 0.01%) and normal weight
women (n = 5,316; 12.9%) accounted for 13% of the sample. The overweight women
were largest BMI group (n = 15,599; 37.7 %). The remaining half of the sample was in
one of the three obese categories; obese cat 1 (n = 11,435; 27.6%), obese cat 2 (n =
5,373; 13.0%), obese cat 3 (n = 3,613; 8.7%).
Cervical dilation at time of hospital admission was transformed from a continuous
variable and was reported as a categorical variable by each centimeter of cervical dilation
as noted at time of admission. Approximately 70% of women within this sample had a
reported cervical dilation of 1 - 3.99 cm on admission, meaning these women had a
clinical indication for using cervical ripening methods for inducing labor. Gestational
age was also transformed from a continuous variable to a categorical variable for ease of
describing the sample. The categorical variable is reported by week of gestational age at
time of admission. The sample was limited to term women 37- 41 weeks’ gestation. The
largest group of women in the sample was between 39 - 39.99 weeks’ gestation (37.7%),
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which can be explained by the current standard that the mother must be 39 weeks for
elective IOL.
The birth weight was reported as a continuous variable that was found to be nonnormally distributed. The median birth weight was 3,366 grams, which is 7.42 pounds.
Table 4 summarizes the descriptive statistics for the individual characteristics within this
sample (n = 41,359) of women included in this study.
Table 4
Sample Individual Characteristics
Individual Characteristics
Maternal age (years)
Height (meters)
Parity
Nulliparous
Multiparous
Maternal race/ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Asian or Pacific Islander
Multiracial
Others
Insurance type
Private
Public
Self-pay
Other
Insurance type
Private
Public
Self-pay
Other
Unknown

n (%)

Median (IQR)
27(9)
1.63 (0.08)

20,583 (49.8)
20,776 (50.2)
22.064 (53.3)
7,996 (19.3)
7,605 (18.4)
1,532 (3.7)
27 (0.1)
972 (2.4)
21,693 (52.5)
11,250 (27.2)
444 (1.1)
89 (0.2)
21,693 (52.5)
11,250 (27.2)
444 (1.1)
89 (0.2)
7,883 (19.1)
(Table 4 Continues)
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(Table 4 Continued)
Individual Characteristics
BMI at hospital admission
Underweight <18.5 kg/m2
Normal weight 18.5-25 kg/m2
Overweight 25-29.9 kg/m2
Obese Cat 1 30 -34.9 kg/m2
Obese Cat 2 35-39.9 kg/m2
Obese Cat 3 > 40 kg/m2
Cervical dilation admission (cm)
0.0 -0.99
1.00 -1.99
2.00 - 2.99
3.00 - 3.99
4.00 - 4.99
5.00 - 5.99
Missing data
Gestational age
37.00 - 37.99
38.00 - 38.99
39.00 - 39.99
40.00 - 40.99
41.00 - 41.99
Birth weight (grams)

n (%)

Median (IQR)
29.9 (7.49)

23 (0.1)
5,316 (12.9)
15,599 (37.7)
11,435 (27.6)
5,373 (13.0)
3,613 (8.7)
3,609 (8.7)
9,198 (22.2)
8,380 (20.3)
8,849 (21.4)
3,309 (8.0)
992 (2.4)
7,022 (17.0)
3,791 (9.2)
8,047 (19.5)
15,608 (37.7)
9,959 (24.1)
3,954 (9.6)
3,366

Notes. Abbreviations: centimeters (cm); Body mass index (BMI); interquartile range,
(IQR); kilograms (kg); meter (m).
Systems Characteristics
The majority of the women in the sample had labor induced in university teaching
hospitals (51.5%), with an obstetric level of care designated as a tertiary care center
(85.7%), and with a level 3 NICU (84.4%). The other hospital types were community
teaching hospital (37.7%) and community non-teaching hospitals (10.8%). The NICU
levels were NICU level 2 (11.7%) and No NICU (3.9%). Very few women in this sample
were induced in community non-teaching hospitals or hospitals without a NICU. Table 5
summarizes the descriptive statistics for the systems characteristics in this study.
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Table 5
Sample Systems Characteristics
System Characteristic
Hospital type
University, Teaching
Community, Teaching
Community, Non-teaching
Hospital level for obstetric care
Secondary
Tertiary
Highest level of neonatal care
No NICU
Level 2 (specialty)
Level 3 (subspecialty)
Notes. Abbreviations. NICU, neonatal intensive care unit.

n (%)
21,311 (51.5)
15,578 (37.7)
4,470 (10.8)
5,927 (14.3)
35,432 (85.7)
1,606 (3.9)
4,827 (11.7)
34,926 (84.4)

Descriptive Statistics for Study Intervention and Outcome Variables
This section includes descriptive statistics for study intervention and outcome
variables. The study interventions were the method of cervical ripening used for
induction of labor. The outcome variables include the method used for cervical ripening
for induction of labor (misoprostol, PGE2, and mechanical means), the time from
hospital admission to birth, and the type of birth (vaginal or cesarean).
Interventions
All of the women in the sample underwent induction of labor. Labor was induced
with one or more of the following induction methods; misoprostol, PGE2, mechanical
means, Pitocin or amniotomy. Since this study focuses on the cervical ripening methods
used for induction of labor, cervical ripening methods used for induction of labor
(misoprostol, PGE2, and mechanical means) are the main variables of interest. Of the
cervical ripening methods used for induction of labor women in the sample were induced
with misoprostol (8.8%) of the time, mechanical means (4.4%), and PGE2 (6.5%). The
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missing data (10.2%) within this variable were mostly from one site, which did not
collect or report the induction of labor method used. Cases with missing data for
induction of labor were deleted prior to analysis. Table 3 summarizes the descriptive
statistics for labor induction methods, used alone or in combination. The total in Table 6
is greater than 100% due induction methods being used either alone or in combination.
Table 6
Descriptive Statistics for Methods of Induction of Labor, used alone or in Combination
Induction Method
n (%)
Cervical ripening
6,035 (14.6)
Misoprostol
2,203 (36.5)
PGE2
2,100 (34.8)
Mechanical + Miso
908 (15.0)
Mechanical
504 (8.4)
Mechanical + PGE2
173 (2.9)
Miso+ PGE2
113 (1.9)
Mechanical + Miso + PGE2
34 (0.6)
Oxytocin/Pitocin
26,209 (70.6)
AROM
13,505 (36.4)
Unknown
6,995 (16.9)
Notes. Women may have been induced with one or more methods, totals for induction
methods do not equal 100%. Abbreviations Prostaglandin analogue 2, PGE2;
Misoprostol, Miso; Artificial rupture of membranes, AROM
Outcomes
The study outcome variables were the methods used for induction of labor
requiring cervical ripening, the time from hospital admission to birth, and the type of
birth. The methods used for induction of labor requiring cervical ripening are both
exposure and outcome variables within this study. The median time to birth was 1,018
minutes. The type of birth for the majority of the women included in the sample was a
vaginal birth (81.7%) with the remaining having a cesarean birth (18.3%).
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The maternal adverse outcomes were rare in this sample of women but included
either a third- or fourth-degree perineal laceration, postpartum hemorrhage, maternal
fever, maternal transfer to ICU during hospitalization, transfusion of blood or blood
products, shoulder dystocia and maternal death.
The neonatal adverse outcomes were also rare in this sample. The neonatal
adverse outcomes included APGAR < 7 at 5 min, NICU admission, neonatal sepsis,
birth-related injury, and/or neonatal death. Table 7 summarizes the descriptive statistics
for the major study outcome variables.
Table 7
Descriptive Statistics for Study Outcome Variables
Outcome variables
n (%)
Median (IQR)
Time to birth (min)
1,018 (638)
Missing
118 (0.0)
Type of birth
Vaginal
33,802 (81.7)
Cesarean
7,557 (18.3)
Maternal adverse outcomes
3r - 4th degree perineal
882 (2.1)
laceration
Postpartum Hemorrhage
517 (1.3)
Maternal fever
496 (1.2)
Transfer to ICU during
185 (0.4)
hospitalization
Transfusion of blood or
1,285 (3.1)
blood products
Shoulder dystocia
565 (1.4)
Maternal death
1 (0.0)
Neonatal adverse outcomes
APGAR < 7 at 5 min
256 (0.01)
NICU admission
2,060 (5.0)
Neonatal sepsis
302 (0.7)
Birth-related injury
404 (1.0)
Neonatal death
9 (0.0)
Notes. Inter quartile range, IQR; minutes, min; intensive care unit, ICU; neonatal
intensive care unit, NICU
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Bivariate Relationships among Individual and System
Characteristics by BMI Category
Bivariate correlations were calculated between individual and system
characteristics and BMI category. Categorical variables were analyzed with the Crosstabs
function in SPSS using chi square analysis for significance. The continuous variables
were analyzed using the Kruskal Wallis test for significance. Median values were
reported due to the non-normal distribution (right skew) of the data.
Three variables were collapsed for analysis due to small cell size. The maternal
race/ethnicity, insurance status, and BMI at time of hospital admission variables had
categories that were collapsed as outlined below. The maternal racial/ethnicity categories
of Asian/Pacific Islander (n = 1,523; 3.7%), multiracial (n = 27; 0.1%), other (n = 972;
2.4%) and unknown (n = 1,163; 2.8%) were collapsed into a group named other (20.3%).
For insurance status the categories of self-pay (n = 444; 0.1%) and other (89; 0.2%) were
collapsed into the unknown category (n = 7,883; 19.1%). This created a collapsed
category named other/unknown (n = 8,416; 20.3%). Due to the low number of
underweight women (n = 23), the BMI category of underweight was combined with the
normal weight category for the analysis (n = 5,339; 12.9%).
Bivariate correlations showed there was a statistically significant relationship
between BMI and age, height, parity, race, insurance type, cervical dilation at time of
admission, gestational age and birthweight. There was a statistically significant
relationship between BMI and hospital type, obstetric level of care, and neonatal level of
care. Tables 8 and 9 summarize descriptive statistics for individual characteristics, and
systems characteristics by BMI category. Table 10 summarizes the type of birth by BMI
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category. Categorical variables reported as n (%). Continuous variables are reported as
median.
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Table 8
Bivariate Analysis of Individual Characteristics within BMI Category
Individual
Characteristics
n (%)
Age (y) *
Height (m) *
Parity
Nulliparous
Multiparous
Race/ethnicity
White
Black
Hispanic
Other/unknown
Insurance type
Private
Public
Unknown

Normal weight
(n = 5,339)

Overweight
(n = 15,599)

Obese Cat 1
(n = 11,435)

Obese Cat 2
(n = 5,373)

Obese Cat 3
(n = 3,613)

P value

27
1.65

28
1.63

27
1.63

27
1.63

27
1.63

< .001
< .001
< .001

2,879 (53.9)
2,460 (46.1)

7,901 (50.7)
7,698 (49.3)

5,431 (47.5)
6,004 (52.8)

2,535 (47.2)
2,838 (52.8)

1,837 (50.8)
1,776 (50.2)

3,149 (59.0)
776 (14.5)
817 (15.3)

8,956 (57.4)
2,213 (14.2)
2,805 (18.0)

5,873 (51.4)
2,312 (20.2)
2,332 (20.4)

2,551 (47.5)
1,435 (26.7)
1,054 (19.6)

1,535 (42.5)
1,260 (34.9)
597 (16.5)

597 (11.2)

1,625 (10.4)

918 (8.0)

333 (6.2)

221 (6.1)

2,778 (52.0)
1,153 (21.6)
1,408 (26.4)

8,576 (55.0)
3,437 (22.0)
3,586 (23.0)

5,970 (52.2)
3,268 (28.6)
2,197 (19.2)

2640 (49.1)
1,921 (35.8)
812 (15.1)

1,729 (47.9)
1,471 (40.7)
413 (11.4)

< .001

< .001

(Table 8 Continues)
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(Table 8 Continued)
Individual
Characteristics
n (%)

Normal
weight
(n = 5,339)

Overweight
(n = 15,599)

Obese Cat 1
(n = 11,435)

Obese Cat 2
(n = 5,373)

Obese Cat 3
(n = 3,613)

P value

Cervical dilation
< .001
0.00-.99
419 (9.0)
1,234 (9.3)
972 (10.4)
545 (12.8)
439 (10.5)
1.00-1.99
1,162 (25.1)
3,418 (25.7)
2,590 (27.7)
1,189 (28)
839 (26.8)
2.00-2.99
1,177 (25.4)
3,391 (25.5)
2,220 (23.7)
962 (22.7)
630 (22.5)
3.00-3.99
1,324 (28.6)
3,545 (26.6)
2,410 (25.8)
999 (23.6)
571 (20.3)
4.00-4.99
420 (9.1)
1,338 (10.1)
864 (9.2)
420 (9.9)
267 (9.5)
5.00-5.99
128 (2.8)
385 (2.9)
292 (3.1)
127 (3.0)
60 (2.1)
Gestational age
< .001
37.00-37.99
608 (11.4)
1,204 (7.7)
1,017 (8.9)
537 (10.0)
425 (9.2)
38.00-38.99
1,069 (20.0)
2,903 (18.6)
2,127 (18.6)
1,156 (25.1)
792 (19.5)
39.00-39.99
2,109 (39.5)
6,184 (39.6)
4,278 (37.4)
1,799 (33.5)
1,238 (37.7)
40.00-40.99
1,169 (21.9)
3,922 (25.1)
2,774 (24.3)
1,286 (23.9)
808 (22.4)
41.00-41.99
384 (7.2)
1,386 (8.9)
1,239 (10.8)
595 (11.1)
350 (9.7)
Birth weight (g)*
3,195
3,345
3,424
3,440
3,440
< .001
Notes. Abbreviations Chi squared for significance. Continuous variables (*), median reported, Kruskal Wallis test for
significance. Abbreviations. Cat, category; y, year; m, meters; g, grams.
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Table 9
Bivariate Analysis for System Characteristics and BMI
System Characteristics

Normal (n = 5,339)

Overweight
(n = 15,599)

Obese Cat 1 Obese Cat 2 Obese Cat 3
(n =11,435) (n = 5,373) (n = 3,613)

P value

Hospital type
< .001
University
2,932 (54.9)
8,010 (51.3) 5,801 (50.7) 2,727 (50.8) 1,841 (51.0)
Community, Teaching
1,817 (34.0)
5,751 (36.9) 4,411 (38.6) 2,126 (39.6) 1,473 (40.8)
Community, Non-teaching
590 (11.1)
1,838 (11.8) 1,223 (10.7)
520 (9.7)
299 (8.3)
Obstetric care level
< .001
Secondary
723 (13.5)
2,315 (14.8) 1,661 (14.5) 758 (14.1)
470 (13.0)
Tertiary
4,616 (86.5)
13,284 (82.5) 9,774 (85.5) 4,615 (85.9) 3,143 (85.7)
NICU level
< .001
No NICU
212 (4.0)
688 (4.3)
443 (3.9)
175 (3.3)
108 (3.0)
Level 2
542 (10.2)
1,793 (11.5) 1,365 (11.9) 681 (12.7)
446 (12.3)
Level 3
4,584 (85.9)
13,138 (84.2) 9,627 (84.2) 4,517 (84.1) 3,059 (84.7)
Notes. Abbreviations: Cat, category; NICU, neonatal intensive care unit; Level 2 (specialty); Level 3 (subspecialty). Chi
square for significance
Table 10
Bivariate Analysis of Type of Birth by BMI category for all Women being Induced n = 41,359
Normal weight Overweight
(n = 5,339)
(n = 15,599)
Vaginal
4,831 (90.5) 13,296 (85.2)
Cesarean
508 (9.5)
2,303 (14.8)
Notes. Chi squared for significance
Type of birth

Obese Cat 1 Obese Cat 2 Obese Cat 3
Total
p-value
(n = 11,435) (n = 1,348) (n = 1,149) (n = 41,359)
9,236 (80.8) 4,025 (74.9) 2,414 (66.8) 33,802 (81.7) < .001
2,199 (19.2) 1,348 (25.1) 1,199 (33.2) 7,557 (18.3)
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While bivariate analyzes were performed for the variables of cervical status and
gestational age, these variables were not included as predictors in analysis of the aims
due to several factors. First the sample was selected based on women with induction of
labor, so all of the women in the sample had an initial cervical exam of less than 6 cm,
which is the cut off for active labor. This cut point was chosen because a cervical exam of
less than 6 cm indicates a woman is not yet in active labor, and there is a clinical
indication for induction of labor. Additionally, the variable cervical dilation at time of
admission had a large amount of missing data (17%). Lastly, cervical status tends to a
collinear relationship with BMI. Gestational age was not included as a predictor for the
use of cervical ripening for induction of labor due to the sample selection criteria, the
whole sample selected has a term gestational age based on sample inclusion and
exclusion criteria.
Analysis of Aims
The following bivariate and multivariate analyses are reported findings that either
support or do not support the individual hypotheses of study. All data were analyzed
using the Statistical Package for the Social Sciences (SPSS) version 25.0. Prior to
addressing the hypotheses, data were examined for normality, outliers, and missing data.
Aim One
Aim 1 states “Interventions: Describe the effectiveness of labor induction methods
(misoprostol, PGE2, and mechanical means) in women undergoing labor induction
requiring cervical ripening by BMI category”.
Aim 1 Hypothesis 1: The odds of requiring intervention to initiate labor will be higher
by each BMI category compared with normal weight women.
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Analysis.
Binary logistic regression assumptions and requirements. A binary logistic
regression predicts the probability that an observation falls into one of two categories
(Meyers, Gamst, & Guarino, 2017). Basic assumptions for logistic regression are
adequate sample size, absence of multicollinearity, independence of errors, and absence
of outliers (Meyers et al., 2017; Stoltzfus, 2011). Logistic regression is based on
estimation, so the assumptions for this test are less restrictive than the assumptions in a
linear model. The data were assessed for independence of observations, outliers, and
multicollinearity. Multicollinear variables were BMI and height, hospital type, obstetric
care level, and NICU level. Height was not included in the models. Obstetric care level
and NICU level were not included as predictors in the models. Hospital type was
retrained as a predictor, as the collinear relationship improved with the exclusion of the
other variables from the models.
Adequate sample size is generally 10 to 20 events per covariate (Stoltzfus, 2011). The
sample size within this analysis meets this assumption and is considered an adequate size
for logistic regression. A binary logistic regression requires a dichotomous dependent
variable, and two or more independent variables that are measured at the scale interval or
ratio level (dichotomous dummy variables are also allowed) (Meyers et al., 2017). The
data meet these assumptions and are adequate for linear regression.
Unadjusted model. A standard binary logistic regression was used to model the binary
variable Cervical ripening. Cervical ripening is a newly created variable that describes
whether or not cervical ripening (misoprostol, other prostaglandin, or mechanical means)
was used for induction of labor (using ‘no’ (0) as the reference category). The
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independent or predictor variable in this study was BMI at time of hospital admission.
Based on classification threshold predictive probability of having used cervical ripening
as 0.5, results of the logistic regression analysis indicate the single categorical predictor
of BMI within the model provided a statistically significant prediction of the use of
cervical ripening (χ2 (4, N= 37,149 = 119.99, p < .001). The Nagelkerke pseudo R2
indicated the model accounted for approximately .5% of the total variance. Classification
accuracy for all the cases was based on a classification cut off value of .500 for predicting
the use of cervical ripening by BMI category was moderately high, with an overall
correct prediction rate of 83.8%, and correct prediction rates of 100 % in women not
receiving cervical ripening and 0 % in women receiving cervical ripening, Table 11
summarizes the unadjusted binary logistic regression reporting the unadjusted odds of
being induced with one or more of the following misoprostol, PGE2, or mechanical
means by BMI within the selected sample.
Table 11
Unadjusted Odds for Women undergoing Induction of Labor requiring Cervical Ripening
with one or more of the following Misoprostol, PGE2, or Mechanical Means by BMI
Variables in the
Equation

B

S.E.

Wald

df

Odds
ratio

95%
CI
Lower

95%
CI
Upper

P
value

Normal weight
121.86 4
1.00
< .001
Overweight
0.14 0.05 8.29
1
1.15
1.05
1.26
.004
Obese Cat 1
0.25 0.05 25.22 1
1.28
1.16
1.41
< .001
Obese Cat 2
0.42 0.06 57.78 1
1.53
1.37
1.71
< .001
Obese Cat 3
0.54 0.06 78.13 1
1.71
1.52
1.93
< .001
Notes. Normal weight used as the referent category. Table abbreviations. df, degrees of
freedom; CI, confidence interval; cat, category
Adjusted model. A standard binary logistic regression was used to model the binary
variable aim 1 outcome. Aim 1 outcome describes whether or not cervical ripening
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methods (misoprostol, other prostaglandin, or mechanical means) were used for induction
of labor (using ‘no’ (0) as the reference category). The independent or predictor variables
in this study were maternal age, parity, maternal race, insurance status, hospital type, and
birth weight (g). Based on classification threshold predictive probability of having used
cervical ripening as 0.5, results of the 6 categorical variables and 3 continuous variables
in the logistic regression analysis indicate the predictors within the model provided a
statistically significant prediction of the use of cervical ripening (χ2 (14, N= 37,149) =
2097.69, p < .001). The model had a low predictive value, the Nagelkerke pseudo R2
indicated the model accounted for approximately 9.4% of the total variance.
Classification accuracy for all the cases was based on a classification cut off value of .500
for predicting the use of cervical ripening by BMI category was moderately high, with an
overall correct prediction rate of 83.7%, and correct prediction rates of 99.8 % in women
not receiving cervical ripening and 0.5 % in women receiving cervical ripening, Table 12
presents the partial regression coefficients, the odds ratio [Exp (B)], and the confidence
interval (CI) for the odds ratio for each predictor and the p value.
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Table 12
Adjusted Odds Ratios for use of one or more Cervical Ripening Methods for Induction of
Labor
Variables in the
95%
95%
equation
B
S.E.
Wald
df
OR
C.I.
C.I.
P value
(n = 37,149)
LB
UB
Normal weight
131.20 4
1.00
< .001
Overweight
0.15 0.05
9.71
1
1.17
1.06
1.28
.002
Obese Cat 1
0.29 0.05
30.80
1
1.33
1.20
1.48
< .001
Obese Cat 2
0.48 0.06
67.13
1
1.62
1.44
1.82
< .001
Obese Cat 3
0.59 0.07
83.71
1
1.81
1.59
2.05
< .001
Maternal age
0.01 0.00
18.26
1
1.01
1.01
1.02
< .001
Parity
0.86 0.03 694.43
1
2.36
2.21
2.52
< .001
White Non30.62
3
1.00
< .001
Hispanic
Black Non-0.17 0.05
11.40
1
0.84
0.76
0.93
.001
Hispanic
Hispanic
0.10 0.04
5.82
1
1.11
1.02
1.21
.016
Other
-0.07 0.05
1.66
1
0.93
0.84
1.04
.198
Insurance-Private
112.40
2
1.00
< .001
Insurance- Public
0.41 0.04 106.56
1
1.50
1.39
1.62
< .001
Insurance-Other
0.33 0.05
44.71
1
1.39
1.26
1.53
< .001
University
1,084.02 2
1.00
< .001
teaching hospital
Community
1.26 0.04 919.04
1
3.51
3.23
3.80
< .001
teaching hospital
Community non0.32 0.06
25.76
1
1.38
1.22
1.60
< .001
teaching hospital
Birth weight (g)
0.00 0.00
4.88
1
1.00
1.00
1.00
.027
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance,
University teaching hospital. Abbreviations. OR odds ratio; CI, confidence interval; LB,
lower bound; UB, upper bound; cat, category
Model testing. Model testing includes testing outliers, leverage and influence (Field,
2013; Zhang, 2016). Testing for model outliers displays a pattern with an unusual
condition (Zhang, 2016). A univariate outlier is not necessarily a regression outlier. A
regression outlier is a record or case that has an unusual value on the outcome variable
(Field, 2013). Leverage is defined as a case that has an unusual x value (Zhang, 2016).

85
Whereas, influence refers to the amount of influence a covariate has on the y value
(Zhang, 2016). Influence is a product of leverage and outliers, that is when an influence is
dropped from the model there is a significant shift in the coefficient or intercept of the
model (Zhang, 2016). Cook’s distance is a commonly used measure of influence of
covariates within a model (Field, 2013). A Cook’s distance of greater than one calls for
further investigation into individual covariates. If the Cook’s distance is less than one
“just move ahead” (Field, 2013). Model testing, betas were checked. There were no cases
of leverage, influence or outliers. The maximum Cook’s distance was .01017, which is
less than one, requiring no additional investigation.
Aim 1 summary. Results of A1H1 analysis show the odds of requiring cervical
ripening as part of the induction process were higher by each BMI category compared
with normal weight women. The adjusted model showed BMI was a statistically
significant predictor of the use of cervical ripening methods for induction of labor.
Additionally, maternal age, parity, race categories (except other), insurance, hospital
type, and birth weight were statistically significant predictors for the use of cervical
ripening for labor induction.
Aim Two
Aim 2 [should the #2 be spelled out?] states “Time to birth: Compare the
effectiveness of cervical ripening methods during labor induction (misoprostol, PGE2,
and mechanical means) by the time from hospital admission to birth with results
stratified by BMI category”
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Aim 2 Hypotheses
A2H1: Women induced with misoprostol will have a shorter time to birth as
compared to women induced using other prostaglandins, and this time differential will be
more pronounced with each successive BMI category.
A2H2: Women induced with mechanical means will have a shorter time to birth
as compared to women induced using either prostaglandin (misoprostol or other
prostaglandins), and this time differential will be more pronounced with each successive
BMI category.
Aim 2 Sample
A new, smaller sample was created for the analysis of Aims 2 and 3. The smaller
sample is comprised of women undergoing induction of labor requiring cervical ripening
(n = 6,035). These data are escribed in comparison to the sample of 41,539 women
undergoing induction of labor. The median maternal age and height were similar to the
original sample. There were a greater number of nulliparous women in this new smaller
sample. A greater number of women were non-Hispanic white, with fewer women being
non-Hispanic black. Insurance type was similar between both samples.
The cervical dilation differences between the two groups, induction of labor and
induction of labor with cervical ripening, were difficult to assess as there were a greater
number of missing data on cervical dilation in the women undergoing cervical ripening
17% verses 30%, respectively. The gestational age was similar between the two groups of
women. Birthweight was similar between the groups. Table 13 summarizes the
descriptive statistics for the use of cervical ripening.
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Table 13
Sample Characteristics: Cervical Ripening for Induction of Labor
Individual Characteristics
Maternal age (y)
Height (m)
Parity
Nulliparous
Multiparous
Maternal race/ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Other/unknown
Insurance type
Private
Public
Other/Unknown
BMI at hospital admission
Normal weight
Overweight
Obese Cat 1
Obese Cat 2
Obese Cat 3
Cervical dilation admission (cm)
0-.99
1.00-1.99
2.00-2.99
3.00-3.99
4.00-4.99
5.00-5.99
Missing data

n (%)

Median (IQR)
27 (9)
1.65 (0.1)

3,775 (62.6)
2,260 (37.4)
3,466 (57.4)
827 (13.7)
1,224 (20.3)
518 (8.6)
3,202 (53.1)
1,775 (29.4)
1,058 (17.5)
30.5 (7.89)
669 (11.1)
2,154 (35.7)
1,688 (28.0)
889 (14.7)
635 (10.5)
823 (13.6)
1,811 (30)
688 (11.4)
601 (10)
233 (3.9)
48 (1.1)
1,831 (30.3)
(Table 13 Continues)
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(Table 13 Continued)
Individual Characteristics

n (%)

Median (IQR)

Gestational age
37.00-37.99
587 (9.6)
38.00-38.99
963 (16)
39.00-39.99
1,852 (30.7)
40.00-40.99
1,160 (27.5)
41.00-41.99
982 (16.3)
Birth weight (g)
3,373 (618)
Hospital type
University Affiliated, Teaching
2,535 (42.0)
Community, Teaching
3,028 (50.2)
Community, Non-teaching
472 (7.8)
Hospital level for obstetric care
Secondary
472 (1.8)
Tertiary
5,563 (90.2)
Highest level of neonatal care
No NICU
172 (2.9)
Level 2 (specialty)
535 (9.0)
Level 3 (subspecialty)
5,328 (88.3)
Notes. Abbreviations: years (y); meter (m); centimeters (cm); Body mass index (BMI);
grams (g); interquartile range, IQR; Grams, (g); Neonatal care unit. NICU.
Descriptive Statistics for Induction of Labor Methods
Descriptive statistics are provided for cervical ripening methods (misoprostol,
PGE2, and mechanical means used alone or in combination) and the use of Pitocin or
amniotomy for induction of labor. Since there are no defined temporal relationships in the
CSL database, Pitocin and amniotomy will be used as covariates. Table 14 describes the
use of cervical ripening methods (misoprostol, PGE2, and mechanical means used alone
or in combination) along with the use Pitocin and amniotomy for induction of labor.
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Table 14
Labor Induction Methods including Cervical Ripening Methods (Misoprostol, PGE2 and
Mechanical Means), Pitocin, and Amniotomy n (%).
n (%)
Pitocin
Cervical Ripening Method (n = 6,035)
(n = 2,930)
Misoprostol
2,203 (36.5)
203 (6.9)
PGE2
2,100 (34.8)
1,328 (45.3)
Mechanical + Miso
908 (15.0)
908 (31.0)
Mechanical
504 (8.4)
215 (7.3)
Mechanical + PGE2
173 (2.9)
146 (5.0)
Miso+ PGE2
113 (1.9)
96 (3.3)
Mechanical +Miso +PGE2
34 (0.6)
34 (1.2)
Notes. PGE2 Prostaglandin analogue 2; miso, misoprostol

Amniotomy
(n = 2,841)
105 (3.7)
1,237 (43.5)
889 (31.6)
340 (12.0)
145 (5.1)
84 (3.0)
31 (1.1)

Bivariate Analysis
Bivariate analysis of induction of labor methods requiring cervical ripening by
BMI category showed most women requiring cervical ripening were induced with
misoprostol, other prostaglandins, mechanical means, or mechanical means with
misoprostol. Misoprostol alone was used 36.5% of the time, other prostaglandins were
used with 34.8%, mechanical means were used with 8.4%, and mechanical means with
miso were used with 15% of inductions requiring cervical ripening. The other methods
(Miso+ PGE2, Mechanical + PGE2, and Mechanical +Miso +PGE2) were rarely used
and were not included in hypothesis testing for Aim 2. Table 15 summarizes the bivariate
analysis of cervical ripening method by BMI category with chi squared for significance.
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Table 15
Cervical Ripening Induction Methods by BMI Category using Chi-square for Significance
Induction Method

Normal
weight
(n = 669)

Overweight
(n = 2,154)

Obese Cat
1
(n = 1,688)

Obese Cat
2
(n = 889)

Obese Cat
3
(n = 635)

Total
(n = 6,035)

Cervical ripening

P
value
< .001

2,203
(36.5)
2,100
(34.8)
504 (8.4)
908 (15.0)
113 (1.9)
173 (2.9)
34 (0.6)

Misoprostol

229 (34.2)

765 (35.5)

645 (38.2)

340 (38.2)

224 (35.3)

PGE2

279 (41.7)

812 (37.7)

552 (32.7)

256 (28.8)

201 (31.7)

Mechanical
Mechanical + Miso
Miso+ PGE2
Mechanical + PGE2
Mechanical +M+P
Cervical ripening
(collapsed)

39 (5.8)
85 (12.7)
12 (1.8)
20 (3.0)
5 (0.7)

150 (7.0)
335 (15.6)
26 (1.2)
56 (2.6)
10 (0.5)

148 (8.8)
259 (15.3)
32 (1.9)
40 (2.4)
12 (0.7)

86 (9.7)
143 (16.1)
25 (2.8)
36(4.0)
3 (0.3)

81 (12.8)
86 (13.5)
18 (2.8)
21 (3.3)
4 (0.1)

Misoprostol

241(36.0)

791 (36.7)

677 (40.1)

365 (41.1)

242 (38.1)

PGE2

279 (41.7)

812 (37.7)

552 (32.7)

256 (28.8)

201 (31.7)

Mechanical

149 (22.3)

551 (25.6)

459 (27.7)

268 (30.1)

192 (30.2)

Pitocin

332 (49.6)

1,075
(49.9)

802 (47.5)

429 (48.3)

292 (46.0)

2,930
(48.6)

.363

265 (41.7)

2,841
(47.1)

.020

< .001

1.055
781 (46.3) 414 (46.6)
(49.0)
Notes. Miso, misoprostol; PGE2, Prostaglandin analogue 2; M, miso; P, PGE2.
Amniotomy

326 (48.7)

2,316
(38.4)
2,100
(34.8)
1,619
(26.8)
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Kruskal Wallis for significance. A Kruskal Wallis is appropriate if there is
independence of observations and the outcome variable is ordinal and non-parametric
(Meyers, Gamst, & Guarino, 2017). Kruskal Wallis is a one-way ANOVA on ranks and
is an extension of the Mann Whitney U test where there are two groups being compared.
The Kruskal-Wallis test comparing time from hospital admission to birth in minutes by
BMI category showed there was a statistically significant difference in time to birth in
minutes between the different BMI groups, χ2(4) = 193.129, p < .001. This level was
found to be significant, meaning at least one sample dominates one other sample when
looking at the time to birth for all BMI groups. The Kruskal- Wallis test does not show
where the differences in rank occur.
The Kruskal-Wallis test showed a statistically significant difference in time from
hospital admission to birth in minutes between the different cervical ripening method
groups, χ2(6) = 446.285, p < .001 and χ2(3) = 331.533, p < .001 for the cervical ripening
groups. These levels were found to be significant, meaning at least one sample
dominates one other sample when looking at the time to birth for all BMI groups. We are
unable to determine which sample is dominate with the Kruskal Wallis test. The median
time to birth can help illustrate the difference in time to birth between groups. Table 16
summarizes the number of women induced with each cervical ripening method, n (%),
the median time to birth in minutes, with the interquartile range noted, and finally the
significance value from the Kruskal Wallis test is included
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Table 16
Kruskal Wallis, Comparison for Time to Birth (Time from Hospital Admission to Birth in
Minutes) by Cervical Ripening Method
Variable

N = 6,035

Median
(minutes)

Interquartile range

P
value
< .001

BMI
Normal weight
668 (11.1)
831.50
539.00 – 1,203.75
Overweight
2,151 (35.7)
929.00
596.00 – 1,327.00
Obese Cat 1
1,685 (28.0)
1,058.00
705.50 – 1,449.00
Obese Cat 2
884 (14.7)
1,114.00
753.00 -1,477.50
Obese Cat 3
634 (10.5)
1,182.00
802.00 -1,708.75
Cervical ripening
< .001
Misoprostol
2,191 (36.5)
1,103.50
785.00 – 1,483.00
Other prostaglandins
2,099 (34.8)
753.00
465.00 – 1,343.00
Mechanical
504 (8.4)
1,098.50
853.25 – 1,335.75
Mechanical + and PGE2
173 (2.9)
1,299.00
1,081.50 – 1,502.50
Mechanical and miso
908 (15.0)
1,007.00
663.25 – 1,309.25
Miso and PGE2
113 (1.9)
1,670.00
1,020.00 - 2,321.50
Mechanical+miso+PGE2
34 (0.6)
1,569.00
1,202.25 – 2,062.00
Cervical ripening
< .001
(collapsed categories)
Misoprostol
2,304 (38.2)
1,103.50
789.00 – 1,524.00
Other prostaglandins
2,099 (34.8)
753.00
465.00 – 1,343.00
Mechanical
1,619 (26.8)
1,068.00
769.00 – 1,358.00
Type of Birth
< .001
Vaginal
4,314 (71.6)
893.00
589.00 – 1,264.00
Cesarean
1,708 (28.4)
1,307.00
949.00 – 1,737.75
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance,
University teaching hospital. Kruskal-Wallis test for significance; reporting median,
interquartile range and significance value.
Multivariate Analysis
Survival analysis. Survival analysis was chosen for the analysis of Aim 2 due to

the non-normal distribution of the data. Survival analysis is a time to event analysis, often
reported using lifetables, Kaplan-Meier curves, or the Cox proportional hazard regression
model (Meyers et al., 2017; Singh & Mukhopadhyay, 2011). Life tables are commonly
used in epidemiology as they can be used in large samples, whereas the Kaplan Meier
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survival analysis is more appropriately used in smaller populations (Meyers et al., 2017).
Neither of these analyses are able to assess the relationships of covariates within a model.
The cox proportional hazard regression model simply known as the cox regression was
used to analyze Aim 2 as there is no distributional assumptions required and covariates
can be used within the model (Meyers et al., 2017). The cox regression method is used to
predict the occurrence of an event at a particular time and to model the time to a specific
event (Meyers et al., 2017). In this case, we are modeling the time from hospital
admission to birth.
Assumptions for cox regression are that the independent variable or predictor
variables (covariates) are time constant (Meyers et al., 2017). The cox regression is
typically represented in terms of a hazard ratio (i.e., the rate per unit time a case will
experience the event given it survived to that point). A cox regression requires a
dichotomously coded status variable (in this case the type of birth vaginal or cesarean,
with data being censored at time of cesarean birth) that serves as the dependent measure,
a time variable (can be continuous or categorical) that assesses the duration to the event
defined by the status variable, and covariates that are independent or predictor variables,
either continuous or categorical. As stated, the status variable is type of birth. For time,
the minutes from hospital admission to birth represented the time to birth. The variable
type of birth is an indicator of censorship, with birth type vaginal birth coded as 0
(uncensored) and cesarean birth coded as 1 (censored). The null model shows among the
6,022 cases 4,314 (71.8%) were uncensored because they were able to have a vaginal
birth, with 1,708 (28.3%) cases censored for cesarean birth. Figure 4 summarizes the time
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from hospital admission to birth for all women needing cervical ripening for labor
induction.

Figure 5. Time from Hospital Admission to Birth for Women needing Cervical Ripening
for Labor Induction
Building on the previous model, adding BMI as a covariate, type of birth is an
indicator of censorship, with birth type vaginal birth coded as 0 (uncensored) and
cesarean birth coded as 1 (censored). The model shows among the 6,022 cases 4,314
(71.8%) were uncensored because they were able to have a vaginal birth, with 1,708
(28.3%) cases censored for cesarean birth. After adjusting for the covariates, there was a
statistically significant effect on time to birth 2 (4, N = 6,022), = 288.40, p = < .001.
Cumulative survival rates for time from hospital admission to birth by BMI category for
women requiring cervical ripening for labor induction are displayed in Figure 6.
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Figure 6. Minutes from Admission to Birth by BMI Category
Table 17 summarizes the hazard ratios for time from hospital admission to birth
by BMI category.
Table 17
Hazard Ratios for Time from Hospital Admission to Birth by BMI Category
BMI
Hazard
B
SE
Wald
df
category
ratio
Normal
weight
279.19
4
1.00
Overweight
-0.21
0.05
18.75
1
0.81
Obese Cat 1
-0.50
0.05
92.81
1
0.61
Obese Cat 2
-0.64
0.06
112.79
1
0.53
Obese Cat 3
-0.91
0.07
181.51
1
0.40
Notes. Normal weight used as reference category.

95.0%
CI LB

95% CI
UB

P
value

0.74
0.55
0.47
0.35

0.89
0.67
0.60
0.46

< .001
< .001
< .001
< .001
< .001
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Survival analysis by BMI category. Aim 2 is a comparison of the time from
hospital admission to the time to birth for women using different cervical ripening
methods for induction of labor by BMI category. In order to test the hypotheses within
Aim 2, a survival analysis was run for each BMI category. Using the type of birth as an
indicator of censorship and the variable Cervical ripening collapsed as a covariate on step
one of the models. Step 2 has the additional covariates of maternal age, parity, race,
insurance status, hospital type, Pitocin, amniotomy and birth weight(g). Table 18
summarizes the Omnibus Tests of Model Coefficients as well as significance levels of the
side by side models using chi square for significance
Table 18
Omnibus Tests of Model Coefficients for Covariates entered into the Survival Analyses
that were run Side by Side to Reports Stratified Results by BMI Category
BMI Category
Chi-square
Normal weight
328.82
Overweight
1,150.05
Obese Cat 1
841.21
Obese Cat 2
520.69
Obese Cat 3
320.17
Notes. Model scores for significance in overall models.
BMI; degrees of freedom, DF; category, cat.

df
P value
14
< .001
14
< .001
14
< .001
14
< .001
14
< .001
Abbreviations Body mass index,

Normal Weight. Among the 665 cases of normal weight women 562 (84 %)
were uncensored for vaginal birth, with 103 (15.4%) cases censored for cesarean birth.
After adjusting for the covariates, there was a statistically significant effect on time to
birth at step 1 2(2, N = 665), = 39.35, p < .001, and step 2 2(12, N = 665), = 267.50, p <
.001. Cumulative survival rates for time to birth are displayed in Figure 4.
Overweight. Among the 2,147 cases of overweight women 1,655 (76.8%) cases
were uncensored for vaginal birth, with 492 (22.8%) cases censored for cesarean birth.
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After adjusting for the covariates, there was a statistically significant effect on time to
birth at step 1 2(2, N = 2,147), = 157.58 p < .001, and step 2 2(12, N = 2,147),
= 992.21, p < .001. Cumulative survival rates for time to birth are displayed in Figure 5.
Obese cat 1. Among the 1,676 cases 1,165 in obese cat 1 (69 %) were event cases
for vaginal birth, with 511 (30.3 %) cases censored for cesarean birth. After adjusting for
the covariates, there was a non-statistically significant effect on time to birth at step 1
2(2, N = 1,676), = 58.63, p < .001 at step 2 2(12, n= 1676), 775.56, p < .001.
Cumulative rates for time to birth for obese cat 1 are displayed in Figure 6.
Obese cat 2. Among the 880 cases in obese cat 2 559 (62.9%) were uncensored
because they were able to have a vaginal birth, with 321 (36.1 %) cases censored for
cesarean birth. After adjusting for the covariates, there was a non-statistically significant
effect on time to birth step 1 2(2, N = 880), = 39.33, p < .001 at step 2 2(12, N = 880),
= 486.60, p < .001. Cumulative survival rates for time to birth for obese cat 2 are
displayed in Figure 7.
Obese cat 3. Among the 629 cases 357 (56.2%) were uncensored for vaginal
birth, with 272 (42.8%) cases censored for cesarean birth. After adjusting for the
covariates, there was a statistically significant effect on time to birth at step 1 2(2,
N = 629), = 17.74, p < .001, at step 2 2(12, N = 629), = 301.90, p < .001. Cumulative
survival rates for time to birth for obese cat 3 are displayed in Figure 8.
These survival analyses were run as side by side by each BMI category. Table 19
describes the unadjusted hazard ratios on step 1 and the adjusted Hazard ratios on step 2
for cervical ripening methods used for induction of labor by BMI category. The adjusted
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hazard ratios include the following covariates age, parity, race, insurance, hospital type,
birth weight, Pitocin and amniotomy by BMI category.
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Table 19
Hazard Ratios for Induction Methods and Covariates by BMI Category
BMI
category
Normal
weight

Step
entered

Variable in the
equation

Step 1

Misoprostol

Step 2

Other
prostaglandins
Mechanical
Misoprostol
Other
prostaglandins
Mechanical
Maternal age
Parity
Race-white
Race-non-Hispanic
black
Race-Hispanic
Race-other
unknown
Insurance-Private
Insurance Public
Insurance-other
unknown
University teaching

B

SE

Wald

df

Hazard
ratio

95.0% CI
LB

95.0%
CI UB

p value

39.15

2

1.00

-

-

< .001

0.61

0.10

38.43

1

1.84

1.52

2.22

< .001

0.27

0.12

5.39
32.04

1
2

1.31
1.00

1.04
-

1.65
-

.020
< .001

0.24
-0.47
-0.05
-1.04

0.12 4.05
0.15 9.45
0.01 26.84
0.10 109.16
5.36

1
1
1
1
3

1.27
0.63
0.96
0.35
1.00

1.01
.47
.94
.29
-

1.61
.84
.97
.43
-

.044
.002
< .001
< .001
.148

-0.44

0.19

5.30

1

0.65

.45

.94

.021

-0.11

0.14

.60

1

0.90

.69

1.18

.438

-0.03

0.15

.03

1

0.98

.73

1.30

.860

-0.52

0.13

40.22
15.66

2
1

1.00
0.59

.46

.77

< .001
< .001

0.52

0.19

7.66

1

1.67

1.16

2.41

.006

26.82

2

1.00

-

-

< .001

(Table 19 Continues)
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BMI
category

Overweight

Step
entered

Step 1

Step 2

Variable in the
equation
Community
teaching
Community nonteaching
Pitocin
Amniotomy
Birth weight (g)
Misoprostol
Other
prostaglandins
Mechanical
Misoprostol
Other
prostaglandins
Mechanical
Maternal age
Parity
Race-white
Race-non-Hispanic
black
Race-Hispanic
Race- other
unknown
Insurance-Private

B

SE

Wald

df

Hazard
ratio

95.0% CI
LB

95.0%
CI UB

p value

0.76

0.16

23.29

1

2.14

1.57

2.92

< .001

0.41

0.24

2.79

1

1.50

.93

2.42

.095

0.11
-0.72
0.00

0.14
0.15
0.00

.58
24.18
.05
152.91

1
1
1
2

1.11
0.49
1.00
1.00

.85
.37
1.00
-

1.47
.65
1.00
-

.446
< .001
.820
< .001

0.73

0.06 152.61

1

2.07

1.85

2.33

< .001

0.45

0.06

47.93
134.93

1
2

1.56
1.00

1.38
-

1.77
-

< .001
<.001

0.18

0.07

5.98

1

1.19

1.04

1.38

.014

-0.63
-0.03
-.1.14

0.09 47.87
0.01 32.36
0.06 432.04
23.84

1
1
2
3

0.54
0.97
0.32
1.00

.45
.96
.29
-

.64
.98
.36
-

<.001
<.001
<.001
<.001

-0.20

0.10

3.85

1

0.82

.67

1.00

.050

-0.31

0.08

16.32

1

0.73

.63

.85

<.001

-0.35

0.10

11.98

1

0.71

.58

.86

.001

174.86

2

1.00

-

-

<.001
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BMI
category

Obese Cat 1

Step
entered

Step 1

Step 2

Variable in the
equation
Insurance Public
Insurance-other
unknown
University teaching
Community
teaching
Community nonteaching
Pitocin
Amniotomy
Birth weight (g)
Misoprostol
Other
prostaglandins
Mechanical
Misoprostol
Other
prostaglandins
Mechanical
Maternal age
Parity
Race-white

1

Hazard
ratio
0.75

95.0% CI
LB
.65

95.0%
CI UB
.867

97.25

1

2.90

2.35

3.59

<.001

185.21

2

1.00

-

-

<.001

1.28

0.10 183.35

1

3.60

2.99

4.33

<.001

1.12

0.14

66.00

1

3.05

2.33

3.99

<.001

-0.22
-0.47
0.00

0.08
0.09
0.00

7.61
29.56
.53
56.21

1
1
1
2

0.80
0.63
1.00
1.00

.68
.53
1.00
-

.94
.74
1.00
-

.006
<.001
.469
< .001

0.46

0.07

43.27

1

1.59

1.39

1.83

< .001

0.47

0.07

40.00
48.93

1
2

1.60
1.00

1.38
-

1.84
-

< .001
< .001

0.08

0.09

.82

1

1.08

0.91

1.29

.365

-0.48
-0.02
-1.19

0.11 21.70
0.01 17.19
0.07 341.64
12.46

1
1
1
3

0.61
0.98
0.30
1.00

0.49
0.97
0.27
-

0.75
0.99
0.34
-

< .001
< .001
< .001
.006

B

SE

Wald

df

-0.28

0.07

15.50

1.07

.011

p value
<.001
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BMI
category

Obese Cat 2

Step
entered

Step 1

Variable in the
equation
Race-non-Hispanic
black
Race-Hispanic
Race- other
unknown
Insurance-private
Insurance public
Insurance-other
unknown
University teaching
Community
teaching
Community nonteaching
Pitocin
Amniotomy
Birth weight (g)
Misoprostol
Other
prostaglandins
Mechanical

B

SE

Wald

df

Hazard
ratio

95.0% CI
LB

95.0%
CI UB

p value

-0.35

0.11

10.40

1

0.70

0.57

0.87

.001

-0.19

0.09

4.78

1

0.83

0.70

0.98

.029

-0.20

0.11

2.97

1

0.82

0.66

1.03

.085

-0.37

0.08

137.89
19.47

2
1

1.00
0.69

0.59

0.82

< .001
< .001

1.06

0.13

71.88

1

2.89

2.27

3.70

< .001

127.84

2

1.00

-

-

< .001

1.29

0.12 126.93

1

3.65

2.91

4.57

< .001

1.32

0.16

71.99

1

3.75

2.76

5.09

< .001

-0.01
-0.50
0.00

0.09
0.10
0.00

.02
25.31
.02
39.16

1
1
1
2

0.99
0.61
1.00
1.00

0.83
0.50
1.00
-

1.18
0.74
1.00
-

.900
< .001
.902
< .001

0.64

0.10

39.10

1

1.90

1.55

2.32

< .001

0.35

0.11

11.13

1

1.42

1.16

1.75

.001
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BMI
category

Step
entered
Step 2

Variable in the
equation
Misoprostol
Other
prostaglandins
Mechanical
Maternal age
Parity
Race-white
Race-non-Hispanic
black
Race-Hispanic
Race- other
unknown
Insurance-private
Insurance public
Insurance-other
unknown
University teaching
Community
teaching
Community nonteaching
Pitocin
Amniotomy
Birth weight (g)

B

SE

2

Hazard
ratio
1.00

95.0% CI
LB
-

95.0%
CI UB
-

Wald

df

50.33

p value
< .001

0.50

0.13

14.95

1

1.64

1.28

2.11

< .001

-0.33
-0.03
-1.57

0.15 4.72
0.01 10.90
0.10 249.41
11.98

1
1
1
3

0.72
0.97
0.21
1.00

0.54
0.96
0.17
-

0.97
0.99
0.25
-

.030
.001
< .001
.007

-0.23

0.15

2.19

1

0.80

0.59

1.08

.139

-0.46

0.13

11.89

1

0.63

0.49

0.82

.001

-0.17

0.19

.85

1

0.84

0.59

1.21

.356

-0.08

0.12

105.72
.42

2
1

1.00
0.93

0.73

1.17

< .001
.520

1.64

0.19

75.92

1

5.14

3.55

7.42

< .001

111.50

2

1.00

-

-

< .001

1.55

0.15 107.35

1

4.69

3.50

6.29

< .001

1.17

0.22

29.32

1

3.21

2.10

4.89

< .001

0.08
-0.57
0.00

0.13
0.14
0.00

.41
17.61
4.15

1
1
1

1.09
0.57
1.00

0.85
0.44
1.00

1.39
0.74
1.00

.520
< .001
.042
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BMI
category
Obese Cat 3

Step
entered
Step 1

Step 2

Variable in the
equation
Misoprostol
Other
prostaglandins
Mechanical
Misoprostol
Other
prostaglandins
Mechanical
Maternal age
Other
prostaglandins
Mechanical
Maternal age
Parity
Race-white
Race-non-Hispanic
black
Race-Hispanic
Race-other
unknown
Insurance-private
Insurance public

B

SE

2

Hazard
ratio
1.00

95.0% CI
LB
-

95.0%
CI UB
-

Wald

df

17.53

p value
.000

0.31

0.13

5.72

1

1.37

1.06

1.77

.017

0.55

0.13

17.40
18.52

1
2

1.73
1.00

1.34
-

2.24
-

< .001
< .001

0.48

0.15

10.20

1

1.62

1.20

2.17

.001

-0.09
-0.04

0.17
0.01

.28
12.66

1
1

0.91
0.97

0.65
0.95

1.28
0.98

.600
< .001

0.50

0.13

14.95

1

1.64

1.28

2.11

<.001

-0.33
-0.03
-1.57

0.15 4.72
0.01 10.90
.10 249.41
11.98

1
1
1
3

0.72
0.97
0.21
1.00

0.54
0.96
0.17
-

0.97
0.99
0.25
-

0.030
.001
<.001
.007

-0.23

0.15

2.19

1

0.80

0.59

1.08

.139

-0.46

0.13

11.89

1

0.63

0.49

0.82

.001

-0.17

0.19

.85

1

.84

0.59

1.21

.356

-0.08

105.72
0.12
.42

2
1

1.00
0.93

0.73

1.17

<.001
.520

(Table 19 Continues)
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(Table 19 Continued)
BMI
category

Step
entered

Variable in the
Hazard
95.0% CI
95.0%
B
SE Wald df
p value
equation
ratio
LB
CI UB
Insurance-other
1.64 0.19 75.92 1
5.14
3.55
7.42
<.001
unknown
University teaching
111.50 2
1.00
<.001
Community
1.55 0.15 107.35 1
4.69
3.50
6.29
<.001
teaching
Community non1.17 0.22 29.32 1
3.21
2.10
4.89
<.001
teaching
Pitocin
0.08 0.13
.41
1
1.09
0.85
1.39
.520
Amniotomy
-0.57 0.14 17.61 1
0.57
0.44
0.74
<.001
Birth weight (g)
0.00 0.00 4.15
1
1.00
1.00
1.00
.042
Obese Cat 3
Step 1
Misoprostol
17.53 2
1.00
.000
Other prostaglandin
0.31 0.13 5.72
1
1.37
1.06
1.77
.017
Mechanical
0.55 0.13 17.40 1
1.73
1.34
2.24
<.001
Step 2
Misoprostol
18.52 2
1.00
<.001
Other prostaglandin
0.48 0.15 10.20 1
1.62
1.20
2.17
.001
Mechanical
-0.09 0.17
.28
1
0.91
0.65
1.28
.600
Maternal age
-0.04 0.01 12.66 1
0.97
0.95
0.98
<.001
Notes Referent categories: Misoprostol, Non-Hispanic white, Private insurance, University teaching hospital. Abbreviations.
BMI, body mass index; CI, confidence interval; LB, lower bound; UB, upper bound; cat, category
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Figures for cumulative survival rates. These figures represent the time from
hospital admission to birth (in minutes) for each BMI category. Cumulative survival rates
for time to birth for cases in the normal weight category are displayed in Figure 7.
Cumulative survival rates for time to birth for cases in the overweight category are
displayed in Figure 8. Cumulative survival rates for time to birth with cases in the obese
cat 1 category are displayed in Figure 9. Cumulative survival rates for time to birth with
cases in the obese cat 2 category are displayed in Figure 10. Cumulative survival rates for
time to birth with cases in the obese cat 3 category are displayed in Figure 11.

Figure 7. Cumulative Survival Rates for Time to Birth for Normal Weight Women
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Figure 8. Cumulative Survival Rates for Time to Birth for Overweight Women

Figure 9. Cumulative Survival Rates for Time to Birth for Obese Category 1 Women
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Figure 10. Cumulative Survival Rates for Time to Birth for Obese Category 2 Women

Figure 11. Cumulative Survival Rates for Time to Birth for Obese Category 3 Women
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A2H1 Analysis. Women induced with misoprostol will have a shorter time to
birth as compared to women induced using Other prostaglandins, and this time
differential will be more pronounced with each successive BMI category.
To test this hypothesis the use of misoprostol (referent group) was compared to
the use of other prostaglandins as a single method for induction of labor requiring
cervical ripening. The adjusted hazard ratios for the use of other prostaglandins were
stratified by BMI category finding normal weight, (aHR 1.27 [CI 1.001 - 1.61], p = .044);
overweight, (aHR 1.19, [CI 1.04 – 1.38], p = 0.014); obese cat 1, (aHR 1.08, [CI .91 –
1.29], p = .365); obese cat 2, (aHR 1.64, [CI 1.28 – 2.11], p < .001); and obese cat 3
(aHR 1.62, [CI 1.20 – 2.17], p = .001). Obese cat 2 and 3 had statistically significant
relationships with time from hospital admission to birth after using other prostaglandins
for labor induction requiring cervical ripening by BMI category when compared to using
misoprostol. The time from hospital admission to birth was shorter in each BMI category
for women using misoprostol as compared to the use of other prostaglandins. However,
the difference in Hazard ratios was not successively greater by each increase in BMI
category.
A2H2 Analysis. The time to birth will be shorter with the use mechanical
methods than the use of either prostaglandin (misoprostol or other prostaglandins). The
difference will be more pronounced by each increase in BMI category.
To test hypothesis two the use of mechanical means was compared to the use of
other prostaglandins. Misoprostol was the referent group in this analysis, so the use of
misoprostol is equal to one. For normal weight women the time from hospital admission
to birth was shorter with the use of mechanical means (aHR 0.62, [CI .47-.84], p = .002)
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than with the use of prostaglandins (aHR 1.27, [CI 1.00-1.61] p = .044). For overweight
women the use of mechanical means (aHR 0.53, [CI .44 -.64] p < .001) as compared to
the use of prostaglandins (aHR 1.19, [CI 1.04 – 1.38], p = .014). For women with obese
cat 1, the time from hospital admission to birth was shorter with the use of mechanical
means (aHR 0.61, [CI .49-.75], p <.001) than with the use of prostaglandins (aHR 1.08,
[CI .91 – 1.29], p = .365). For women with obese cat 2 the time to birth was shorter with
the use of mechanical means (aHR 0.72, [CI .54 – .97], p = .030) than with the use of
prostaglandins (aHR 1.64, [CI 1.28 – 2.11], p < .001). For women with obesity cat 3 the
time to birth was shorter with the use of mechanical means (aHR 0.91, [CI .65-1.28] p =
.600) than than with the use of prostaglandins (aHR 1.62, [CI 1.20 – 2.17], p = .001).
Relationships in the adjusted model show the use of mechanical means for
induction of labor requiring cervical ripening have a shorter time from hospital admission
to birth than the use of either prostaglandin (misoprostol or other prostaglandins). The
results of this study were statistically significant within all groups except for the use other
prostaglandins in obese cat 1 and use of mechanical means in obese cat 3 women. Table
20 summarizes the adjusted hazard ratios for the time from hospital admission to birth in
women requiring cervical ripening (misoprostol, other prostaglandins, or mechanical
means) as part of labor induction.
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Table 20
Unadjusted and Adjusted Hazard Ratios for the time from Hospital Admission to Birth in Women requiring Cervical Ripening as part
of Labor Induction
BMI
Category
Normal
weight

Cervical Ripening
Method

HR

Misoprostol

1.00

95.0% CI
LB

95.0% CI
UB

P value

aHR

< .001

1.00

95.0%
CI LB

95.0%
CI UB

P value
< .001

Other prostaglandins
1.84
1.52
2.22
< .001
1.27
1.01
1.61
.044
Mechanical
1.31
1.04
1.65
.283
0.63
0.47
0.84
.002
Overweight
Misoprostol
1.00
< .001
1.00
< .001
Other prostaglandins
2.07
1.85
2.33
< .001
1.19
1.04
1.38
.014
Mechanical
1.56
1.38
1.77
< .001
0.54
0.45
0.64
< .001
Obese Cat 1
Misoprostol
1.00
< .001
1.00
< .001
Other prostaglandins
1.59
1.39
1.83
< .001
1.08
0.91
1.29
.365
Mechanical
1.60
1.38
1.84
< .001
0.61
0.49
0.75
< .001
Obese Cat 2
Misoprostol
1.00
< .001
1.00
< .001
Other prostaglandins
1.90
1.55
2.32
< .001
1.64
1.28
2.11
< .001
Mechanical
1.42
1.16
1.75
.001
0.72
0.54
0.97
.030
Obese Cat 3
Misoprostol
1.00
.000
1.00
< .001
Other prostaglandins
1.37
1.06
1.77
.017
1.62
1.20
2.17
.001
Mechanical
1.73
1.34
2.24
< .001
0.91
0.65
1.28
.600
Notes. General table notes. Misoprostol used a referent group. Adjusted for age, parity, insurance, race, hospital type, birthweight,
Pitocin and amniotomy.
Abbreviations. BMI, body mass index; HR hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval; LB, lower bound; UB,
upper bound; cat, category
P value .05 for significance
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Predictors. Predictor variables included in the model were maternal age, parity,
race, insurance type, hospital type, birth weight, Pitocin use and amniotomy. Maternal
age and parity had statically significant relationships with the time from hospital
admission to birth in all BMI categories. Race had somewhat mixed results as a predictor
for time to birth, with a statistically significant relationship among all variable categories
noted only for the overweight category. Insurance type was statistically significant for all
BMI categories with the exceptions of obese cat 1 and obese cat 3. Hospital type was
statistically significant predictor among all BMI categories except normal weight women.
Birth weight was not a statistically significant predictor for time to birth, except for in the
overweight category. Pitocin was statistically significant for overweight weight, and
obese category 3 women, but not for other groups. Amniotomy was a statistically
significant predictor of time to birth in all BMI categories. Age, parity, and amniotomy
were statistically significant predictors across all BMI categories within the models.
Aim 2 Summary
The analysis of Aim 2 included two hypothesis found statistically significant
associations between the time from hospital admission to the time to birth in minutes and
BMI category. Bivariate analysis revealed a longer time to birth in minutes with each
successive BMI category. Hypothesis testing for A2H1 compared the use of misoprostol
to the use of other prostaglandins for cervical ripening finding a longer time from hospital
admission to birth after using other prostaglandins for labor induction requiring cervical
ripening in each BMI category when compared to using misoprostol. This relationship
remained statically significant in all categories for the use of misoprostol however the
relationship was not statistically significant for the use of other prostaglandins.
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Hypothesis testing A2H2 compared the use of prostaglandins with the use of mechanical
means for cervical ripening finding the relationships in the adjusted model show the use
of mechanical means alone or mechanical means with misoprostol for induction of labor
requiring cervical ripening have a shorter time from hospital admission to birth than the
use of either prostaglandin (misoprostol, or other prostaglandin). The results of this study
found a statistically significant relationship for all cervical ripening methods except other
prostaglandins. Predictors with the models that remained statistically significant across
all BMI categories were maternal age, parity, insurance status, hospital type, and the use
of amniotomy.
Aim Three
Aim 3 states “Cesarean birth: Examine the risk of cesarean birth after labor
induction involving cervical ripening among women by BMI category.”
Hypotheses-Aim 3. Aim three has three hypotheses; listed below.
A3H1: Compared to women with normal range BMI, the odds of cesarean birth
following labor induction requiring cervical ripening will be higher with each increase in
body mass index category.
A3H2. The odds of cesarean birth in women induced with misoprostol will be lower
compared to the odds in similar women induced using other prostaglandins.
A3H3. Women with obesity (in any obesity category) who are induced using
mechanical means will have lower odds of cesarean birth than women with obesity (in
any obesity category) induced with prostaglandins (misoprostol or other prostaglandins)
when compared to normal weight women.
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Bivariate analysis. Bivariate analysis was conducted by using the crosstabs function
is SPSS. The results of the chi squared test showed a significant association between type
of birth and BMI category. The selected sample had a overall cesarean birth rate of
28.4%. Table 21 summarizes the bivariate analysis (crosstabs) of Type of Birth by BMI
and the variable Induct_method_Cervical by BMI Category.
Table 21
Bivariate Analysis of type of Birth by BMI Category for needing Cervical Ripening for
Labor Induction n = 6,035
Variable

Vaginal birth
4,321 (71.6)

Cesarean birth
1,714 (28.4)

Total
6,035

Cervical ripening method
Miso
1,346 (61.1)
857 (38.9)
2,203
PGE2
1,664 (79.2)
436 (20.8)
2,100
Mechanical + Miso
759 (83.6)
149 (16.4)
908
Mechanical
365 (72.4)
139 (27.6)
504
Mechanical+PGE2
105 (60.7)
68 (39.3)
173
Miso+PGE2
60 (53.1)
53 (46.9)
113
Mechanical+PGE2+Miso
22 (64.7)
12 (35.3)
34
BMI category
Normal weight
566 (84.6)
103 (15.4)
669
Overweight
1,661 (77.1)
493 (22.9)
2,154
Obese Cat 1
1,171 (69.4)
517 (30.6)
1,688
Obese Cat 2
562 (63.2)
327 (36.6)
889
Obese Cat 3
361 (56.9)
274 (43.1)
635
Notes. Chi squared for significance. Abbreviations. Miso, Misoprostol; PGE2,
prostaglandin analogue 2; cat, category

P value
< .001

< .001

A3H1: Compared to women with normal range BMI, the odds of cesarean birth
following labor induction requiring cervical ripening will be higher with each increase in
body mass index category.
Multivariate Analysis A3H1.
Unadjusted model. A standard binary logistic regression was used to model the binary
variable type of birth (using 0 ‘vaginal’ as the reference category). The predictor variable
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in this study was the variable BMI at time of hospital admission. Based on classification
threshold predictive probability of having used cervical ripening as 0.5, results of the
logistic regression analysis indicate the single categorical predictor of BMI within the
model provided a statistically significant prediction of the use of cervical ripening (χ2 (4,
N = 6,035) = 192.33, p < .001). The Nagelkerke pseudo R2 indicated the model
accounted for approximately 4.5 % of the total variance. Classification accuracy for all
the cases was based on a classification cut off value of 0.50 for predicting vaginal birth
by BMI category was moderately high, with an overall correct prediction rate of 71.6%,
and correct prediction rates of 100 % in women having a vaginal birth and 0% in women
having a cesarean birth. Table 22 summarizes the logistic regression model by displaying
the unadjusted odds of having a cesarean birth after labor induction requiring cervical
ripening with misoprostol, PGE2 or mechanical means by BMI category.
Table 22
Unadjusted Odds of having a Cesarean Birth after Labor Induction requiring Cervical
Ripening with Misoprostol, PGE2 or Mechanical Means by BMI Category
Variables in the
Equation

B

S.E.

Wald

df

OR

95%
C.I.
LB

95%
C.I.
UB

P
value

Normal weight
183.55 4 1.00
< .001
Overweight
0.49 0.12 16.97 1 1.63
1.29
2.06
< .001
Obese Cat 1
0.89 0.12 55.07 1 2.43
1.92
3.06
< .001
Obese Cat 2
1.16 0.13 82.82 1 3.20
2.49
4.10
< .001
Obese Cat 3
1.43 0.13 183.55 4 4.17
3.20
5.42
< .001
Notes. Normal weight used as reference group. Abbreviations. OR odds ratio; CI,
Confidence interval; LB, lower bound; UB Upper bound; cat, category.
Adjusted model. A standard binary logistic regression was used to model the
binary variable type of birth (using 0 ‘vaginal birth’ as the reference category). The
predictor variables in this study were BMI at time of hospital admission, maternal age,
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parity, insurance status, race, hospital type, birth weight, Pitocin and amniotomy. Based
on classification threshold predictive probability of having used cervical ripening as 0.5,
results of the logistic regression analysis indicate the seven categorical variables and two
continuous variables as predictors within the model provided a statistically significant
prediction of type of birth (χ2 (16, N = 6,035) = 2257.49, p < .001). The Nagelkerke
pseudo R2 indicated the model accounted for approximately 44.9 % of the total variance.
Classification accuracy for all the cases was based on a classification cut off value of 0.50
for predicting the type of birth was moderately high, with an overall correct prediction
rate of 81.8%, and correct prediction rates of 92.2% in women having a vaginal birth and
55.5% of women having a cesarean birth. BMI at time of hospital admission, maternal
age, parity, insurance types (private, public and unknown), maternal race, and hospital
type all remained statistically significant predictors within the model. Table 23
summarizes the logistic regression model by displaying the adjusted odds ratio for
cesarean birth following induction of labor
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Table 23
Adjusted Odds Ratio for Cesarean Birth following Induction of Labor
Variables in the
Equation

B

S.E.

Wald

df

aOR

95% C.I.
LB

95%
C.I
UB

P
value

Normal weight
131.81 4 1.00
< .001
Overweight
0.54
0.14 14.65 1 1.72
1.30
2.27
< .001
Obese Cat 1
0.99
0.15 46.52 1 2.68
2.02
3.56
< .001
Obese Cat 2
1.29
0.16 68.42 1 3.62
2.60
4.92
< .001
Obese Cat 3
1.50
0.16 83.00 1 4.47
3.24
6.17
< .001
Maternal age
0.09
0.01 171.27 1 1.09
1.08
1.11
< .001
Parity
2.40
0.10 568.85 1 11.04
9.06
13.447 < .001
White-non25.56 3
< .001
Hispanic
Black non0.29
0.12 5.82
1 1.33
1.06
1.68
.016
Hispanic
Hispanic
0.44
0.11 17.91 1 1.56
1.27
1.91
< .001
Race0.45
0.13 12.80 1 1.57
1.23
2.00
< .001
other/unknown
Private insurance
602.54 2 1.00
< .001
Public insurance
0.66
0.09 48.89 1 1.93
1.60
2.32
< .001
Other insurance
-2.56 0.14 357.63 1 0.08
0.06
0.11
< .001
University
241.54 2 1.00
< .001
teaching
Community
-1.67 0.11 238.58 1 0.19
0.15
0.23
< .001
teaching
Community non-1.17 0.15 58.37 1 0.31
0.23
0.42
< .001
teaching
Pitocin
0.48
0.10 21.34 1 1.61
1.32
1.98
< .001
Amniotomy
-0.08 0.11 0.54
1 0.92
0.75
1.14
.462
Birth weight (g)
0.00
0.00 17.59 1 1.00
1.00
1.00
< .001
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance,
University teaching hospital. Abbreviations. aOR, adjusted odds ratio; CI, Confidence
interval; LB, lower bound; UB Upper bound; cat, category.
A3H1 summary. As compared to women with normal range BMI, the odds of
cesarean birth following labor induction involving cervical ripening will be higher with
each increase in body mass index category was supported with this analysis.
Hypothesis A3H1 was tested using a binary logistic regression analysis of the type of
birth and BMI at time of hospital admission. The findings showed increased odds of
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having a cesarean birth which increased with each successive increase in BMI category
for women requiring cervical ripening for induction of labor. After adjusting for maternal
age, parity insurance, race, hospital type, birth weight, Pitocin and amniotomy, all
relationships remained statistically significant except the use of amniotomy. This
hypothesis is was supported.
A3H2 and A3H3 Analysis
A3H2. The odds of cesarean birth in women induced with misoprostol will be lower
compared to the odds in similar women induced using Other prostaglandins.
Hypothesis. Women with obesity (in any obesity category) who are induced using
mechanical means will have lower odds of cesarean birth than women with obesity (in
any obesity category) induced with prostaglandins (misoprostol or other prostaglandins)
when compared to normal weight women.
Bivariate analysis. Bivariate analysis showing cross tabs with chi-square for
significance for BMI category and method of cervical ripening used for induction
misoprostol, other prostaglandins, mechanical, or mechanical with any prostaglandin
(miso, other prostaglandin or both). A new variable was created from the previous
induction method for cervical ripening with the collapsed categories. The misoprostol
category has cases of misoprostol alone as well as cases who used both miso and other
prostaglandins together (n = 113). The other prostaglandin category has cases where
other prostaglandins were used alone. The mechanical category has cases when
mechanical means were used alone or in combination with misoprostol, other
prostaglandins or both. Table 24 summarizes the bivariate analysis using the cross tabs
function for type of birth and method used for cervical ripening.
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Table 24
Bivariate Analysis using Crosstabs for BMI Category and Cervical Ripening Method
used for Induction of Labor
Induction Method Cervical Ripening
Cesarean
Vaginal Birth
Collapsed Categories
Birth
Misoprostol
1,406 (60.7)
910 (39.3)
Other prostaglandins
1,664 (79.2)
436 (20.8)
Mechanical
1.251 (77.3)
368 (22.7)
Total
4,321 (71.6) 1,714 (28.4)
Notes. Using chi-square test for significance. 0.05 used for significance.

P
value

Total
2,316
2,100
1,619
6,035

< .001

Multivariate Analysis
Unadjusted binary logistic regression. A standard binary logistic regression was used
to model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of
treatment groups where women were induced with misoprostol, other prostaglandins or
mechanical means were run in a side by side fashion. The single predictor variable in
these unadjusted studies was BMI at time of hospital admission. Based on classification
threshold predictive probability of having a cesarean birth as 0.5, results of the logistic
regression analyses are reported for each treatment group.
Misoprostol. With the use of misoprostol, the single variable model provided a
statistically significant prediction of type of birth (χ2 (4, N = 2,316) = 61.65, p < .001).
The Nagelkerke pseudo R2 indicated the model accounted for approximately 5.5% of the
total variance. Classification accuracy for all the cases was based on a classification cut
off value of 0.50 for predicting the type of birth was moderately high, with an overall
correct prediction rate of 61.0%, and correct prediction rates of 91.6% in women having a
vaginal birth and 13.6% of women having a cesarean birth.
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Other prostaglandins. With the use of other prostaglandins, the single variable
model provided a statistically significant prediction of the type of birth (χ2 (4, N = 2,100)
= 81.96, p < .001). The Nagelkerke pseudo R2 indicated the model accounted for
approximately 6.0% of the total variance. Classification accuracy for all the cases was
based on a classification cut off value of 0.5 for predicting the type of birth was
moderately high, with an overall correct prediction rate of 79.2%, and correct prediction
rates of 100% in women having a vaginal birth and 0% of women having a cesarean
birth.
Mechanical means. With the use of mechanical means, the single variable model
provided a statistically significant prediction of the type of birth (χ2 (4, N = 1,619)
= 60.34 p < .001). The Nagelkerke pseudo R2 indicated the model accounted for
approximately 5.5% of the total variance. Classification accuracy for all the cases was
based on a classification cut off value of 0.5 for predicting the type of birth was
moderately high, with an overall correct prediction rate of 77.3%, and correct prediction
rates of 100% in women having a vaginal birth and 0% of women having a cesarean
birth.
The three regression models arre summarized together. Table 25 summarizes the
unadjusted binary logistic regression models for cesarean birth after using cervical
ripening methods for induction of labor with results stratified by BMI category.
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Table 25
Unadjusted Logistic Regression for Cesarean Birth following the use of Cervical
Ripening for Induction of Labor
Cervical
ripening
method
Miso

Variables in
the equation

B

S.E.

Wald

df

Odds
ratio

95%
C.I.
LB

95%
C.I.
UB

P value

Normal weight
58.68 4 1.00
< .001
Overweight
0.54 0.17 10.31 1 1.72 1.24 2.40
< .001
Obese Cat 1
0.80 0.17 21.90 1 2.22 1.59 3.10
< .001
Obese Cat 2
1.12 0.18 37.12 1 3.07 2.14 4.41
< .001
Obese Cat 3
1.22 0.20 37.76 1 3.39 2.30 5.01
< .001
PGE2
Normal weight
77.17 4 1.00
< .001
Overweight
0.70 0.23 9.19
1 2.01 1.28 3.15
.002
Obese Cat 1
1.21 0.23 27.30 1 3.35 2.13 5.28
< .001
Obese Cat 2
1.14 0.26 19.60 1 3.11 1.88 5.14
< .001
Obese Cat 3
1.91 0.25 56.07 1 6.72 4.08 11.06 < .001
Mech
Normal weight
58.78 4 1.00
< .001
Overweight
0.09 0.26 0.12
1 1.10 0.65 1.84
.727
Obese Cat 1
0.58 0.26 4.95
1 1.79 1.07 2.98
.026
Obese Cat 2
1.11 0.27 17.01 1 3.03 1.79 5.13
< .001
Obese Cat 3
1.25 0.28 20.12 1 3.50 2.02 6.04
< .001
Notes. Normal weight used as referent category.
Abbreviations: df, degrees of freedom. CI confidence interval. LB, Lower bound. UB,
upper bound. Cat, category. Miso, Misoprostol (used alone or with PGE2). PGE2
prostaglandin analogue 2 (used alone), mech, mechanical means used alone or with either
prostaglandins.
Significance 0.05
Adjusted binary logistic regression. A standard binary logistic regression was used to
model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of
treatment groups where women were induced with misoprostol, other prostaglandins,
mechanical, or mechanical with prostaglandins were run as side by side models. The
predictor variable in these studies were BMI at time of hospital admission, maternal age,
parity, race, insurance, hospital type, birthweight, Pitocin and amniotomy. Based on
classification threshold predictive probability of having a cesarean birth as 0.5, results of
the nine variable logistic regression analysis are given below.
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Misoprostol. With the use of misoprostol, the nine variable model provided a
statistically significant prediction of the type of birth (χ2 (15, N = 2,305) = 1431.34, p <
.001). The Nagelkerke pseudo R2 indicated the model accounted for approximately
64.5% of the total variance. Classification accuracy for all the cases was based on a
classification cut off value of 0.5 for predicting the type of birth was moderately high,
with an overall correct prediction rate of 85.8%, and correct prediction rates of 90.1% in
women having a vaginal birth and 79.1% of women having a cesarean birth.
Other prostaglandins. With the use of other prostaglandins, the nine variable model
provided a statistically significant prediction of the type of birth (χ15 (4, N = 2,090) =
556.50, p < .001). The Nagelkerke pseudo R2 indicated the model accounted for
approximately 41.1% of the total variance. Classification accuracy for all the cases was
based on a classification cut off value of 0.5 for predicting the type of birth was
moderately high, with an overall correct prediction rate of 84%, and correct prediction
rates of 94.6% in women having a vaginal birth and 43.4% of women having a cesarean
birth.
Mechanical means. With the use of mechanical means, the nine variable model
provided a statistically significant prediction of the type of birth after being induced with
PGE2 (χ2 (15 N = 503) = 102.688, p < .001). The Nagelkerke pseudo R2 indicated the
model accounted for approximately 32.7% of the total variance. Classification accuracy
for all the cases was based on a classification cut off value of 0.5 for predicting the type
of birth was moderately high, with an overall correct prediction rate of 75.7%, and
correct prediction rates of 90.4% in women having a vaginal birth and 37.4% of women
having a cesarean birth.
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The three logistic regression models for cervical ripening with predictors follow.
Table 26 summarizes the adjusted the odds ratios for cesarean birth after using cervical
ripening method misoprostol for induction of labor. Table 27 summarizes the adjusted the
odds ratios for cesarean birth after using cervical ripening method other prostaglandins
for induction of labor. Table 28 summarizes the adjusted the odds ratios for cesarean
birth after using cervical ripening method mechanical methods alone or in combination
with prostaglandins (misoprostol and/ or other prostaglandin) for induction of labor. All
models include BMI, age, parity, race, insurance, hospital type, birth weight, Pitocin and
amniotomy as predictors.
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Table 26
Adjusted Odds Ratios for Cesarean Birth following the use of Misoprostol for Cervical Ripening for Induction of Labor
Variables in the
equation
Normal weight
Overweight
Obese Cat 1
Obese Cat 2
Obese Cat 3
Maternal age
Parity
White nonHispanic white
Black nonHispanic
Hispanic
Raceother/unknown
Private
insurance
Public insurance
Other insurance
White nonHispanic white
Black nonHispanic

B
0.45
0.79
1.29
1.24
0.09
2.27

S.E.

Wald

df

aOR

0.24
0.25
0.27
0.29
0.01
0.17

35.89
3.58
10.16
22.94
18.15
56.90
178.68

4
1
1
1
1
1
1

1.00
1.57
2.19
3.62
3.44
1.09
9.71

5.47

3

1.00

95% C.I.
LB
0.98
1.35
2.14
1.95
1.07
6.96

95% C.I.
UB
2.51
3.56
6.12
6.07
1.11
13.55

P value
< .001
.059
.001
< .001
< .001
< .001
< .001
.141

0.34

0.2

2.76

1

1.40

0.94

2.08

.097

0.36

0.18

4.18

1

1.43

1.02

2.02

.041

0.36

0.23

2.53

1

1.43

0.92

2.23

.112

599.82

2

1.00

63.44
250.21

1
1

4.24
0.05

5.47

3

1.00

2.76

1

1.40

1.45
-3.08

0.34

0.18
0.20

0.2

< .001
2.97
0.03

6.05
0.07

< .001
< .001
.141

0.94

2.08

.097
(Table 26 Continues)
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Variables in the
95% C.I. 95% C.I.
B
S.E.
Wald
df
aOR
P value
equation
LB
UB
Hispanic
0.36
0.18
4.18
1
1.43
1.02
2.02
.041
Race0.36
0.23
2.53
1
1.43
0.92
2.23
.112
other/unknown
Private
599.82
2
1.00
< .001
insurance
Public insurance
1.45
0.18
63.44
1
4.24
2.97
6.05
< .001
Other insurance
-3.08
0.20
250.21
1
0.05
0.03
0.07
< .001
University
76.25
2
1.00
< .001
teaching
Community
-1.75
0.20
73.52
1
0.17
0.12
0.26
< .001
teaching
Community non-1.46
0.29
25.96
1
0.23
0.13
0.41
< .001
teaching
Birth weight
0.00
0.00
5.92
1
1.00
1.00
1.00
.015
Pitocin
0.74
0.20
13.97
1
2.10
1.42
3.00
< .001
Amniotomy
0.14
0.22
0.44
1
1.15
0.76
1.76
.509
Table notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital.
Abbreviations. aOR, adjusted odds ratio; CI, Confidence interval; LB, Lower Bound; UB Upper Bound; cat, category.
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Table 27
Adjusted Odds Ratios for Cesarean Birth Following the use of Other Prostaglandins (PGE2) for Cervical Ripening for
Induction of Labor
Variables in the
equation
Normal weight
Overweight
Obese Cat 1
Obese Cat 2
Obese Cat 3
Maternal age
Parity
Race-nonHispanic white
Race-nonHispanic black
Race-Hispanic
Raceother/unknown
Private
insurance
Public insurance
Other insurance
University
teaching

B
0.84
1.35
1.32
1.95
0.08
2.49

S.E.

Wald

df

aOR

0.25
0.26
0.29
0.29
0.01
0.18

55.82
11.15
27.23
20.74
44.96
41.51
188.65

4
1
1
1
1
1
1

2.32
3.84
3.74
7.03
1.08
12.06

6.22

3

1.00

95% C.I.
LB
1.42
2.32
2.12
3.98
1.06
8.45

95% C.I.
UB
3.79
6.37
6.60
12.43
1.11
17.21

P value
< .001
.001
< .001
< .001
< .001
< .001
< .001
.101

0.26

0.21

1.56

1

1.30

0.86

1.94

.212

-0.13

0.23

0.32

1

0.88

0.56

1.38

.574

0.46

0.23

4.07

1

1.58

1.01

2.46

.044

10.26

2

1.00

0.17
9.11

1
1

1.07
0.46

64.50

2

1.00

0.07
-0.78

0.16
0.26

.006
0.78
0.28

1.46
0.76

.681
.003
< .001
(Table 27 Continued)
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Variables in the
95% C.I. 95% C.I.
B
S.E.
Wald
df
aOR
P value
equation
LB
UB
Community
-1.33
0.17
64.48
1
0.27
0.19
0.37
< .001
teaching
Community non-0.74
0.37
4.03
1
0.48
0.23
0.98
.045
teaching
Birth weight
3.28
1
1.00
1.00
1.00
.070
Pitocin
0.18
0.22
0.66
1
1.20
0.78
1.85
.416
Amniotomy
-0.18
0.23
0.62
1
0.84
0.54
1.31
.432
Table notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital.
Abbreviations. aOR, adjusted odds ratio; CI, Confidence interval; LB, Lower Bound; UB Upper Bound; cat, category.
Table 28
Adjusted Odds Ratios for Cesarean Birth Following the Use of Mechanical Means for Cervical Ripening for Induction of
Labor
Variables in the
equation
Normal weight
Overweight
Obese Cat 1
Obese Cat 2
Obese Cat 3
Maternal age
Parity
Race-nonHispanic white

B

S.E.

Wald

df

aOR

0.13
0.71
1.06
1.31
0.06
2.40

0.28
0.28
0.29
0.30
0.01
0.21

45.89
0.23
6.65
13.59
18.66
18.54
125.96

4
1
1
1
1
1
1

1.00
1.14
2.04
2.88
3.69
1.06
11.04

8.83

3

1.00

95% C.I.
LB

95% C.I.
UB

0.66
1.19
1.64
2.04
1.03
7.26

1.97
3.51
5.05
6.68
1.09
16.78

P value
< .001
.629
.010
< .001
< .001
< .001
< .001
.032

(Table 28 Continues)
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Variables in the
95% C.I. 95% C.I.
B
S.E.
Wald
df
aOR
P value
equation
LB
UB
Race-nonHispanic black
0.37
0.27
1.92
1
1.45
0.86
2.46
.166
Race-Hispanic
0.57
0.22
6.6
1
1.77
1.14
2.72
.010
Race0.34
0.23
2.16
1
1.41
0.89
2.21
.141
other/unknown
Private
insurance
2.99
2
1.00
.225
Public insurance
0.27
0.18
2.31
1
1.31
0.93
1.84
.129
Other insurance
0.81
0.78
1.08
1
2.25
0.49
10.36
.298
University
17.09
2
1.00
.000
teaching
Community
-1.08
0.38
8.24
1
0.34
0.16
0.71
.004
teaching
Community non-0.57
0.41
1.96
1
0.57
0.26
1.26
.162
teaching
Birthweight
0.00
0.00
8.54
1
1.00
1.00
1.00
.003
Pitocin
0.56
0.18
9.12
1
1.74
1.22
2.50
.003
Amniotomy
0.00
0.26
0.00
1
1.00
0.61
1.65
.995
Table notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital.
Abbreviations. aOR, adjusted odds ratio; CI, Confidence interval; LB, Lower Bound; UB Upper Bound; cat, category.
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Model fitting. The model was evaluated for cases of leverage, influence, or outliers.
here were 23 missing cases noted. Leverage was checked, using the variable Lev_4,
created when running a logistic regression model. A max value of .01498 and a minimum
of .00006. DBetas were checked within the model, no model outliers were identified.
The Cook distance was run, with a maximum value of .04335 and a minimum of .00000.
The model is a good fit for the data.
Predictors. Three regression models were run side by side for type of birth
following induction methods used for cervical ripening. The predictors in the model were
BMI at time of hospital admission, maternal age, parity, race, insurance, type of hospital,
birth weight, Pitocin and amniotomy. The BMI at time of hospital admission variable was
statistically significant in most of the BMI categories. For BMI with use of misoprostol
or other prostaglandins all BMI categories remained significant expect the overweight
category with the use of misoprostol and the use of mechanical meas. Overall, BMI had
a statistically significant relationship with all induction methods.
Maternal age was a statistically significant predictor for all induction methods.
Maternal race was statistically significant in a few of the categories but overall was not a
statistically significant predictor within the models. Insurance had a statically significant
relationship with the use of misoprostol and other prostaglandins but not with mechanical
means for cervical ripening. Hospital type was a statistically significant predictor for type
of birth after using misoprostol, and prostaglandin but not mechanical means for cervical
ripening. relationships identified; birthweight was statistically significant predictor within
the model but may have little clinical relevance due to the odds ratio of 1. Pitocin was
statistically significantly predictor of birth outcomes after using misoprostol or
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mechanical means but not after using other prostaglandins for cervical ripening.
Amniotomy was not statistically significantly predictor of type of birth within the
models. BMI at time of hospital admission, maternal age, parity, and birthweight were
found to be predictive within the models.
A3H2 hypothesis testing. To test A3H2 which compared the odds of cesarean
birth in women induced with misoprostol to the odds in similar women induced using
other prostaglandins. The comparison of the adjusted odds ratios showed higher odds of
cesarean birth following the use of other prostaglandins for cervical ripening. All of the
relationships within the model were statically significant except for the use of
misoprostol in the overweight category. Additionally, there were increased odds of
cesarean birth with each successive increase in BMI category. This hypothesis is
supported. See Table 29 summarizing the odds ratios for misoprostol use and other
prostaglandin use for cervical ripening as part of induction of labor.
Table 29
Adjusted Odds Ratios for Cesarean Birth Following Incursion of Labor with Cervical
Ripening Method of Misoprostol or other Prostaglandins
Cervical
ripening
method
Misoprostol

BMI
category
Normal
weight
Overweight
Obese Cat 1
Obese Cat 2
Obese Cat 3

aOR

95% C.I.
LB

95% C.I.
UB

1.00
1.57
2.19
3.62
3.44

P value
< .001

0.98
1.35
2.14
1.95

2.51
3.56
6.12
6.07

.059
.001
< .001
< .001

(Table 29 Continues)
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Cervical
BMI
95% C.I.
95% C.I.
ripening
aOR
P value
category
LB
UB
method
Other
Normal
1.00
< .001
prostaglandins weight
Overweight
2.32
1.42
3.79
.001
Obese Cat 1
3.84
2.32
6.37
< .001
Obese Cat 2
3.74
2.12
6.60
< .001
Obese Cat 3
7.03
3.98
12.43
< .001
Notes. Normal weight used as referent group. Abbreviations. Body mass index, BMI.
Adjusted odds ratio, aOR. Confidence interval, CI. Lower bound, LB. Upper bound, UB.
Category, cat.
A3H2 summary. The results showed higher odds of cesarean birth following the use
of other prostaglandins for cervical ripening as compared with misoprostol. Additionally,
there was a greater risk of cesarean birth with each increase in BMI category. This
hypothesis was supported.
A3H3 Hypothesis testing- To test the hypothesis for A3H3 a binary logistic regression
was run with side by side models cervical ripening methods of prostaglandins (either
prostaglandin) and mechanical means (mechanical means alone or mechanical with the
use of prostaglandins). The results for cesarean birth following the use of cervical
ripening methods are listed below.
Unadjusted binary logistic regression. A standard binary logistic regression was used
to model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of
cervical ripening (either prostaglandin or mechanical means with or without the use of
prostaglandins) were run as side by side models. BMI was the singe predictor included in
the model.
Either prostaglandin. Based on classification threshold predictive probability of
having a cesarean birth as 0.5, results of the logistic regression analyses for the single
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variable model provided a statistically significant prediction of the type of birth (χ2 (4, N
= 4,416) = 146.69, p < .001). The Nagelkerke pseudo R2 indicated the model accounted
for approximately 4.6% of the total variance. Classification accuracy for all the cases was
based on a classification cut off value of 0.5 for predicting the type of birth was
moderately high, with an overall correct prediction rate of 68.5%, and correct prediction
rates of 100% in women having a vaginal birth and 0% of women having a cesarean
birth.
Mechanical means. Based on classification threshold predictive probability of
having a cesarean birth as 0.5, results of the logistic regression analyses for the single
variable model provided a statistically significant prediction of the type of birth (χ2 (4, N
= 1,619) = 60.33 p < .001). The Nagelkerke pseudo R2 indicated the model accounted for
approximately 5.6% of the total variance. Classification accuracy for all the cases was
based on a classification cut off value of 0.50 for predicting the type of birth was
moderately high, with an overall correct prediction rate of 77.2% and correct prediction
rates of 100% in women having a vaginal birth and 0% of women having a cesarean
birth. Table 30 summarizes the adjusted logistic regression for birth outcome after being
induced by prostaglandins (misoprostol or other prostaglandins) or mechanical methods
(alone or with prostaglandins).
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Table 30
Unadjusted Odds Ratios for Cesarean Birth after using Prostaglandins or Mechanical Means for Cervical Ripening
95% C.I. 95% C.I.
P value
LB
UB
Either prostaglandins
Normal weight
137.61 4 1.00
< .001
Overweight
0.60 0.13 20.29 1 1.82
1.40
2.37 < .001
Obese Cat 1
0.98 0.14 53.16 1 2.67
2.05
3.48 < .001
Obese Cat 2
1.19 0.15 66.26 1 3.28
2.47
4.37 < .001
Obese Cat 3
1.51 0.15 96.67 1 4.54
3.36
6.14 < .001
Mechanical
Normal weight
59.04 4 1.00
< .001
Overweight
0.09 0.26
0.12 1 1.10
0.65
1.84
.727
Obese Cat 1
0.58 0.26
5.00 1 1.79
1.08
2.98
.025
Obese Cat 2
1.11 0.27 17.18 1 3.05
1.80
5.16 < .001
Obese Cat 3
1.25 0.28 20.12 1 3.50
2.02
6.04 < .001
Notes. Referent category Normal weight. Abbreviations. BMI, Body mass index; OR, odds ratio; CI, Confidence interval; LB,
lower bound; UB Upper bound; cat, category.
Cervical ripening method

BMI category

B

S.E.

Wald

df

OR
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Adjusted binary logistic regression. A standard binary logistic regression was used to
model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of
cervical ripening methods where women were induced with either prostaglandins, or the
use of mechanical means were run as side by side models. The predictor variable in these
models were BMI at time of hospital admission, maternal age, parity, race, insurance,
hospital type, birthweight, Pitocin and amniotomy.
Either prostaglandin. Based on classification threshold predictive probability of
having a cesarean birth as 0.5, results of the logistic regression analyses for the nine
variable model provided a statistically significant prediction of the type of birth (χ2 (16,
N = 4,416) = 1965.34, p < .001). The Nagelkerke pseudo R2 indicated the model
accounted for approximately 51% of the total variance. Classification accuracy for all the
cases was based on a classification cut off value of 0.50 for predicting the type of birth
was moderately high, with an overall correct prediction rate of 82.5%, and correct
prediction rates of 90.5% in women having a vaginal birth and 64.2% of women having a
cesarean birth.
Mechanical means. Based on classification threshold predictive probability of
having a cesarean birth as 0.5, results of the logistic regression analyses for the nine
variable model provided a statistically significant prediction of the type of birth (χ2 (16,
N = 1,619) = 300.50 p < .001). The Nagelkerke pseudo R2 indicated the model accounted
for approximately 25.8% of the total variance. Classification accuracy for all the cases
was based on a classification cut off value of 0.50 for predicting the type of birth was
moderately high, with an overall correct prediction rate of 79.3% and correct prediction
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rates of 95.2% in women having a vaginal birth and 25.0% of women having a cesarean
birth. Table 31 summarizes the adjusted logistic regression for birth outcome after being
induced by prostaglandins (misoprostol or other prostaglandins). Table 32 summarizes
the adjusted logistic regression for birth outcome after being induced by mechanical
methods (alone or with prostaglandins).
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Table 31
Table Description Odds Ratios for Cesarean after using Prostaglandins (Misoprostol or Other Prostaglandins Alone or in
Combination) Cervical Ripening by BMI Category
Variable in the
equation
Normal weight
Normal weight
Obese Cat 1
Obese Cat 2
Obese Cat 3
Maternal age
Parity
Race-nonHispanic white
Race-nonHispanic black
Race-Hispanic
Raceother/unknown
Private
insurance

B

95% C.I.
LB

95% C.I.
UB

S.E.

Wald

df

aOR

0.17
0.19
0.20
0.01
0.12

84.45
84.45
40.32
49.78
60.25
152.54
425.67

4
4
1
1
1
1
1

1.00
1.00
2.94
3.73
4.61
1.10
11.11

16.49

3

1.00

0.28 0.14

4.11

1

1.32

1.01

1.72

.043

0.39 0.12
0.50 0.15

10.18
10.38

1
1

1.48
1.63

1.16
1.21

1.88
2.20

.001
.001

596.22

2

-

-

< .001

1.08
1.32
1.53
0.10
2.41

2.11
2.59
3.14
1.09
8.84

4.11
5.38
6.79
1.12
13.96

P value
< .001
< .001
< .001
< .001
< .001
< .001
< .001
.001

(Table 31 Continues)
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Variable in the
95% C.I. 95% C.I.
B
S.E. Wald
df
aOR
P value
equation
LB
UB
Public insurance 0.83 0.11 53.70
1
2.28
1.83
2.85
< .001
Other insurance -2.60 0.14 324.10
1
0.08
0.06
0.10
< .001
University
185.69
2
< .001
teaching
Community
-1.68 0.12 183.41
1
0.19
0.15
0.24
< .001
teaching
Community
-1.27 0.22 34.79
1
0.28
0.19
0.43
< .001
non-teaching
Birth weight
0.00 0.00 9.11
1
1.00
1.00
1.00
.003
Pitocin
0.49 0.13 13.29
1
1.63
1.25
2.12
< .001
Amniotomy
-0.02 0.14 0.02
1
0.98
0.75
1.28
.886
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital
Abbreviations. OR odds ratio; CI, Confidence interval; LB, lower bound; UB Upper bound; cat, category.
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Table 32
Table Description Odds Ratios for Cesarean after using Mechanical Means (with or without the use of Prostaglandins) for
Cervical Ripening by BMI Category
Variable in the
equation
Normal weight
Overweight
Obese Cat 1
Obese Cat 2
Obese Cat 3
Maternal age
Parity
Race-nonHispanic white
Race-nonHispanic black
Race-Hispanic
Raceother/unknown
Private
insurance
Public insurance
Other insurance

B
0.13
0.71
1.06
1.31
0.06
2.40

S.E.

Wald

df

aOR

0.28
0.28
0.29
0.30
0.01
0.21

45.89
0.23
6.65
13.59
18.66
18.54
125.96

4
1
1
1
1
1
1

1.00
1.14
2.04
2.88
3.69
1.06
11.04

8.83

3

1.00

95% C.I.
LB
0.66
1.19
1.64
2.04
1.03
7.26

95% C.I.
UB
1.97
3.51
5.05
6.68
1.09
16.78

P value
.000
.629
.010
< .001
< .001
< .001
< .001
.032

0.37

0.27

1.92

1

1.45

0.86

2.46

.166

0.57

0.22

6.60

1

1.77

1.14

2.72

.010

0.34

0.23

2.16

1

1.41

0.89

2.21

.141

2.99

2

1.00

2.31
1.08

1
1

1.31
2.25

0.27
0.81

0.18
0.78

.225
0.93
0.49

1.84
10.36

.129
.298
(Table 32 Continues)
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Variable in the
95% C.I. 95% C.I.
B
S.E. Wald
df
aOR
P value
equation
LB
UB
University
17.09
2
1.00
< .001
teaching
Community
-1.08 0.38 8.24
1
0.34
0.16
0.71
.004
teaching
Community
-0.57 0.41 1.96
1
0.57
0.26
1.26
.162
non-teaching
Birth weight
0.00 0.00 8.54
1
1.00
1.00
1.00
.003
Pitocin
0.56 0.18 9.12
1
1.74
1.22
2.50
.003
Amniotomy
0.00 0.26 0.00
1
1.00
0.61
1.65
.995
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital
Abbreviations. OR odds ratio; CI, Confidence interval; LB, lower bound; UB Upper bound; cat, category.
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Predictors. Two regression models were run side by side for type of birth
following induction requiring cervical ripening. The predictors in the model were BMI at
time of hospital admission, maternal age, parity, race, insurance, type of hospital, birth
weight, Pitocin and amniotomy. The BMI at time of hospital admission was statistically
significant in all BMI categories, except in overweight women after using machinal
means for cervical ripening. Overall, BMI had a statistically significant relationship with
the use of prostaglandins and mechanical means for cervical ripening.
Maternal age and parity were statistically significant predictors for all both
cervical ripening methods. Maternal race and insurance remined statistically significant
with the use of prostaglandins for cervical ripening but not with the use of mechanical
means. Hospital type was a statistically significant predictor for type of birth after using
prostaglandins and mechanical means for cervical ripening with all hospital types except
in community nonteaching hospital after the use of mechanical means for cervical
ripening. Birth weight was statistically significant within the models but was not
clinically related to type of birth. The use of Pitocin was a statistically significantly
predictor of higher cesarean births which may be related to a difference in labor initiation
and processes. Amniotomy was not a statistically significant predictor of type of birth
within the models. BMI at time of hospital admission, maternal age, parity, birthweight,
and the use of Pitocin for induction were found to be predictive of within the models.
Table 33 summarizes the adjusted odds ratios for cesarean after cervical ripening with
either type of prostaglandin or mechanical means alone or with prostaglandin
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Table 33
Adjusted Odds Ratios for Cesarean after Cervical Ripening with either type of
Prostaglandin or Mechanical Means alone or with Prostaglandins
Cervical ripening
method
Either prostaglandin

95% C.I.
95% C.I.
P
LB
UB
value
Normal weight
1.00
< .001
Overweight
1.98
1.43
2.73
< .001
Obese Cat 1
2.94
2.11
4.11
< .001
Obese Cat 2
3.73
2.59
5.38
< .001
Obese Cat 3
4.61
3.14
6.79
< .001
Mechanical
Normal weight
1.00
.000
Overweight
1.14
0.66
1.97
.629
Obese Cat 1
2.04
1.19
3.51
.010
Obese Cat 2
2.88
1.64
5.05
< .001
Obese Cat 3
3.69
2.04
6.68
< .001
Notes. Normal weight used as referent group. Abbreviations. BMI, Body mass index;
aOR, adjusted odds ratio; CI, Confidence interval; LB, lower bound; UB, Upper bound;
cat, category.
BMI category

aOR

Aim 3 summary. A3H1 hypothesis was supported, as there were higher odds of
having a cesarean birth after labor induction requiring cervical ripening with each
increase in BMI category when compared to normal weight women. A3H2 hypothesis for
was supported, as there were lower odds of cesarean birth after receiving misoprostol for
induction as compared to receiving other prostaglandins. A3H3 hypothesis for was
supported, as women had lower odds of cesarean birth in any obesity category after using
mechanical means for induction method as compared to women induced with either
prostaglandin. This hypothesis is supported.
Chapter Summary
This chapter presents the results of this retrospective cohort study on the
influences of maternal obesity on induction of labor processes and outcomes. The sample
selection was described. A description of the sample characteristics for the entire sample
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was given. The demographic variables as well as other variables used in individual and
system characteristics were described. The findings from the statistical analysis and the
results of hypothesis testing were reported for the three aims of this study.

CHAPTER V
DISCUSSION AND CONCLUSIONS
This study was designed to examine induction of labor requiring cervical ripening
processes and outcomes and the influences of maternal BMI among a cohort of women
with low-risk pregnancy. Obesity continues to be an epidemic in the US, and this obesity
epidemic includes childbearing women. It is important to understand if there are
differences in labor induction processes and outcomes for women of differing BMI
categories when cervical ripening is required. Chapter five presents a discussion of the
study results and conclusions regarding the research aims and hypotheses. This chapter
concludes with a discussion of the study strengths and limitations, implications for
practice, theory development, and model testing, and future research.
This study adds to the limited body of knowledge regarding the influences of BMI
on labor induction processes and outcomes. This study focused on the different cervical
ripening methods used for induction of labor including misoprostol, PGE2, and
mechanical means. This study was not the first to focus on labor induction methods while
stratifying results by BMI category, but this study is the first to use a large existing
national database that was gathered to study contemporary labor patterns (Zhang et al.,
2010).
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Evaluation of the Influences of BMI on the use of
Cervical Ripening for Labor Induction
Overall, this sample of more than 43,000 women with healthy, singleton,
cephalic, term pregnancies shows that maternal does BMI influence labor induction
processes and outcomes. In a smaller sample of 6,035 women requiring cervical
ripening, the time to birth and type of birth were also influenced by BMI. The following
discussion is organized by each aim of the study, including a discussion of individual and
system characteristics, and other confounding variables.
Discussion of Aim 1: Use of Cervical Ripening Methods for Induction of
Labor. Aim 1 explored the methods used for induction of labor requiring cervical
ripening. Logistic regression was used to determine the odds of using cervical ripening
(misoprostol, other prostaglandins, or mechanical means) for induction of labor. The
cervical ripening methods were used either alone or in combination to initiate labor. The
odds for requiring cervical ripening with labor induction were higher by each BMI
category when compared with normal weight women. This relationship was found in
both the unadjusted and adjusted models. The model was adjusted for age, height, parity,
race, insurance, hospital type, NICU level, and birth weight. This study found that BMI
was a statistically significant predictor for the use of cervical ripening methods for
induction of labor. Additionally, this study found maternal age, maternal height, parity,
racial categories of Hispanic, and other/unknown, insurance status, hospital type, hospital
level, NICU level and birth weight were statistically significant predictors for the use of
cervical ripening for labor induction.
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Little is known from previous studies about the differences in use and the
effectiveness of cervical ripening methods for induction of labor in women belonging to
BMI categories 1, 2, and 3. In previous studies of induction of labor requiring cervical
ripening, small sample sizes were used requiring the obesity categories to be collapsed
into one obese category for analysis (Anabusi, Mei-Dan, Hallak, & Walfisch, 2016;
Beckwith, Magner, Kritzer, & Warshak, 2016; Melamed, Ben-Haroush, Kremer, Hod, &
Yogev, 2010; O'Dwyer et al., 2011; Roloff, Peng, Sanchez-Ramos, & Valenzuela, 2015;
Vinturache, Moledina, McDonald, Slater, & Tough, 2014). Two studies were identified
where the BMI categories for obesity were not collapsed into lean (< 30 kg/m2) and
obese (> 30 kg/m2). In the first the categories were instead collapsed into 30 - 39 kg/m2,
and > 40kg/m2 (Lassiter et al., 2016; Pevzner, Powers, Rayburn, Rumney, & Wing,
2009). The second study used BMI categories of normal weight (20 - 25 kg/m2),
moderate obesity (30 - 35 kg/m2), severe obesity (35 - 40 kg/m2) and morbid obesity (>
40 kg/m2) (Gauthier et al., 2012).
When looking for comparable rates of cervical ripening from the literature Only
one of these studies reported the rate of use of cervical ripening in women with a higher
BMI. One study reported a lower rate of PGE2 cervical ripening use among obese
women as compared to normal weight women (Gauthier, 2012). The women in the lean
group had a higher mean age so there is a chance the increase in cervical ripening need
among this group of lean women could be due to another factor outside of BMI. One
study included only women needing cervical ripening for induction of labor (Lassiter et
al., 2016), having a 100% use rate for cervical ripening
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This study offers a look into contemporary labor induction requiring cervical
ripening in a nationally representative sample. The data for this sample were collected
from 2006 to 2012. This retrospective observational study describes the use of cervical
ripening for labor induction in modern women with results stratified by standardized BMI
categories. This study shows a statistically significant relationship between BMI and the
use of cervical ripening methods to initiate labor.
Discussion of Aim 2: Time to Birth. Aim 2 explores the time to birth (time from
hospital admission to birth, in minutes) after using differing cervical ripening methods
with the results stratified by BMI category. Bivariate analysis shows a longer time to
birth with each successive BMI category. Survival analysis was used for hypothesis
testing. This study compared the hazard ratios for the use of misoprostol to the use of
other prostaglandins for cervical ripening, finding an increased time to birth after using
other prostaglandins for labor induction requiring cervical ripening as compared to
misoprostol. While these findings were not statistically significant in all BMI categories,
there may be clinical significance. For example, bivariate analysis showed there was a
351-minute time to birth difference between normal weight women and obese cat 3
women. This time difference makes a difference in the clinical setting where the time in
the hospital is longer, nursing staff is needed at the bedside for a longer period of time, all
resulting in higher cost for the hospital and the woman being induced. This study
supported women needing a longer time to birth with an increase in BMI, despite the lack
of statistical significance. The increased hazard ratios did not have a successive increase
with each increase in BMI. category.
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The time difference seen in this study is similar to what is seen in previous
research. One previous study found a 5-hour difference in the time from induction to
birth in obese women as compared to normal weight women (Gauthier, 2012). Another
found a 5-hour difference in women with a BMI  30 kg/m2 compared to women with a
BMI  40 kg/m2 (Lasstier, 2016).
This study also compared the use of prostaglandins with the use of mechanical
means for cervical ripening. The time to birth after the use of mechanical means alone or
mechanical means with misoprostol for induction of labor requiring cervical ripening
were shorter when compared to the use of either prostaglandin (misoprostol or other
prostaglandins). Predictors within the models remaining statistically significant across all
BMI categories were maternal age, parity, insurance status, hospital type, NICU level,
and the use of Amniotomy. This study showed that mechanical means were more
effective than either prostaglandin for cervical ripening for women in all BMI categories.
Little is known about differences in the time to birth for differing cervical
ripening methods by BMI category from previous research. Previous studies have shown
misoprostol seems to be more effective than dinoprostone (PGE2/other prostaglandins)
for cervical ripening in women with obesity (Gauthier et al., 2012; Kunzier, Park, Cioffi,
Calixte, & Vintzileos, 2016; Suidan, Rondon, Apuzzio, & Williams, 2015). One previous
study reported a shorter time to birth after the use of misoprostol for induction of labor
versus the use of other prostaglandins, resulting in an overall shorter hospital stay.
(Kunzier et al., 2016). This study suggests misoprostol is more effective than other
prostaglandins for cervical ripening among women in any BMI category and especially
for women with obesity. The results of the previous research support this study which
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also found the use of misoprostol resulted in a shorter time to birth than the use of other
prostaglandins,
Little is known about the time to birth after using mechanical means versus
prostaglandins for cervical ripening. There were two previous studies with time to birth
as an outcome after the use of cervical ripening (mechanical means, prostaglandins, or
both) for induction of labor (Anabusi et al., 2016; Beckwith et al., 2016). One of the
studies reported an increased time to birth in women with obesity as compared to normal
weight women (Anabusi et al., 2016). The other study reported an increased failure of
cervical ripening with misoprostol; however, the same failure of cervical ripening was
not seen with mechanical methods. (Beckwith et al., 2016). The findings of these
previous studies are consistent with the findings from this research study. Based on the
results of this study, mechanical means appears to be more effective than the use of
prostaglandins alone for cervical ripening in women of any BMI category.
Discussion of Aim 3: Type of Birth. Aim 3 explored the type of birth (vaginal or
cesarean) following the use of cervical ripening methods for induction of labor with
results stratified by BMI category. Logistic regression was used for analysis. This study
showed there was a greater risk of cesarean birth with each increase BMI category when
compared to normal weight women regardless of cervical ripening method used for
induction of labor. Previous studies have shown a higher cesarean birth rate in women
with obesity compared to normal weight women (Anabusi et al., 2016; Beckwith et al.,
2016; O'Dwyer et al., 2011; Pevzner et al., 2009). The risk of cesarean birth increases
with each increase in BMI category.
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This study showed there were higher odds of cesarean birth following the use of
other prostaglandins for cervical ripening than with the use of misoprostol, meaning
misoprostol is more effective for inducing labor. Previous studies have shown obese
patients who underwent induction using misoprostol (PO or PV) had a lower cesarean
birth rate than those induced with other prostaglandins (dinoprostone) (39.1 vs. 51.3%;
OR, 0.61; 95% CI, 0.44-0.85; p. 0.003) (Suidan et al., 2015). The use of misoprostol for
cervical ripening seems to result in fewer cesarean births that the use of Other
prostaglandins for cervical ripening.
This study showed there were lower odds of cesarean birth in any obesity
category after using mechanical means for cervical ripening method for induction of
labor than women induced with either prostaglandin. Two previous studies looked at the
outcome of cesarean birth following induction with either prostaglandins and/or
mechanical means (Anabusi et al., 2016; Beckwith et al., 2016). Both studies were
conducted with a relatively small sample of women (n = 181) and (n = 709), respectively.
The small sample size required researchers to collapse the BMI categories for analysis to
less than 30 mg/kg2 and greater than 30 mg/kg2,, so the results were not stratified by BMI
category. One study reports a higher number of cesarean births in women with obesity
compared to normal weight women (17.6% vs. 25.3%) (Anabusi et al., 2016). The
researchers in the other study found a higher number of cesarean births in women with
obesity after being induced with misoprostol as compared to normal weight women
(Beckwith et al., 2016). The same relationship was not seen in women with obesity who
were induced with mechanical means as compared to normal weight women (Beckwith
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et al., 2016). Mechanical means seem to be more effective than prostaglandins
(misoprostol) for inducing women with higher BMI’s and women with obesity.
Strengths of the Study
This study had several strengths. First, it used a multi-site, national sample of
women undergoing induction of labor, also allowing for a larger sample size than
previously used. When comparing the demographic characteristic of this study to national
birth data from 2006 to 2008 we see similar characteristic within the study (Martin,
2010). The median age of women in this study is similar to the median age in the Birth
data for 2008 (27 years, 27.4 years, respectively). The make up the maternal racial and
ethnic groups is the same for Non-Hispanic white women between this study national
data (53.3%). The rates of Non-Hispanic black women were higher in this study when
compared to national birth data (19.3%, 14.6%, respectively). The rates of Hispanic
women were lower in this study as compared to national birth data (18.4%, 24.5%,
respectively).
Second, this study was the first to use a large sample size to better evaluate
induction by BMI category. Third, no other study to date has evaluated mechanical
cervical ripening alone or in conjunction with the use of prostaglandins in a sample as
large as the sample in this study. By evaluating a larger group of women, it is easier to
see the impact of BMI category on induction of labor. While the hazard ratios for the
time to birth were not statistically significant after being induced with prostaglandins, the
cesarean birth rates did show a statically significant increase with each increase in BMI
category. Finally, this study adds to the body of knowledge on the influences of BMI on
induction of labor processes and outcomes.
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Limitations of the Study
The study findings must be considered in the context of some limitations. One of
the study limitations is the representativeness of the sample. While this study utilized a
large sample, it may not be representative of all women undergoing induction of labor.
Most of the birth occurred in large urban medical centers. When comparing these study
findings (cesarean birth and induction of labor) to national birth data for the years of birth
in this sample 2006-2008 (Martin, 2010) we see some difference in the outcomes. The
cesarean birth rate in this study was lower than cesarean birth rates in national data for
2008 (32.3% of all births) (Martin, 2010). This study found 18.3% of women undergoing
induction of labor had a cesarean birth, and 28.4% of women undergoing induction of
labor with cervical ripening had a cesarean birth. These differences could be due to
differences in provider practices or regional differences in practice. This study had an
18% induction of labor rate which is lower induction of labor rates national data where
22.9% of women were induced (Martin, 2010). This difference is likely due to the
inclusion of low-risk pregnancies the study where national data included all women
undergoing induction of labor.
A second limitation is inconsistencies in data collection. The data were collected
from multiple sites, and the collection of data and data reporting varied between sites. For
example, one site did not collect or report the induction type (n = 4,210). However, we
cannot assume there were no inductions at this site. While the site was included in the
sample to better describe women undergoing induction of labor, the data were deleted for
analysis. Sites may have collected other information inconsistently such as the first
cervical exam was not always documented in the medical record.
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A third limitation is the missingness of the data. On the variables for BMI, 30% of
the data were missing and thus were deleted for missingness. A sensitivity analysis
should be run on Aim 1-3 of this study to see if there are differences in the median time
to birth or the odds ratios for cesarean birth in the women with missing data compared to
the included women. The sensitivity analysis would help verify the outcomes by
assessing the impact of the missing data.
A fourth limitation is the sample size. Many statistically significant findings may
be due to the extremely large sample size, and not represent clinically significant
findings. A fourth limitation relates to the statistical analysis. The data could be analyzed
using other techniques to go beyond the correlational analyses that were planned for this
study. By using logistic regression to analyze the sample as a whole the nuances of
individual sites were not accounted for in the modeling process. This multisite database
included twelve different sites; hierarchical modeling could have been used to represent
the site differences. A fifth limitation is the use of survival analysis for time to birth. By
using survival analysis, a unique set of women were created, who were able to have a
vaginal birth. More obese women required cesarean birth, so it is likely the two groups
vary in a significant way.
These study limitations are in part due to the study design and the use of
secondary data. These limitations may impact the generalizability of the study findings.
These study limitations warrant closer inspection.
Implications for Practice
Clinicians should account for maternal BMI when considering induction of labor
and or cervical ripening. As shown with this research, women with obesity are more
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likely to experience a longer time to birth and end labor induction with a cesarean birth.
This study found women with obesity had longer labors of approximately 3.78 hours
longer, and in the highest category of obesity, there were an additional 5.85 hours in labor
when compared to normal weight women. The number of cesarean births within this
sample were higher for women with cervical ripening compared to women undergoing
induction of labor without cervical ripening (28.4% versus 18.3%). Among women
induced using cervical ripening methods, women with obesity were twice as likely to end
labor with cesarean birth as compared to normal weight women. Among women in the
highest obesity category, there was a 4-fold increase in cesarean birth as compared to
normal weight women. Therefore, clinicians should use careful consideration before
recommending or counseling on elective induction of labor.
There were different associations of time to birth and cesarean birth with the use
of differing cervical ripening methods. When using mechanical means for induction of
labor women had a shorter time to birth to birth in all BMI categories as compared to
using misoprostol. The odds of cesarean birth were four times higher in women induced
with misoprostol or PGE2, and three times higher in women induced with mechanical
means compared to normal weight women induced with any cervical ripening method.
These associations suggest mechanical means may be more effective for cervical ripening
in women with a high BMI or obesity.
Maternal BMI calculated at the time of hospital admission or close to birth should
help clinics determine the best method(s) for cervical ripening. Although pre-pregnancy
BMI may be helpful for guiding antenatal care, maternal BMI at the end of pregnancy
better reflects a woman’s metabolic condition near labor. Clinicians should expect
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induction will take longer in women with obesity. This should be reflected in their
counseling. Clinicians should prepare the clinical team, support person and possibly the
women for the longer time frame to induce labor in women with a higher BMI or women
with obesity.
Maternal obesity and labor induction are “the new normal” in contemporary
childbearing. Clinicians need better information on preparing women with higher BMI’s
for induction of labor. This study adds to the body of knowledge for clinical use in the
timing of labor induction and the choice of method for women with a high BMI or
women with obesity. This research supports the need for new labor induction protocols
that are individualized by the degree of maternal obesity both in the timing and choice of
induction methods. With patience and time, many more women with obesity might
achieve normal labor outcomes following safe and effective labor induction.
Implications for Theory Building and Model Testing
Theory Building
There is a theoretical concept that labor initiation is different for women with
obesity than it is for women with a normal BMI. These differences are thought to be
related to physiologic differences that exist among the different BMI groups, where
women with obesity have difficulty initiating labor at term when compared with normal
weight women (Harper et al., 2012; Hermesch, Allshouse, & Heyborne, 2016; Stirrat et
al., 2014). This study supports this theory, a higher number of women with a high BMI
were induced compared to normal weight women.
While one potential explanation for a longer time for labor initiation in women
with obesity is increased leptin levels which appear to increase placental PGE2 release

155
(Wendremaire et al., 2013) however we did not measure or have access to raw data with
leptin or prostaglandin levels in this study. It is thought that women with obesity have
higher levels of endogenous prostaglandins (PGE2). Knowing PGE2 is increased would
suggest that inducing women with a high BMI with prostaglandins and especially PGE2
would likely be ineffective. The findings from this study support this theory by finding a
longer time from induction to birth and higher cesarean section rates in obese women
being induced with prostaglandins and especially PGE2.
Other alternative explanations may exist for these study findings. Since this is was
not a prospective study, we can’t know if other factors could be explaining the observed
associations. For example, women with higher BMI could have been more at risk for
cesarean birth because their babies were more likely to have fetal heart rate abnormalities
following dinoprostone vs. misoprostol. Another alternative explanation for these
findings could be that clinicians dosed the prostaglandins differently by maternal BMI
and this difference in dosing was the problem causing women’s higher risk for cesarean
birth and longer labor course. Since we cannot tell temporal relationships in the use of
cervical ripening or other IOL methods, we cannot rule this out.
Model Testing
Based on these study findings the Quality Health Outcome Model (Mitchell &
Lang, 2004) adapted for this study is useful in explaining the influences of maternal BMI
on the labor induction processes and outcomes with a few changes as noted. Future
model testing could include post hoc analysis of BMI as a mediator or moderator as wells
using BMI as a continuous variable rather than categorical within the model.
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Individual Characteristics. The individual characteristics of maternal age, BMI,
parity and cervical status were included in the proposed model. The sample as a whole
was selected based on having an unfavorable cervical status, therefore this researcher
would move cervical status out of the proposed model as an individual factor contributing
to interventions and outcomes of labor induction. Additionally, the characteristics of
height, race, and insurance status were found to be individual predictors of the study
outcomes, the effectiveness of induction method, time to birth, and the type of birth.
Therefore height, race, and insurance status should be added as individual characteristics
to the model.
Systems Characteristics. The system characteristics of hospital type, size, and
geographic location were included in the proposed model. The characteristics of hospital
type (university, community teaching, and community non-teaching) were included as
system variables and found to be a significant predictor within most models in this study.
Additionally, hospital level (obstetric level), and NICU level were found to be
independent predictors of the study outcomes, the effectiveness of induction methods, the
time to birth and the type of birth. These system characteristics account for some of the
variances within the models. The system characteristics are site-specific (there were 12
hospital systems included) and could be used/may be better represented by higher level
statistical modeling. The system characteristics should be included as covariates in future
multilevel or hierarchical modeling.
Interventions/Outcomes. The interventions in the model were the specific
methods for induction of labor misoprostol, PGE2, and mechanical means. All of the
women in the sample were induced, effectively creating a group that was induced with
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oxytocin alone or in combination with amniotomy or one or more of the previously listed
induction methods. Outcomes of time to birth and type of birth were given for each
induction method included in the study. Outcomes were found to be increased time to
birth for women with a higher BMI and increased odds ratio for cesarean birth among
women with a higher BMI. A multidirectional arrow could be added between
intervention and outcomes since they seem to have a well-defined relationship.
Model Summary. This modified Quality Health Outcomes Model is appropriate
for explaining the observed relationships among the study variables. A few minor
changes are needed in the proposed model. Variables need to be added to the individual
characteristics as to better reflect the variables used for analysis within this study.
Overall, the QHOM explains the relationships between the observed client
characteristics, system characteristics, interventions and outcomes. This study showed
cervical ripening methods were used more frequently among women with obesity as
compared to normal weight women. The time to birth was increased among women using
PGE2 for cervical ripening and decreased for women using mechanical means as
compared to the use of misoprostol. Cesarean births were more common among women
with obesity as compared to normal weight women. Cesarean births were more common
after using PGE2 for cervical ripening than misoprostol. Cesarean births were less
common after using mechanical means for cervical ripening than the use of either
prostaglandin in women with obesity as compared to normal weight women.
Implications for Future Research
This study contained a cohort of women with healthy low-risk pregnancies.
Future research should include all women being induced, both high-risk and low-risk to
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see if the influences of BMI are similar in both groups of women. Many women with
high-risk pregnancies are induced for medical reasons, making this group just as
important to study. One way to do this would be to include all women in the sample and
look at all women being induced after 24 weeks (Suidan, Apuzzio, & Williams, 2012).
Maternal and fetal outcomes should be included along with gestational age for
comparison to the limited research available.
Additional secondary analysis is needed on the influences of race and insurance
status in relation to outcomes of induction methods used, time to birth and cesarean birth
rates. Additional analyses of the larger sample including high-risk women would give
researchers insight into induction of labor processes and outcomes for all women
including those needing pre-term and post-term induction of labor. This additional
research could potentially increase the effectiveness of labor induction for medical
indications. This study reported the use of private or public insurance whereas national
data report the number of births to married or unmarried women. Future research in the
data set should focus on using comparable variables to national outcomes. Closer
inspection of BMI and the difference between pregnancy BMI and BMI at the time of
hospital admission are warranted. Additionally, there are national data on pregnancy
weight gain which could be used for comparisons.
Multilevel modeling. Future analysis of this dataset using a multi-level model to
account for differences between the sites. Additional areas for secondary analysis could
include the racial disparities seen in cesarean section rates. It is important to understand if
minority women are being induced differently than the general population. The outcomes
for vulnerable women such as outcomes for ethnic and racial minority women and
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women who are using public health insurance due to disadvantaged socio-economic
status are also important to explore. If cesarean section rates are higher it could be
important for insurers, policy makers and other stake holders to understand the
differences in these cesarean birth rates.
Prospective studies are needed using standardized BMI categories, standardized
labor induction protocols, and a consistent definition of active labor. Women should be
included from all BMI categories to further our knowledge of timing and choice of
induction method on the processes and outcomes of labor induction. Future research is
needed on the effectiveness of individual methods as well as those used in combination.
Individualized labor induction plans or protocols should be created by the degree
of maternal obesity and the choice and timing of labor induction methods. An increased
understanding of labor initiation and outcomes among women with obesity could lead to
more effective individualized care for women in general and especially for women with
obesity.
Finally, additional bench research is needed to increase our understanding of the
metabolic shifts in women with obesity in general and especially at the time of birth. We
have an idea that the protein levels of leptin are altered at the time of birth and
prostaglandins levels are increased. It would be useful to develop a point of care test for
these altered levels to determine the most effective way to induce low-risk women with
obesity.
Conclusions
This study adds to the body of literature regarding the influences of BMI on
induction of labor in a cohort of healthy low-risk women. A combination of individual
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and system characteristics influence induction of labor requiring cervical ripening. These
study findings emphasize that maternal BMI influences both labor induction processes
and outcomes. Clinicians should take the responsibility to individualize care for women
with obesity and explain the altered physiology, longer time for labor induction in terms
that women and their labor support person can understand.
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